US20150013033A1 - Lignification reduction in plants - Google Patents
Lignification reduction in plants Download PDFInfo
- Publication number
- US20150013033A1 US20150013033A1 US14/232,018 US201214232018A US2015013033A1 US 20150013033 A1 US20150013033 A1 US 20150013033A1 US 201214232018 A US201214232018 A US 201214232018A US 2015013033 A1 US2015013033 A1 US 2015013033A1
- Authority
- US
- United States
- Prior art keywords
- plant
- hchl
- promoter
- plants
- lignin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009467 reduction Effects 0.000 title description 11
- 101710179178 Hydroxycinnamoyl-CoA hydratase-lyase Proteins 0.000 claims abstract description 223
- 230000014509 gene expression Effects 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 46
- 241000196324 Embryophyta Species 0.000 claims description 280
- 101000977762 Homo sapiens Iroquois-class homeodomain protein IRX-5 Proteins 0.000 claims description 125
- 102100023529 Iroquois-class homeodomain protein IRX-5 Human genes 0.000 claims description 124
- 210000002421 cell wall Anatomy 0.000 claims description 72
- 102000040430 polynucleotide Human genes 0.000 claims description 66
- 108091033319 polynucleotide Proteins 0.000 claims description 66
- 239000002157 polynucleotide Substances 0.000 claims description 66
- 239000002028 Biomass Substances 0.000 claims description 47
- 210000004027 cell Anatomy 0.000 claims description 36
- 241000219194 Arabidopsis Species 0.000 claims description 31
- 235000000346 sugar Nutrition 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 17
- 240000007594 Oryza sativa Species 0.000 claims description 15
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 101001009086 Pseudomonas fluorescens Hydroxycinnamoyl-CoA hydratase-lyase Proteins 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 150000008163 sugars Chemical class 0.000 claims description 11
- 244000061176 Nicotiana tabacum Species 0.000 claims description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 7
- 240000000111 Saccharum officinarum Species 0.000 claims description 7
- 244000062793 Sorghum vulgare Species 0.000 claims description 7
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 5
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 5
- 241000743774 Brachypodium Species 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 5
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 5
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 244000020551 Helianthus annuus Species 0.000 claims description 5
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 5
- 240000003433 Miscanthus floridulus Species 0.000 claims description 5
- 241001520808 Panicum virgatum Species 0.000 claims description 5
- 244000082204 Phyllostachys viridis Species 0.000 claims description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000219000 Populus Species 0.000 claims description 5
- 241000124033 Salix Species 0.000 claims description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 244000098338 Triticum aestivum Species 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 239000011425 bamboo Substances 0.000 claims description 5
- 235000009120 camo Nutrition 0.000 claims description 5
- 235000005607 chanvre indien Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 239000011487 hemp Substances 0.000 claims description 5
- 235000019713 millet Nutrition 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 241001233957 eudicotyledons Species 0.000 claims description 4
- 244000004281 Eucalyptus maculata Species 0.000 claims 2
- 240000004658 Medicago sativa Species 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 abstract description 7
- 229920005610 lignin Polymers 0.000 description 105
- 108090000623 proteins and genes Proteins 0.000 description 91
- 102000004169 proteins and genes Human genes 0.000 description 61
- 235000018102 proteins Nutrition 0.000 description 60
- 235000001014 amino acid Nutrition 0.000 description 42
- 229940024606 amino acid Drugs 0.000 description 41
- 150000001413 amino acids Chemical class 0.000 description 41
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 35
- 150000007523 nucleic acids Chemical class 0.000 description 34
- 235000013824 polyphenols Nutrition 0.000 description 34
- 238000004458 analytical method Methods 0.000 description 33
- 230000000694 effects Effects 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 29
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 102000039446 nucleic acids Human genes 0.000 description 27
- 108020004707 nucleic acids Proteins 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000000463 material Substances 0.000 description 24
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 22
- 230000009261 transgenic effect Effects 0.000 description 22
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 18
- -1 feruloyl-CoA thioester Chemical class 0.000 description 18
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 229910001868 water Inorganic materials 0.000 description 17
- 239000000178 monomer Substances 0.000 description 16
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000835 fiber Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 125000002293 monolignol group Chemical group 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 15
- 101710100170 Unknown protein Proteins 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 150000004676 glycans Chemical class 0.000 description 13
- 229930014251 monolignol Natural products 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 229920001282 polysaccharide Polymers 0.000 description 13
- 239000005017 polysaccharide Substances 0.000 description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 238000010186 staining Methods 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 12
- 238000013518 transcription Methods 0.000 description 12
- 230000035897 transcription Effects 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 11
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 11
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 101710142587 Short-chain dehydrogenase/reductase Proteins 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 238000001542 size-exclusion chromatography Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- GBXZVJQQDAJGSO-KBJLHTFASA-N Feruloyl-CoA Natural products S(C(=O)/C=C/c1cc(OC)c(O)cc1)CCNC(=O)CCNC(=O)[C@H](O)C(CO[P@@](=O)(O[P@](=O)(OC[C@@H]1[C@H](OP(=O)(O)O)[C@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C GBXZVJQQDAJGSO-KBJLHTFASA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 8
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 150000002772 monosaccharides Chemical class 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 108010081900 4-hydroxycinnamoyl-CoA hydratase-lyase Proteins 0.000 description 7
- 229920002488 Hemicellulose Polymers 0.000 description 7
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 238000010240 RT-PCR analysis Methods 0.000 description 7
- 108091023040 Transcription factor Proteins 0.000 description 7
- 102000040945 Transcription factor Human genes 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical class OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000007619 statistical method Methods 0.000 description 6
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 6
- QAPSNMNOIOSXSQ-YNEHKIRRSA-N 1-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)C1 QAPSNMNOIOSXSQ-YNEHKIRRSA-N 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 5
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- QHRGJMIMHCLHRG-FUEUKBNZSA-N caffeoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C=CC1=CC=C(O)C(O)=C1 QHRGJMIMHCLHRG-FUEUKBNZSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 230000007071 enzymatic hydrolysis Effects 0.000 description 5
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229930015704 phenylpropanoid Natural products 0.000 description 5
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 5
- GBXZVJQQDAJGSO-NBXNMEGSSA-N trans-feruloyl-CoA Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)OP(O)(O)=O)=C1 GBXZVJQQDAJGSO-NBXNMEGSSA-N 0.000 description 5
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 5
- 235000012141 vanillin Nutrition 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- XSSDYIMYZONMBL-UHFFFAOYSA-N 4-hydroxybenzoic acid 4-o-glucoside Chemical compound OC1C(O)C(O)C(CO)OC1OC1=CC=C(C(O)=O)C=C1 XSSDYIMYZONMBL-UHFFFAOYSA-N 0.000 description 4
- 102000003669 Antiporters Human genes 0.000 description 4
- 108090000084 Antiporters Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229930192334 Auxin Natural products 0.000 description 4
- 108010078791 Carrier Proteins Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- 102000005720 Glutathione transferase Human genes 0.000 description 4
- 101710152581 Glycine-rich protein 3 short isoform Proteins 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000589540 Pseudomonas fluorescens Species 0.000 description 4
- 102000004357 Transferases Human genes 0.000 description 4
- 108090000992 Transferases Proteins 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000002363 auxin Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000002551 biofuel Substances 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000002309 gasification Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 4
- 230000009758 senescence Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 108010084185 Cellulases Proteins 0.000 description 3
- 102000005575 Cellulases Human genes 0.000 description 3
- 241000218631 Coniferophyta Species 0.000 description 3
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 3
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 244000166124 Eucalyptus globulus Species 0.000 description 3
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101710180399 Glycine-rich protein Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 241000219823 Medicago Species 0.000 description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 3
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 3
- 101710128228 O-methyltransferase Proteins 0.000 description 3
- 101710204244 Processive diacylglycerol beta-glucosyltransferase Proteins 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 102100028262 U6 snRNA-associated Sm-like protein LSm4 Human genes 0.000 description 3
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 102000041082 aldo/keto reductase family Human genes 0.000 description 3
- 108091060803 aldo/keto reductase family Proteins 0.000 description 3
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- QNBLWPGKPNANOY-UHFFFAOYSA-N benzene-1,3,5-triol;hydrochloride Chemical compound Cl.OC1=CC(O)=CC(O)=C1 QNBLWPGKPNANOY-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 108010040093 cellulose synthase Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- DKZBBWMURDFHNE-NSCUHMNNSA-N coniferyl aldehyde Chemical compound COC1=CC(\C=C\C=O)=CC=C1O DKZBBWMURDFHNE-NSCUHMNNSA-N 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 235000019621 digestibility Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013861 fat-free Nutrition 0.000 description 3
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 3
- 239000004459 forage Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 230000001744 histochemical effect Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 101710093406 p-coumarate 3-hydroxylase Proteins 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000008121 plant development Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 3
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- DMZOKBALNZWDKI-MATMFAIHSA-N trans-4-coumaroyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)\C=C\C1=CC=C(O)C=C1 DMZOKBALNZWDKI-MATMFAIHSA-N 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 101710143241 12-oxophytodienoate reductase 1 Proteins 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- RRKMWVISRMWBAL-UHFFFAOYSA-N 3,4-dihydroxy-5-methoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(O)=C1O RRKMWVISRMWBAL-UHFFFAOYSA-N 0.000 description 2
- KWCCUYSXAYTNKA-UHFFFAOYSA-N 3-O-methylgallic acid Chemical compound COC1=CC(C(O)=O)=CC(O)=C1O KWCCUYSXAYTNKA-UHFFFAOYSA-N 0.000 description 2
- DMZOKBALNZWDKI-JBNLOVLYSA-N 4-Coumaroyl-CoA Natural products S(C(=O)/C=C/c1ccc(O)cc1)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@@](=O)(O[P@@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C DMZOKBALNZWDKI-JBNLOVLYSA-N 0.000 description 2
- 108010016192 4-coumarate-CoA ligase Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 108010084469 Aldo-Keto Reductases Proteins 0.000 description 2
- 102000005602 Aldo-Keto Reductases Human genes 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 101000762164 Arabidopsis thaliana Cytochrome P450 84A1 Proteins 0.000 description 2
- 101000813249 Arabidopsis thaliana Expansin-B3 Proteins 0.000 description 2
- 101100281118 Arabidopsis thaliana FLA9 gene Proteins 0.000 description 2
- 101001068308 Arabidopsis thaliana Glutathione S-transferase U1 Proteins 0.000 description 2
- 101001026145 Arabidopsis thaliana Glutathione S-transferase U19 Proteins 0.000 description 2
- 101100025351 Arabidopsis thaliana MYB46 gene Proteins 0.000 description 2
- 101100132355 Arabidopsis thaliana MYB63 gene Proteins 0.000 description 2
- 101000615922 Arabidopsis thaliana Mitogen-activated protein kinase kinase 9 Proteins 0.000 description 2
- 101001030383 Arabidopsis thaliana NAC transcription factor 32 Proteins 0.000 description 2
- 101001060422 Arabidopsis thaliana Protein QQS Proteins 0.000 description 2
- 101100483365 Arabidopsis thaliana UGT73B4 gene Proteins 0.000 description 2
- 101100427141 Arabidopsis thaliana UGT75B1 gene Proteins 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 101710195293 Beta-galactosidase 2 Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- 108010067661 Caffeate O-methyltransferase Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010024679 Coniferyl-alcohol dehydrogenase Proteins 0.000 description 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- 102100027887 Deaminated glutathione amidase Human genes 0.000 description 2
- 108020005199 Dehydrogenases Proteins 0.000 description 2
- 101710116650 FAD-dependent monooxygenase Proteins 0.000 description 2
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 108010056771 Glucosidases Proteins 0.000 description 2
- 102000004366 Glucosidases Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 101000617805 Homo sapiens Staphylococcal nuclease domain-containing protein 1 Proteins 0.000 description 2
- 108030003368 Hydroxycinnamoyl-CoA reductases Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 101150079105 MYB58 gene Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 101710092624 NAC domain-containing protein 102 Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108010033272 Nitrilase Proteins 0.000 description 2
- 101710089010 Organic cation/carnitine transporter 5 Proteins 0.000 description 2
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 2
- 108010081996 Photosystem I Protein Complex Proteins 0.000 description 2
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 101710097810 Polyol transporter 5 Proteins 0.000 description 2
- 101710140185 Receptor-like protein kinase Proteins 0.000 description 2
- 108091007187 Reductases Proteins 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- UZMZQIZIJQTHDK-VXAHOBLNSA-N S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-hydroxy-3-phenylprop-2-enethioate Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C(O)=CC1=CC=CC=C1 UZMZQIZIJQTHDK-VXAHOBLNSA-N 0.000 description 2
- 102100021996 Staphylococcal nuclease domain-containing protein 1 Human genes 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108010036937 Trans-cinnamate 4-monooxygenase Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 108010035812 caffeoyl-CoA O-methyltransferase Proteins 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000001461 cytolytic effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004665 defense response Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000007824 enzymatic assay Methods 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 2
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002029 lignocellulosic biomass Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 230000004983 pleiotropic effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000004537 pulping Methods 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 102000004314 ribosomal protein S14 Human genes 0.000 description 2
- 108090000850 ribosomal protein S14 Proteins 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LUOAEJWSKPQLJD-UHFFFAOYSA-N syringyl alcohol Chemical compound COC1=CC(CO)=CC(OC)=C1O LUOAEJWSKPQLJD-UHFFFAOYSA-N 0.000 description 2
- 108010026424 tau Proteins Proteins 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- DKZBBWMURDFHNE-UHFFFAOYSA-N trans-coniferylaldehyde Natural products COC1=CC(C=CC=O)=CC=C1O DKZBBWMURDFHNE-UHFFFAOYSA-N 0.000 description 2
- LZFOPEXOUVTGJS-ONEGZZNKSA-N trans-sinapyl alcohol Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O LZFOPEXOUVTGJS-ONEGZZNKSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- TZJZQIWWEAFXLF-ASEORRQLSA-N (2S,3R,4R,5R)-2-bromo-3-chloro-2,3,4,5-tetrahydroxy-4-(1H-indol-2-yl)-6-oxohexanoic acid Chemical compound Br[C@@]([C@]([C@@]([C@H](C=O)O)(O)C=1NC2=CC=CC=C2C1)(O)Cl)(O)C(=O)O TZJZQIWWEAFXLF-ASEORRQLSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 108010058022 12-oxophytodienoate reductase Proteins 0.000 description 1
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 1
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 1
- QSZQTGNYQLNKAQ-UHFFFAOYSA-N 2-hydroxy-3-phenylprop-2-enal Chemical group O=CC(O)=CC1=CC=CC=C1 QSZQTGNYQLNKAQ-UHFFFAOYSA-N 0.000 description 1
- YTKKDFTVSNSVEE-TYHXJLICSA-N 2-hydroxybenzoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C1=CC=CC=C1O YTKKDFTVSNSVEE-TYHXJLICSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-M 3,4-dihydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1O YQUVCSBJEUQKSH-UHFFFAOYSA-M 0.000 description 1
- HNVRRHSXBLFLIG-UHFFFAOYSA-N 3-hydroxy-3-methylbut-1-ene Chemical compound CC(C)(O)C=C HNVRRHSXBLFLIG-UHFFFAOYSA-N 0.000 description 1
- DMZOKBALNZWDKI-FUEUKBNZSA-N 4-coumaroyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C=CC1=CC=C(O)C=C1 DMZOKBALNZWDKI-FUEUKBNZSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- IEHPLRVWOHZKCS-UHFFFAOYSA-N 5-hydroxyconiferyl aldehyde Natural products COC1=CC(C=CC=O)=CC(O)=C1O IEHPLRVWOHZKCS-UHFFFAOYSA-N 0.000 description 1
- 101710108158 ATP synthase epsilon chain Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100215796 Arabidopsis thaliana AKR4C9 gene Proteins 0.000 description 1
- 101000729838 Arabidopsis thaliana Beta-1,3-galactosyltransferase GALT1 Proteins 0.000 description 1
- 101100165785 Arabidopsis thaliana CYP704B1 gene Proteins 0.000 description 1
- 101100121331 Arabidopsis thaliana GAUT12 gene Proteins 0.000 description 1
- 101001026158 Arabidopsis thaliana Glutathione S-transferase U7 Proteins 0.000 description 1
- 101100179978 Arabidopsis thaliana IRX10 gene Proteins 0.000 description 1
- 101100074137 Arabidopsis thaliana IRX12 gene Proteins 0.000 description 1
- 101100132367 Arabidopsis thaliana MYB80 gene Proteins 0.000 description 1
- 101100132370 Arabidopsis thaliana MYB83 gene Proteins 0.000 description 1
- 101100403794 Arabidopsis thaliana NAC002 gene Proteins 0.000 description 1
- 101100239718 Arabidopsis thaliana NAC012 gene Proteins 0.000 description 1
- 101100155005 Arabidopsis thaliana UGT72B1 gene Proteins 0.000 description 1
- 101100483362 Arabidopsis thaliana UGT73B1 gene Proteins 0.000 description 1
- 101100483364 Arabidopsis thaliana UGT73B3 gene Proteins 0.000 description 1
- 101100427146 Arabidopsis thaliana UGT76B1 gene Proteins 0.000 description 1
- 101100540949 Arabidopsis thaliana XERO2 gene Proteins 0.000 description 1
- 101100429155 Arabidopsis thaliana XTH4 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 101000984031 Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) Cytochrome P450 monooxygenase lnaD Proteins 0.000 description 1
- 101150083009 BGLU11 gene Proteins 0.000 description 1
- 101500000959 Bacillus anthracis Protective antigen PA-20 Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
- 101150041564 CAX3 gene Proteins 0.000 description 1
- 101150053502 CESA4 gene Proteins 0.000 description 1
- 108010047695 Ca2+-binding protein-1 Proteins 0.000 description 1
- 101100328886 Caenorhabditis elegans col-2 gene Proteins 0.000 description 1
- 101100067708 Caenorhabditis elegans galt-1 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 101100226898 Candida albicans (strain SC5314 / ATCC MYA-2876) FCA1 gene Proteins 0.000 description 1
- 108010061190 Cinnamyl-alcohol dehydrogenase Proteins 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 101150107638 DHAR2 gene Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 229940124143 Endopeptidase inhibitor Drugs 0.000 description 1
- 108010023922 Enoyl-CoA hydratase Proteins 0.000 description 1
- 102000011426 Enoyl-CoA hydratase Human genes 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108090000038 Glutathione dehydrogenase (ascorbate) Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 102100036753 Glutathione peroxidase 6 Human genes 0.000 description 1
- 101710119058 Glutathione peroxidase 6 Proteins 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 102100031497 Heparan sulfate N-sulfotransferase 1 Human genes 0.000 description 1
- 102100031496 Heparan sulfate N-sulfotransferase 2 Human genes 0.000 description 1
- 101800002189 Hevein Proteins 0.000 description 1
- 101000632167 Homo sapiens Deaminated glutathione amidase Proteins 0.000 description 1
- 101000588589 Homo sapiens Heparan sulfate N-sulfotransferase 1 Proteins 0.000 description 1
- 101000588595 Homo sapiens Heparan sulfate N-sulfotransferase 2 Proteins 0.000 description 1
- 101001053444 Homo sapiens Iroquois-class homeodomain protein IRX-1 Proteins 0.000 description 1
- 101001053430 Homo sapiens Iroquois-class homeodomain protein IRX-3 Proteins 0.000 description 1
- 101000977692 Homo sapiens Iroquois-class homeodomain protein IRX-6 Proteins 0.000 description 1
- 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 1
- 101000996087 Homo sapiens Omega-amidase NIT2 Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 101150054536 IRX14 gene Proteins 0.000 description 1
- 101150061769 IRX9 gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- 102100024374 Iroquois-class homeodomain protein IRX-3 Human genes 0.000 description 1
- 102100023527 Iroquois-class homeodomain protein IRX-6 Human genes 0.000 description 1
- 241000221089 Jatropha Species 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101150064308 LAC17 gene Proteins 0.000 description 1
- 101150022713 LAC4 gene Proteins 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 101000715941 Mus musculus Cyclin-dependent kinase 4 Proteins 0.000 description 1
- 101000775238 Myceliophthora thermophila (strain ATCC 42464 / BCRC 31852 / DSM 1799) ADP/ATP translocase Proteins 0.000 description 1
- 101710137445 NAC domain-containing protein 2 Proteins 0.000 description 1
- 101150070935 NIA2 gene Proteins 0.000 description 1
- 108091008747 NR2F3 Proteins 0.000 description 1
- 101000996085 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) Nitrogen catabolic enzyme regulatory protein Proteins 0.000 description 1
- 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 102100034446 Omega-amidase NIT2 Human genes 0.000 description 1
- 102000017356 Ornithine cyclodeaminase/mu-crystallin Human genes 0.000 description 1
- 108050005396 Ornithine cyclodeaminase/mu-crystallin Proteins 0.000 description 1
- 101150072055 PAL1 gene Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 101150009729 Pal2 gene Proteins 0.000 description 1
- 102000005327 Palmitoyl protein thioesterase Human genes 0.000 description 1
- 108020002591 Palmitoyl protein thioesterase Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 101710181100 Phenolic glucoside malonyltransferase 1 Proteins 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 101000904094 Pinus pinaster Antifungal protein ginkbilobin-like protein Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108010030975 Polyketide Synthases Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000012500 Proto-Oncogene Proteins c-crk Human genes 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 101150051586 RIM21 gene Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 238000001237 Raman spectrum Methods 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 108700039010 SET domains Proteins 0.000 description 1
- 102000051614 SET domains Human genes 0.000 description 1
- 101100192827 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PXA1 gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 102000003673 Symporters Human genes 0.000 description 1
- 108090000088 Symporters Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- PGLIMMMHQDNVRS-YZQQHVNFSA-N [(e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enyl] (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 PGLIMMMHQDNVRS-YZQQHVNFSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical group OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 102000021178 chitin binding proteins Human genes 0.000 description 1
- 108091011157 chitin binding proteins Proteins 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- LZFOPEXOUVTGJS-UHFFFAOYSA-N cis-sinapyl alcohol Natural products COC1=CC(C=CCO)=CC(OC)=C1O LZFOPEXOUVTGJS-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- PGLIMMMHQDNVRS-UHFFFAOYSA-N coniferyl ferulate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 PGLIMMMHQDNVRS-UHFFFAOYSA-N 0.000 description 1
- 230000006552 constitutive activation Effects 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- WBCMGDNFDRNGGZ-ACNVUDSMSA-N coumarate Natural products COC(=O)C1=CO[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3[C@@H]1C=C[C@]34OC(=O)C(=C4)[C@H](C)OC(=O)C=Cc5ccc(O)cc5 WBCMGDNFDRNGGZ-ACNVUDSMSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 108010057167 dimethylaniline monooxygenase (N-oxide forming) Proteins 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940114123 ferulate Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 108091000285 heat shock protein binding proteins Proteins 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- WKMZPSWMEXVKKG-XITFREQTSA-N hevein Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CS)C(=O)NCC(=O)OC(=O)CC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CNC2=CC=CC=C12 WKMZPSWMEXVKKG-XITFREQTSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 229930005346 hydroxycinnamic acid Natural products 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N hydroxycinnamic acid group Chemical class OC(C(=O)O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 235000010359 hydroxycinnamic acids Nutrition 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000004901 leucine-rich repeat Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 108010003007 mannose isomerase Proteins 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 230000001431 metabolomic effect Effects 0.000 description 1
- 238000006198 methoxylation reaction Methods 0.000 description 1
- VBPSVYDSYVJIPX-UHFFFAOYSA-N methylbutenol Natural products CCC=C(C)O VBPSVYDSYVJIPX-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 101150077062 pal gene Proteins 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000010149 post-hoc-test Methods 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 108010048762 protochlorophyllide reductase Proteins 0.000 description 1
- 108010087864 purine permease Proteins 0.000 description 1
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- DBFZTJWNUVVQPZ-TYHXJLICSA-N s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3,4-dihydroxybenzenecarbothioate Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C1=CC=C(O)C(O)=C1 DBFZTJWNUVVQPZ-TYHXJLICSA-N 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000006574 secondary cell wall biogenesis Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- RBFUWESMWRUGFY-GSNIOFLCSA-N sinapoyl-CoA Chemical compound COC1=C(O)C(OC)=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)OP(O)(O)=O)=C1 RBFUWESMWRUGFY-GSNIOFLCSA-N 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 101150014665 tolB gene Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108020005087 unfolded proteins Proteins 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000026338 vacuolar sequestering Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 108010069678 xyloglucan endotransglycosylase Proteins 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01101—Trans-feruloyl-CoA hydratase (4.2.1.101)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- Lignocellulosic plant biomass is utilized as a renewable feedstock in various agro-industrial activities.
- Lignin is an aromatic and hydrophobic branched polymer incrusted within biomass that negatively affects extraction and hydrolysis of polysaccharides during industrial processes.
- Engineering the monomer composition of lignin offers attractive potential for reducing its recalcitrance.
- the present invention offers a new strategy developed in Arabidopsis for the overproduction of rare lignin monomers, which incorporate as end-groups in the polymer and reduce lignin chain extension.
- Biosynthesis of these lignification stoppers' is achieved by expressing a bacterial hydroxycinnamoyl-CoA hydratase-lyase (HCHL) in lignifying tissues of Arabidopsis inflorescence stems.
- HCHL cleaves the propanoid side chain of hydroxycinnamoyl-CoA lignin precursors to produce the corresponding hydroxybenzaldehydes.
- Stems from plants that express HCHL accumulate higher amount of hydroxybenzaldehyde and hydroxybenzoate derivates compared to wild type plants.
- Part of these C 6 C 1 phenolics are alcohol-extractable from plant tissues and are released from extract-free cell walls upon mild alkaline hydrolysis.
- Engineered plants with intermediate HCHL activity level show no reduction of total lignin, sugar content and biomass yield compared to wild type plants.
- cell wall characterization by 2D-NMR reveals the presence of new molecules in the aromatic region and the analysis of lignin isolated from these plants revealed an increased amount of C 6 C 1 phenolic end-groups and a reduced molecular mass distribution.
- these engineered lines show saccharification improvement of pretreated cell wall biomass. Enhancing the incorporation of C 6 C 1 phenolic end-groups in lignin represents a promising strategy to alter lignin structure and reduce cell wall recalcitrance to enzymatic hydrolysis.
- the present invention provides an isolated expression cassette comprising a polynucleotide sequence encoding a hydroxycinnamoyl-CoA hydratase-lyase (HCHL) and a heterologous promoter, and the promoter is operably linked to the polynucleotide sequence.
- the HCHL is Pseudomonas fluorescens HCHL, which has the amino acid sequence set forth in SEQ ID NO:1.
- the promoter used in this expression cassette is a secondary cell wall specific promoter, such as pIRX5, which is within the polynucleotide sequence set forth in SEQ ID NO:3.
- the present invention provides a method for engineering a plant having reduced lignification.
- the method includes these steps: (1) introducing the expression cassette described herein into the plant; and (2) culturing the plant under conditions under which the HCHL is expressed, thereby reducing lignification in the plant.
- the plant is selected from the group consisting of Arabidopsis , poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, and Brachypodium.
- the present invention provides a plant that is engineered by the methods described herein, and a plant cell from such a plant, a seed, flower, leaf, or fruit from such a plant, a plant cell that contains the expression cassette described herein, and biomass comprising plant tissue from the plant or part of the plant described herein.
- the invention provides an engineered plant comprising a heterologous hydroxycinnamoyl-CoA hydratase-lyase (HCHL) operably linked to a promoter.
- HCHL hydroxycinnamoyl-CoA hydratase-lyase
- the polynucleotide encoding the heterologous HCHL is integrated into a plant genome.
- the promoter is heterologous to the plant.
- the promoter is an endogenous promoter. In some embodiment, the promoter is a secondary cell wall-specific promoter, such as an IRX5 promoter. In some embodiments, the HCHL is Pseudomonas fluorescens HCHL.
- the plant may be a monocot or a dicot. In some embodiments, the plant is selected from the group consisting of Arabidopsis , poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, and Brachypodium.
- the invention provide methods of using an engineered plant of the invention, or parts of the plant, or plant biomass comprising material from the plant.
- plant material is used in a saccharificatoni reaction, e.g., enzymatic saccharification, to generate soluble sugars at an increased level of efficiency as compared to wild-type plants that have not been modified to express HCHL.
- the plants, parts of plants, or plant biomass material are used to increase biomass yield or simplify downstream processing for wood industries (such as paper, pulping, and construction) as compared to wild-type plants.
- the plants, parts of plants, or plant biomass material are used to increase the quality of wood for construction purposes.
- the plants, parts of plants, or plant biomass material can be used in a combustion reaction, gasification, pyrolysis, or polysaccharide hydrolysis (enzymatic or chemical).
- the plants, plant parts, or plant biomass material are used as forage that is more readily digested compared to wild-type plants.
- FIG. 1 HCHL-mediated conversion of hydroxycinnamoyl-CoAs into hydroxybenzaldehydes.
- FIG. 2 Analysis of HCHL expression in IRX5:HCHL lines.
- A Detection by RT-PCR of HCHL transcripts using mRNA isolated from secondary stems of five independent five-week-old transformants in the T1 generation. cDNA synthesized from mRNA purified from wild type (WT) stems were used as a negative control. Tub8-specific primers were used to assess cDNA quality for each sample.
- B Detection by western blot of HCHL tagged with the AttB2 peptide (approximate size 32 kDa) using the universal antibody and 5 ⁇ g of total protein extracted from the primary stem of five independent five-week-old IRX5:HCHL transformants in the T2 generation. A protein extract from wild type stems (WT) was used as a negative control.
- FIG. 3 Histochemical staining of stem sections from five-week-old Arabidopsis plants.
- A Frenchule staining.
- B Phloroglucinol-HCl staining.
- C Toluidine blue O staining. i, interfascicular fibers; x, xylem. Bars represent 50 ⁇ m for (A) and (B), and 20 ⁇ m for (C). Note the collapsed xylem vessels (yellow arrows) observed for line IRX5:HCHL (4).
- FIG. 4 Spectral analysis of IRX5:HCHL and wild type plants.
- A Lignin and polysaccharide content in CWR of mature senesced stems from wild type (WT) and line IRX5:HCHL (2) using FT-Raman spectroscopy. Values represent integrated intensities over the range of 1555-1690 cm ⁇ 1 and 1010-1178 cm ⁇ 1 for lignin and polysaccharides (cellulose/hemicellulose) quantification, respectively. Values are means of three biological replicates ⁇ SE.
- FIG. 5 2D-HSQC NMR spectra analysis of line IRX5:HCHL plants.
- FIG. 6 Polydispersity profiles of CEL lignin purified from stems of wild type and line IRX:HCHL (2) plants. SEC chromatograms were obtained using (A) UV-A 300 absorbance and (B) UV-F ex250/em450 fluorescence.
- FIG. 7 Saccharification of biomass from mature senesced stems of IRX5:HCHL and wild type plants. Amount of reducing sugars released from 10 mg of biomass after hot water, dilute alkaline, or dilute acid pretreatment followed by 72-h enzymatic hydrolysis were measured using the DNS assay. Values are means of four biological replicates ⁇ SE.
- FIG. 8 Alignment of amino acid sequences of Pseudomonas fluorescens HCHL (SEQ ID NO:1) and other homologous proteins.
- FIG. 9 Organ and tissue-specific activity of the IRX5 promoter in Arabidopsis .
- Line CS70758 which contains a pIRX5:GUS expression cassette, was used to localize the activity of the IRX5 promoter.
- Young seedlings (A and B), rosettes leaves (C and D), siliques (E and F), cauline leaves (G and H), flowers (I and J), and inflorescence stems (K and L) were incubated in the GUS assay buffer for 1 h and 8 h at 37° C. Gus activity was essentially detected in the stem xylem vessels after a 1-h incubation (K).
- FIG. 10 Growth and development of IRX5:HCHL and wild type (WT) plants at different stages.
- A Three-week-old rosette
- B Five-week-old flowering stage.
- C Eight-week-old senescing stage.
- FIG. 11 Synthesis of C 6 C 1 phenolics production upon HCHL activity and probable associated enzymes.
- the phenylpropanoid pathway (center box) and monolignol pathway (left box) are represented.
- HCHL converts hydroxycinnamoyl-CoAs into their corresponding hydroxybenzaldehydes.
- Metabolomic data showed occurrence of hydroxycinnamic acids and alcohols, suggesting involvement of aldehyde dehydrogenases (DH) and reductases (left box).
- UDP-glucosyltransferases (UGT) are responsible for the formation of C6-C1 phenolic glucose conjugates.
- Syringaldehyde is possibly derived from vanillin and 5OH-vanillin after successive monooxyenase (Monox) and O-methyltransferase activities (OMT). Asterisks indicate compounds found in higher amount in lignin of Arabidopsis expressing HCHL.
- enzymes are: PAL, phenylalanine ammonia lyase; C4H, cinnamate 4-hydroxylase; 4CL, 4-coumarate-CoA ligase; CCR, hydroxycinnamoyl-CoA reductase; CAD, coniferyl alcohol dehydrogenase; HCT, p-hydroxycinnamoyl-CoA:quinate shikimate p-hydroxycinnamoyl-CoA transferase; C3H, p-coumarate 3-hydroxylase; CCoAOMT, caffeoyl-CoA O-methyltransferase; FSH, ferulate 5-hydroxylase (coniferaldehyde 5-hydroxylase); COMT, caffeic acid/5-hydroxyferulic acid O-methyltransferase.
- PAL phenylalanine ammonia lyase
- C4H cinnamate 4-hydroxylase
- 4CL 4-coumarate-CoA ligase
- FIG. 12 Transgenic rice lines that express pAtIRX5::HCHL.
- FIG. 13 Expression analysis of HCHL in the engineered rice lines. Results of an RT-PCR using RNA extracted from rice plants and HCHL-specific primers.
- FIG. 14 Detection of pHBA in stems from the engineered rice lines.
- hydroxycinnamoyl-CoA hydratase-lyase refers to an enzyme that catalyzes the hydration of the double bond of lignin precursor p-coumaroy-CoA, caffeoyl-CoA, or feruloyl-CoA thioester, which is followed by a retro aldol cleavage reaction to produce a corresponding C 6 C 1 hydroxylbenzaldehyde and acetyl-CoA.
- a typical HCHL within the meaning of this invention is an HCHL from bacterium Pseudomonas fluorescens (EC 4.2.1.101-trans-feruloyl-CoA hydratase), which has the amino acid sequence set forth in FIG. 11 as SEQ ID NO:1 (GenBank Accession No. CAA73502), encoded by cDNA sequence set forth in GenBank Accession No. Y13067.1 or by a codon-optimized polynucleotide sequence set forth in SEQ ID NO:2 (synthesized by GenScript, Piscatway, N.J.).
- HCHL includes polymorphic variants, alleles, mutants, and interspecies homologs to the Pseudomonas fluorescens HCHL, some examples of which are provided in FIG. 8 .
- a nucleic acid that encodes an HCHL refers to a gene, pre-mRNA, mRNA, and the like, including nucleic acids encoding polymorphic variants, alleles, mutants, and interspecies homologs of the particular sequences described herein.
- an HCHL nucleic acid (1) has a polynucleotide sequence that has greater than about 50% nucleotide sequence identity, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or higher nucleotide sequence identity, preferably over a region of at least about 10, 15, 20, 25, 50, 100, 200, 500 or more nucleotides or over the length of the entire polynucleotide, to a polynucleotide sequence encoding SEQ ID NO:1 (e.g., SEQ ID NO:2 or the polynucleotide sequence set forth in Y13067.1); or (2) encodes a polypeptide having an amino acid sequence that has greater than about 50% amino acid sequence identity, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%,
- substantially localized when used in the context of describing a plant expressing an exogenous HCHL that is substantially localized to a particular tissue, refers to the enzymatic activity and modified monolignols produced therefore in substantially higher amounts in the particular cell or tissue type of interest as compared to other cell or tissue types.
- the presence of HCHL and modified monolignols is substantially localized to the secondary cell wall of a plant cell and in the stem of a plant.
- polynucleotide and “nucleic acid” are used interchangeably and refer to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5′ to the 3′ end.
- a nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, nucleic acid analogs may be used that may have alternate backbones, comprising, e.g., phosphoramidate, phosphorothioate, phosphorodithioate, or O-methylphosphoroamidite linkages (see Eckstein, Oligonucleotides and Analogues: A Practical Approach, Oxford University Press); positive backbones; non-ionic backbones, and non-ribose backbones.
- nucleic acids or polynucleotides may also include modified nucleotides that permit correct read-through by a polymerase.
- Polynucleotide sequence” or “nucleic acid sequence” includes both the sense and antisense strands of a nucleic acid as either individual single strands or in a duplex. As will be appreciated by those in the art, the depiction of a single strand also defines the sequence of the complementary strand; thus the sequences described herein also provide the complement of the sequence. Unless otherwise indicated, a particular nucleic acid sequence also implicitly encompasses variants thereof (e.g., degenerate codon substitutions) and complementary sequences, as well as the sequence explicitly indicated.
- the nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid may contain combinations of deoxyribo- and ribo-nucleotides, and combinations of bases, including uracil, adenine, thymine, cytosine, guanine, inosine, xanthine hypoxanthine, isocytosine, isoguanine, etc.
- substantially identical used in the context of two nucleic acids or polypeptides, refers to a sequence that has at least 50% sequence identity with a reference sequence. Percent identity can be any integer from 50% to 100%. Some embodiments include at least: 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, compared to a reference sequence using the programs described herein; preferably BLAST using standard parameters, as described below.
- an HCHL may have an amino acid sequence that is at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:1, the amino acid sequence of Pseudomonas fluorescens HCHL.
- nucleic acid sequences or polypeptide sequences are said to be “identical” if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below.
- the terms “identical” or percent “identity,” in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection.
- sequence identity When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity.
- a conservative substitution is given a score between zero and 1.
- the scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers & Miller, Computer Applic. Biol. Sci. 4:11-17 (1988) e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif., USA).
- sequence comparison typically one sequence acts as a reference sequence, to which test sequences are compared.
- test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated.
- sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.
- a “comparison window,” as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.
- Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol.
- These initial neighborhood word hits acts as seeds for initiating searches to find longer HSPs containing them.
- the word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatching residues; always ⁇ 0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached.
- the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
- the BLASTP program uses as defaults a word size (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)).
- the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993)).
- One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
- P(N) the smallest sum probability
- a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.01, more preferably less than about 10 5 , and most preferably less than about 10.
- Nucleic acid or protein sequences that are substantially identical to a reference sequence include “conservatively modified variants.” With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode any given protein. For instance, the codons GCA, GCC, GCG and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded polypeptide.
- nucleic acid variations are “silent variations,” which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes every possible silent variation of the nucleic acid.
- each codon in a nucleic acid except AUG, which is ordinarily the only codon for methionine
- each silent variation of a nucleic acid which encodes a polypeptide is implicit in each described sequence.
- amino acid sequences one of skill will recognize that individual substitutions, in a nucleic acid, peptide, polypeptide, or protein sequence which alters a single amino acid or a small percentage of amino acids in the encoded sequence is a “conservatively modified variant” where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art.
- nucleotide sequences are substantially identical if two molecules hybridize to each other, or a third nucleic acid, under stringent conditions.
- Stringent conditions are sequence dependent and will be different in different circumstances. Generally, stringent conditions are selected to be about 5° C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe.
- stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60° C.
- stringent conditions for hybridization such as RNA-DNA hybridizations in a blotting technique are those which include at least one wash in 0.2 ⁇ SSC at 55° C. for 20 minutes, or equivalent conditions.
- promoter refers to a polynucleotide sequence capable of driving transcription of a DNA sequence in a cell.
- promoters used in the polynucleotide constructs of the invention include cis- and trans-acting transcriptional control elements, translational control elements (5′UTR: untranslated region) and regulatory sequences that are involved in regulating or modulating the timing and/or rate of transcription of a gene.
- a promoter can be a cis-acting transcriptional control element, including an enhancer, a promoter, a transcription terminator, an origin of replication, a chromosomal integration sequence, 5′ and 3′ untranslated regions, or an intronic or exonic sequence, which are involved in transcriptional regulation.
- Promoters are located 5′ to the transcribed gene, and as used herein, include the sequence 5′ from the translation start codon (i.e., including the 5′ untranslated region of the mRNA, typically comprising 50-200 bp). Most often the core promoter sequences lie within 1-3 kb of the translation start site, more often within 1 kbp and often within 500 bp of the translation start site. By convention, the promoter sequence is usually provided as the sequence on the coding strand of the gene it controls.
- a “constitutive promoter” is one that is capable of initiating transcription in nearly all cell types, whereas a “cell type-specific promoter” initiates transcription only in one or a few particular cell types or groups of cells forming a tissue.
- the promoter is secondary cell wall specific. Secondary cell wall is mainly composed of cellulose, hemicellulose, and lignin and is deposited in some, but not all, tissues of a plant, such as woody tissue.
- a “secondary cell wall specific” promoter refers to a promoter that initiates higher levels of transcription in cell types that have secondary cell walls, e.g., lignified tissues such as vessels and fibers, which may be found in wood and bark cells of a tree, as well as other parts of plants such as the leaf stalk.
- a promoter is secondary cell wall specific if the transcription levels initiated by the promoter in secondary cell walls are at least 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 50-fold, 100-fold, 500-fold, 1000-fold higher or more as compared to the transcription levels initiated by the promoter in other tissues, resulting in the encoded protein substantially localized in plant cells that possess secondary cell wall, e.g., the stem of a plant.
- Non-limiting examples of secondary cell wall specific promoters include the promoters directing expression of genes IRX1, IRX3, IRX5, IRX7, IRX8, IRX9, IRX10, IRX14, NST1, NST2, NST3, MYB46, MYB58, MYB63, MYB83, MYB85, MYB103, PAL1, PAL2, C3H, CcOAMT, CCR1, F5H, LAC4, LAC17, CADc, and CADd.
- the promoter is substantially identical to the native promoter sequence directing expression of the IRX5 gene (see, e.g., the promoter and transcriptional regulatory elements for IRX5 are contained in SEQ ID NO:3).
- the promoter and transcriptional regulatory elements for IRX5 are contained in SEQ ID NO:3.
- Some of the above mentioned secondary cell wall promoter sequences can be found within the polynucleotide sequences provided herein as SEQ ID NOs:36-61.
- a promoter originated from one plant species may be used to direct gene expression in another plant species.
- a polynucleotide is “heterologous” to an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form.
- a polynucleotide encoding a polypeptide sequence is said to be operably linked to a heterologous promoter, it means that the polynucleotide sequence encoding the polypeptide is derived from one species whereas the promoter sequence is derived from another, different species; or, if both are derived from the same species, the coding sequence is not naturally associated with the promoter (e.g., is a genetically engineered coding sequence, e.g., from a different gene in the same species, or an allele from a different ecotype or variety).
- operably linked refers to a functional relationship between two or more polynucleotide (e.g., DNA) segments. Typically, it refers to the functional relationship of a transcriptional regulatory sequence to a transcribed sequence.
- a promoter or enhancer sequence is operably linked to a DNA or RNA sequence if it stimulates or modulates the transcription of the DNA or RNA sequence in an appropriate host cell or other expression system.
- promoter transcriptional regulatory sequences that are operably linked to a transcribed sequence are physically contiguous to the transcribed sequence, i.e., they are cis-acting.
- some transcriptional regulatory sequences, such as enhancers need not be physically contiguous or located in close proximity to the coding sequences whose transcription they enhance.
- expression cassette refers to a nucleic acid construct that, when introduced into a host cell, results in transcription and/or translation of an RNA or polypeptide, respectively. Antisense or sense constructs that are not or cannot be translated are expressly included by this definition. In the case of both expression of transgenes and suppression of endogenous genes (e.g., by antisense, RNAi, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only substantially identical to a sequence of the gene from which it was derived. As explained herein, these substantially identical variants are specifically covered by reference to a specific nucleic acid sequence.
- an expression cassette is a polynucleotide construct that comprises a polynucleotide sequence encoding a HCHL protein operably linked to a promoter that is heterologous to the plant cell into which the expression cassette may be introduced.
- an expression cassette comprises a polynucleotide sequence encoding a HCHL protein that is targeted to a position in the genome of a plant such that expression of the HCHL polynucleotide sequence is driven by a promoter that is present in the plant.
- plant refers to whole plants and includes plants of a variety of a ploidy levels, including aneuploid, polyploid, diploid and haploid.
- plant part refers to shoot vegetative organs and/or structures (e.g., leaves, stems and tubers), branches, roots, flowers and floral organs (e.g., bracts, sepals, petals, stamens, carpels, anthers), ovules (including egg and central cells), seed (including zygote, embryo, endosperm, and seed coat), fruit (e.g., the mature ovary), seedlings, and plant tissue (e.g., vascular tissue, ground tissue, and the like), as well as individual plant cells, groups of plant cells (e.g., cultured plant cells), protoplasts, plant extracts, and seeds.
- plant tissue e.g., vascular tissue, ground tissue, and the like
- the class of plants that can be used in the methods of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, and multicellular algae.
- biomass refers to plant material that is processed to provide a product, e.g., a biofuel such as ethanol, or livestock feed, or a cellulose for paper and pulp industry products.
- a product e.g., a biofuel such as ethanol, or livestock feed, or a cellulose for paper and pulp industry products.
- plant material can include whole plants, or parts of plants, e.g., stems, leaves, branches, shoots, roots, tubers, and the like.
- reduced lignification encompasses both reduced size of a lignin polymer, e.g., a shorter lignin polymer chain due to a smaller number of monolignols being incorporated into the polymer, a reduced degree of branching of the lignin polymer or a reduced space filling (also called a reduced pervaded volume).
- a reduced lignin polymer can be shown by detecting a decrease in it molecular weight or a decrease in the number of monolignols by at least 2%, 5%, 10%, 20%, 25%, 30%, 40%, 50%, or more, when compared to the average lignin molecule in a control plant. Methods for detecting reduced lignification are described in detail in the example section of this application.
- Plant cell walls are constituted by a polysaccharidic network of cellulose microfibrils and hemicellulose embedded in an aromatic polymer known as lignin.
- This ramified polymer is mainly composed of three phenylpropanoid-derived phenolics (i.e., monolignols) named p-coumaryl, coniferyl, and sinapyl alcohols which represent the p-hydroxyphenyl (H), guaiacyl (G) and syringyl (S) lignin units (Boerjan et al., 2003).
- Monolignols have a C 6 C 3 carbon skeleton which consists of a phenyl ring (C 6 ) and a propane (C3) side chain.
- Lignin is crucial for the development of terrestrial plants as it confers recalcitrance to plant cell walls. It also provides mechanical strength for upright growth, confers hydrophobicity to vessels that transport water, and acts as a physical barrier against pathogens that degrade cell walls (Boudet, 2007).
- lignin content and composition are finely regulated in response to environmental biotic and abiotic stresses (Moura et al., 2010).
- Plant feedstocks also represent a source of fermentable sugars for the production of synthetic molecules such as pharmaceuticals and transportation fuels using engineered microorganisms (Keasling, 2010).
- Lignin biosynthesis is well characterized and well conserved across land plants (Weng and Chapple 2010). Genetic modifications such as silencing of genes involved in particular steps of this pathway or its regulation have been employed to reduce lignin content (Simmons et al., 2010; Umezawa, 2010) but this approach often results in undesired phenotypes such as dwarfism, sterility, reduction of plant biomass, and increased susceptibly to environmental stress and pathogens (Bonawitz and Chapple, 2010).
- pleiotropic effects are generally the consequences of a loss of secondary cell wall integrity, accumulation of toxic intermediates, constitutive activation of defense responses, or depletion of other phenylpropanoid-derived metabolites which are essential for plant development and defense (Li et al., 2008; Naoumkina et al., 2010, Gallego-Giraldo et al., 2011).
- changing the recalcitrant structure and physico-chemical properties of lignin can be achieved by modifying its monomer composition. For example, incorporation of coniferyl ferulate into lignin improves enzymatic degradation of cell wall polysaccharides (Grabber et al., 2008).
- Such C 6 C 1 phenolics are usually found in trace amount in some lignins and form the so-called ‘benzyl end-groups’ (Kim et al., 2000; Ralph et al., 2001; Kim et al., 2003; Morreel et al., 2004; Ralph et al., 2008; Kim and Ralph, 2010).
- the inventors considered increasing C 6 C 1 end-group phenolics in lignin to reduce its polymerization degree and native branched structure.
- HCHL hydroxycinnamoyl-CoA hydratase-lyase
- HCHL is an enzyme that catalyzes the hydration of the double bond of the lignin precursor p-coumaroyl-CoA, caffeoyl-CoA, and feruloyl-CoA thioesters, followed by a retro aldol cleavage reaction that produces the corresponding C 6 C 1 hydroxybenzaldehydes and acetyl-CoA ( FIG. 1 ; Mitra et al., 1999).
- the promoter of a secondary cell wall cellulose synthase gene (Cesa4/IRX5) was used to restrict HCHL expression in lignified tissues of the stem (xylem and interfascicular fibers) and prevent depletion of hydroxycinnamoyl-CoAs in other tissues in which they are precursors of hydroxycinnamate conjugates and other derivates involved in plant defense and development (Gou et al., 2009; Luo et al., 2009; Buer et al., 2010; Milkowski and Strack, 2010).
- the data disclosed herein show that HCHL expression driven by the IRX5 promoter results for some lines in no significant changes in lignin content, plant development and biomass yields. It has also been demonstrated that C 6 C 1 phenolics accumulate as end-groups in the lignin of HCHL transgenics, which reduces lignin size and renders cell walls less recalcitrant to enzymatic hydrolysis.
- the present invention provides a method for engineering a plant having reduced lignification.
- This method includes these steps: first, introducing into the plant an expression cassette comprising a polynucleotide sequence encoding an HCHL enzyme and a promoter, with the coding sequence and the promoter being in an operably linked arrangement; and second, culturing the plant under conditions permissible for the expression of a functional HCHL to produce C 6 C 1 phenolics, which can be polymerized with other monolignols and thereby reducing lignification in the plant.
- the present invention provides methods of engineering a plant having modified lignin polymers, which may have reduced size, molecular weight, and/or altered (especially reduced or less extensive) branching, that are substantially localized to the lignified tissue of the plant. This is achieved by first introducing into the plant an expression cassette as described above but in particular having a secondary cell wall specific promoter, and then culturing the plant under conditions in which the functional HCHL enzyme is expressed.
- This enzyme converts various hydroxycinnamoyl-coA into their respective hydroxybenzaldehydes that can be either directly incorporated or further modified (e.g., oxidation or reduction of the aldehyde group) by native enzymes prior to their incorporation into the lignin polymer by polymerization with native monolignols.
- the expression cassette as described herein when introduced into a plant, does not necessarily modify the lignin content. Vessel stays intact indicating that the lignin cell wall structure is still robust to prevent vessel collapse, but the lignin composition and properties are modified to a level that its recalcitrance is reduce.
- HCHL that is introduced into the plant by an expression cassette described herein does not have to be identical to the Pseudomonas fluorescens HCHL, which was used in the experiments detailed in the example section of this disclosure.
- the HCHL that is introduced into the plant by an expression cassette is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to the Pseudomonas fluorescens HCHL.
- a variant HCHL will have at least 80%, 85%, 90%, or 95% sequence identity in its amino acid residues as compared to SEQ ID NO:1, especially within one or more of the 8 highly conserved regions (shown in the 8 boxes in FIG. 8 ).
- the expression cassette of this invention comprises a polynucleotide encoding an enzyme that produces modified monoligols that can cause reduced lignification.
- an enzyme is the Pseudomonas fluorescens HCHL, having the amino acid sequence set forth in SEQ ID NO:1. Additional examples of such HCHL suitable for use in the present invention include those shown in FIG. 8 .
- variants HCHL which may be naturally occurring or recombinantly engineered, provided the variants possess (1) substantially amino acid sequence identity to an exemplary HCHL (e.g., SEQ ID NO:1) and (2) the enzymatic activity to convert at least one lignin precursor p-coumaroy-CoA, caffeoyl-CoA, or feruloyl-CoA thioester into a corresponding C 6 C 1 hydroxylbenzaldehyde, as determined by an HCHL enzymatic assay known in the art by way of various scientific publications or described herein.
- SEQ ID NO:1 substantially amino acid sequence identity to an exemplary HCHL
- the variants possess (1) substantially amino acid sequence identity to an exemplary HCHL (e.g., SEQ ID NO:1) and (2) the enzymatic activity to convert at least one lignin precursor p-coumaroy-CoA, caffeoyl-CoA, or feruloyl-CoA thioester
- HCHL p-hydroxycinnamoyl CoA hydratase/lyase
- EH Enoyl-CoA hydratase/isomarase
- FCA Feruloyl-CoA hydratase/lyase
- FIG. 8 the amino acid sequences for which are provided in SEQ ID NOs:4-34.
- the polynucleotide encoding the HCHL is operably linked to a secondary cell wall-specific promoter.
- the secondary cell wall-specific promoter is heterologous to the polynucleotide encoding the HCHL, in other words, the promoter and the HCHL coding sequence are derived from two different species.
- a promoter is suitable for use as a secondary cell wall-specific promoter if the promoter is expressed strongly in the secondary cell wall, e.g., in vessel and fiber cells of the plant, but is expressed at a much lower level or not expressed in cells without the secondary cell wall.
- the promoter is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to the native promoter of a gene encoding a secondary cell wall cellulose synthase Cesa4/IRX5, polynucleotide sequence set forth in Genebank Accession No. AF458083 — 1 and SEQ ID NO:35, and the promoter pIRX5 is contained in SEQ ID NO:3.
- the secondary cell wall-specific promoter comprises SEQ ID NO:3. In some embodiments, the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 or a variant thereof. In some embodiments, the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 comprising about 50 to about 1000 or more contiguous nucleotides of SEQ ID NO:3.
- the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 comprising 50 to 1000, 50 to 900, 50 to 800, 50 to 700, 50 to 600, 50 to 500, 50 to 400, 50 to 300, 50 to 200, 50 to 100; 75 to 1000, 75 to 900, 75 to 800, 75 to 700, 75 to 600, 75 to 500, 75 to 400, 75 to 300, 75 to 200; 100 to 1000, 100 to 900, 100 to 800, 100 to 700, 100 to 600, 100 to 500, 100 to 400, 100 to 300, or 100 to 200 contiguous nucleotides of SEQ ID NO:3.
- the secondary cell wall-specific promoter is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to SEQ ID NO:3.
- the effectiveness of a secondary cell wall-specific promoter may be confirmed by an reporter gene (e.g., ⁇ -glucuronidase or GUS) assay known in the art or as described in the example section of this application.
- the sequences can be used to prepare an expression cassette for expressing the gene of interest in a transgenic plant.
- plant transformation vectors include one or more cloned plant coding sequences (genomic or cDNA) under the transcriptional control of 5′ and 3′ regulatory sequences and a selectable marker.
- Such plant transformation vectors may also contain a promoter (e.g., a secondary cell wall-specific promoter as described herein), a transcription initiation start site, an RNA processing signal (such as intron splice sites), a transcription termination site, and/or a polyadenylation signal.
- a promoter e.g., a secondary cell wall-specific promoter as described herein
- a transcription initiation start site e.g., an RNA processing signal (such as intron splice sites)
- RNA processing signal such as intron splice sites
- transcription termination site e.g., a transcription termination site
- polyadenylation signal e.g., a polyadenylation signal.
- the plant expression vectors may include RNA processing signals that may be positioned within, upstream, or downstream of the coding sequence.
- the expression vectors may include regulatory sequences taken from the 3′-untranslated region of plant genes, e.g., a 3′ terminator region to increase mRNA stability of the mRNA, such as the PI-II terminator region of potato or the octopine or nopaline synthase 3′ terminator regions.
- Plant expression vectors routinely also include selectable marker genes to allow for the ready selection of transformants.
- selectable marker genes include those encoding antibiotic resistance genes (e.g., resistance to hygromycin, kanamycin, bleomycin, G418, streptomycin or spectinomycin), herbicide resistance genes (e.g., phosphinothricin acetyltransferase), and genes encoding positive selection enzymes (e.g. mannose isomerase).
- an expression cassette comprising a polynucleotide encoding the HCHL and operably linked to a promoter (especially a secondary cell wall specific promoter)
- a promoter especially a secondary cell wall specific promoter
- standard techniques may be used to introduce the polynucleotide into a plant in order to express the HCHL and effectuate reduced lignification. See, e.g., protocols described in Ammirato et al. (1984) Handbook of Plant Cell Culture—Crop Species. Macmillan Publ. Co. Shimamoto et al. (1989) Nature 338:274-276; Fromm et al. (1990) Bio/Technology 8:833-839; and Vasil et al. (1990) Bio/Technology 8:429-434.
- Transformation and regeneration of plants is known in the art, and the selection of the most appropriate transformation technique will be determined by the practitioner. Suitable methods may include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG) mediated transformation; transformation using viruses; micro-injection of plant cells; micro-projectile bombardment of plant cells; vacuum infiltration; and Agrobacterium tumeficiens mediated transformation. Transformation means introducing a nucleotide sequence in a plant in a manner to cause stable or transient expression of the sequence. Examples of these methods in various plants include: U.S. Pat. Nos.
- plants can be selected using a selectable marker incorporated into the transformation vector.
- a selectable marker will confer antibiotic or herbicide resistance on the transformed plants or the ability to grow on a specific substrate, and selection of transformants can be accomplished by exposing the plants to appropriate concentrations of the antibiotic, herbicide, or substrate.
- the polynucleotide sequence coding for an HCHL can be obtained according to any method known in the art. Such methods can involve amplification reactions such as polymerase chain reaction (PCR) and other hybridization-based reactions or can be directly synthesized.
- PCR polymerase chain reaction
- An expression cassette comprising a polynucleotide encoding an HCHL operably linked to a promoter, especially a secondary cell wall specific promoter, as described herein, can be expressed in various kinds of plants.
- the plant may be a monocotyledonous plant or a dicotyledonous plant.
- the plant is a green field plant.
- the plant is a gymnosperm or conifer.
- the plant is a plant that is suitable for generating biomass.
- suitable plants include, but are not limited to, Arabidopsis , poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, Jatropha, and Brachypodium.
- the plant into which the expression cassette of this invention is introduced is the same species of plant as the one from which the promoter is derived. In some embodiments, the plant into which the expression cassette is introduced is a different species of plant from the plant species the promoter is derived from.
- the plants or parts of the plants may be evaluated to determine whether expression of the exogenous HCHL can be detected, e.g., by evaluating the level of RNA or protein, by measuring enzymatic activity of the HCHL, as well as by evaluating the size, molecular weight, content, or degree of branching in the lignin molecules found in the plants. These analyses can be performed using any number of methods known in the art.
- plants are screened by evaluating the level of RNA or protein.
- Methods of measuring RNA expression include, for example, PCR, northern analysis, reverse-transcriptase polymerase chain reaction (RT-PCR), and microarrays.
- Methods of measuring protein levels are also known in the art and include, for example, mass spectroscopy or antibody-based techniques such as ELISA, Western blotting, flow cytometry, immunofluorescence, and immunohistochemistry.
- plants are screened by assessing HCHL activity, and also by evaluating lignin size and composition.
- the enzymatic assays for HCHL are well known in the art and are described in this application.
- Lignin molecules can be assessed, for example, by nuclear magnetic resonance (NMR), spectrophotometry, microscopy, klason lignin assays, acetyl-bromide reagent or by histochemical staining (e.g., with phloroglucinol).
- Plants, parts of plants, or plant biomass material from plants having reduced lignification due to the expression of an exogenous HCHL in the secondary cell wall can be used for a variety of methods.
- the plants, parts of plants, or plant biomass material generate less recalcitrant biomass for use in a conversion reaction as compared to wild-type plants.
- the plants, parts of plants, or plant biomass material are used in a saccharification reaction, e.g., enzymatic saccharification, to generate soluble sugars at an increased level of efficiency as compared to wild-type plants.
- the plants, parts of plants, or plant biomass material are used to increase biomass yield or simplify downstream processing for wood industries (such as paper, pulping, and construction) as compared to wild-type plants.
- the plants, parts of plants, or plant biomass material are used to increase the quality of wood for construction purposes.
- the plants, parts of plants, or plant biomass material can be used in a combustion reaction, gasification, pyrolysis, or polysaccharide hydrolysis (enzymatic or chemical).
- the plants, parts of plants, or plant biomass is used as a forage crop and exhibit improved digestibility compared to wild-type plants.
- plants or plant biomass material e.g., leaves and stems
- plants or plant biomass material are optionally pre-treated with hot water, dilute alkaline, AFEX (Ammonia Fiber Explosion), ionic liquid or dilute acid, followed by enzymatic saccharification using a mixture of cell wall hydrolytic enzymes (such as hemicellulases, cellulases and beta-glucosidases) in buffer and incubation of the plants or plant biomass material with the enzymatic mixture.
- the yield of the saccharification reaction can be readily determined by measuring the amount of reducing sugar released, using a standard method for sugar detection, e.g. the dinitrosalicylic acid method well known to those skilled in the art.
- Plants engineered in accordance with the invention provide a higher saccharification efficiency as compared to wild-type plants, while the plants growth, development, or disease resistance is not negatively impacted.
- Sugars generated from a saccharification reaction using plant biomass of the invention can be used for producing any product for which the sugars can serve as a carbon source.
- products include, but are not limited to, alcohols (e.g., ethanol, methanol, butanol); organic acids (e.g., citric acid, acetic acid, itaconic acid, lactic acid, gluconic acid); ketones (e.g., acetone); amino acids (e.g., glutamic acid); gases (e.g., H 2 and CO 2 ); antibiotics (e.g., penicillin and tetracycline); vitamins (e.g., riboflavin, B12, beta-carotene), fatty acids and fatty acid derivatives (as described, e.g., in PCT/US2008/068833); isoprenyl alkanoates (as described, e.g., PCT/US2008/068756, methyl butenol (as described,
- Arabidopsis thaliana (ecotype Columbia, Col-0) seeds were germinated directly on soil. Growing conditions were 14 h of light per day at 100 mmol m ⁇ 2 s ⁇ 1 , 22° C., 55% humidity. Selection of T1 and T2 homozygote transgenic plants was made on solid Murashige and Skoog vitamin medium (PhytoTechnology Laboratories) supplemented with 1% sucrose, 1.5% agar (Sigma-Aldrich) adjusted to pH 5.6-5.8, and containing 50 ⁇ g mL ⁇ 1 kanamycin.
- Murashige and Skoog vitamin medium Plantashige and Skoog vitamin medium (PhytoTechnology Laboratories) supplemented with 1% sucrose, 1.5% agar (Sigma-Aldrich) adjusted to pH 5.6-5.8, and containing 50 ⁇ g mL ⁇ 1 kanamycin.
- Arabidopsis line CS70758 (ecotype Columbia, Col-2) was obtained from the Arabidopsis Biological Resource Center (ABRC). This line has a pMLBART plasmid containing an expression cassette consisting of the genomic fragment located upstream of the CESA4 start codon fused to the GUS gene. Histochemical GUS activity was performed as previously described (Eudes et al., 2006). Various organs of soil-grown line CS70758 were incubated for 1 h or 8 h at 37° C. in the GUS assay buffer using 5-bromo-4-chloro-3-indolyl-D-glucuronic acid (Indofine Chemical Company, Inc.) as a substrate. After staining, stem samples (1 cm) were cross-sectioned (80 ⁇ m) using a vibratome before observation under the microscope (Leica).
- HCHL expression in Arabidopsis the binary vector pTKan which is derived from pPZP212 was used (Hajdukiewicz et al., 2004).
- a Gateway cloning cassette (Invitrogen) was inserted between XhoI and PstI restriction sites to produce a pTKan-GW vector.
- the nucleotide sequence of the IRX5 promoter was amplified by PCR from Arabidopsis (ecotype Columbia, Col-0) genomic DNA using oligonucleotides 5′-CCCG GCGGCCGC ATGAAGCCATCCTCTACCTCGGAAA-3′ and 5′-CCCG GCTAGC GGCGAGGTACACTGAGCTCTCGGAA-3′ (NotI and NheI restriction sites underlined), and inserted between the ApaI and SpeI restriction sites of pTKan-GW to produce a pTKan-pIRX5-GW expression vector.
- a codon-optimized nucleotide sequence encoding the HCHL enzyme from Pseudomonas fluorescens AN103 (accession number CAA73502) for expression in Arabidopsis was synthesized without stop codon (Genescript) and amplified by PCR using oligonucleotides 5′- GGGGACAAGTTTGTACAAAAAAGCAGGCTTC ATGTCTACTTACGAGGGAAGATG G-3′ and 5′- GGGGACCACTTTGTACAAGAAAGCTGGGTC TCTCTTGTAAGCCTGGAGTCC-3′ (attb1 and attb2 sites underlined) for cloning into the Gateway pDONR221-f1 entry vector (Lalonde et al 2010).
- a sequence-verified HCHL entry clone was LR recombined with the pTKan-pIRX5-GW vector to generate the final IRX5:HCHL construct.
- the construct was introduced into wild type Arabidopsis plants (ecotype Col0) via Agrobacterium tumefaciens -mediated transformation (Bechtold and Pelletier, 1998).
- the obtained cDNA preparation was quality-controlled for PCR using tub8-specific oligonucleotides (5′-GGGCTAAAGGACACTACACTG-3′/5′-CCTCCTGCACTTCCACTTCGTCTTC-3′). Oligonucleotides 5′-ATGTCTACTTACGAGGGAAGATGG-3′ and 5′-TCTCTTGTAAGCCTGGAGTCC-3′ were used for the detection of HCHL expression by PCR.
- inflorescence stems of IRX5:HCHL T2 transformants and wild type plants were ground in liquid nitrogen, and 0.25 g of the resulting powder was homogenized with the extraction buffer [100 mM Tris-HCl pH 6.5, 2% (w/v) polyvinylpyrrolidone, 2% (v/v) ⁇ -mercaptoethanol, 1% (w/v) SDS] at 1400 rpm for 30 min. The mixture was centrifuged at 20,000 g for 5 min and the supernatant collected for protein quantification using the Bradford method (Bradford, 1976) and bovine serum albumin as a standard.
- soluble protein 5 ⁇ g
- Tris-HCl pH 6.5
- 8% (w/v) SDS 8% (v/v) ⁇ -mercaptoethanol
- 40% (v/v) glycerol 8% (v/v) ⁇ -mercaptoethanol
- 40% (v/v) glycerol 8% (v/v) ⁇ -mercaptoethanol
- 40% (v/v) glycerol 8% (v/v) ⁇ -mercaptoethanol
- bromophenol blue 0.04%
- Proteins were separated by SDS-PAGE using 8-16% (w/v) polyacrylamide gradient gels (Invitrogen) and electrotransferred (100 volts, 45 min) onto PVDF membranes (Thermo Fisher Scientific).
- inflorescence stems of IRX5:HCHL T2 transformants and wild type plants were ground in liquid nitrogen, and 0.25 g of the resulting powder was homogenized with 25 mg of polyvinylpolypyrrolidone and 1.25 mL of extraction buffer (EB; 100 mM Tris-HCl, pH 8.5, 20 mM DTT, and 10 mM Na 2 EDTA). Extracts were shaken at 1400 rpm for 15 min at 4° C., and centrifuged for 30 min at 20,000 g at 4° C. Supernatants were collected, adjusted to 2.5 mL with EB, and applied to PD10 columns (GE healthcare) pre-equilibrated with 25 mL of EB. Proteins were eluted with 3.5 mL of EB and quantified using the Bradford method (Bradford, 1976) and bovine serum albumin as a standard.
- HCHL activity 5 ⁇ L of protein extract was incubated for 15 min at 30° C. with 150 ⁇ M feruloyl-CoA in 100 m M Tris-HCl pH 8.5 in a total volume of 50 ⁇ L. Total amounts of protein per reaction varied from 4 to 6.5 ⁇ g. Reactions were stopped with 50 ⁇ L of cold acidified methanol (12% glacial acetic acid/88% methanol, v/v) and stored at ⁇ 70° C. until LC-MS analysis.
- IRX5:HCHL and wild type plants were grown until senescence and dried stems were collected without roots, leaves and siliques before weighing.
- Statistical analysis was performed using ANOVA followed by Scheffe post hoc test.
- Stem segments cut between the first and second internodes were embedded in 4% agarose.
- Stem semi-thin sections (100- ⁇ m thickness) were obtained using a vibratome (Leica).
- TBO toluidine blue O
- sections were incubated in a 0.05% (w/v) solution of TBO (Sigma-Aldrich) in water for 30 sec and rinsed with water.
- Wiesner lignin staining sections were incubated for 3 min in phloroglucinol-HCl reagent (VWR International) and rinsed with water.
- Extract-free cell wall residues were obtained by sequentially washing 60 mg of ball-milled stems with 1 ml of 96% ethanol at 95° C. twice for 30 min, and vortexing with 1 mL of 70% ethanol twice for 30 sec. The resulting CWR were dried in vacuo overnight at 30° C. Approximately 6 mg of CWR was mixed with 500 ⁇ L of 2 M NaOH and shaken at 1400 rpm for 24 h at 30° C.
- the mixture was acidified with 100 ⁇ L of concentrated HCl, and subjected to three ethyl acetate partitioning steps. Ethyl acetate fractions were pooled, dried in vacuo, and suspended in 50% (v/v) methanol-water prior to LC-MS analysis.
- the HPLC system was coupled to an Agilent 6210 time-of-flight (TOF) mass spectrometer (MS) via a 1:7 post-column split.
- Analyses were conducted using Electrospray ionization (ESI) in the positive ion mode. Detection of [M+H] + ions was carried out in full scan mode at 0.85 spectra sec and a cycle time of 1.176 sec spectrum ⁇ 1 using the following parameters: capillary voltage 3500 V, fragmentor 165 V, skimmer 50 V and OCT RF 170 V, drying gas flow rate 9 L min ⁇ 1 , nebulizer pressure 15 psig, drying gas temperature 325° C.
- Extract-free samples (CWR) of ball-milled mature senesced stems were prepared using a Soxhlet apparatus by sequentially extracting the ground material with toluene:ethanol (2:1, v/v), ethanol, and water (Sluiter et al., 2008).
- the determination of lignin content using the standard Klason procedure (Dente, 1992) and the thioacidolysis procedure (Lapierre et al., 1995; 1999) were carried out on CWR.
- the lignin-derived monomers were identified by GC-MS as their trimethyl-silylated derivatives. All the lignin analyses were performed in duplicate.
- CWR of ball-milled mature senesced stems 50 mg were swelled in 500 ⁇ L H 2 SO 4 (72%, w/v) at 30° C. for 60 min, and autoclaved at 120° C. for 1 h in dilute H 2 SO 4 (4%, w/v) after addition of deionized water (14 mL). Samples were cooled down at room temperature and filtered using pre-weighted GF/C glass microfiber filters (Whatman). Filtrates were collected and diluted 100 times with deionized water prior to HPAEC-PAD analysis.
- CWR of ball-milled mature dried stems (5 mg) were hydrolyzed in 1 ml of 2 M trifluoroacetic acid (TFA) for 1 h at 120° C. TFA was removed by drying under vacuum and the residue suspended in deionized water (1 mL) prior to HPAEC-PAD analysis.
- TFA trifluoroacetic acid
- Monosaccharide composition was determined by HPAEC-PAD of hydrolyzed material. Chromatography was performed on a PA20 column (Dionex) at a flow rate of 0.5 mL min ⁇ 1 . Before injection of each sample (20 ⁇ L) the column was washed with 200 mM NaOH for 10 min, then equilibrated with 10 mM NaOH for 10 min. The elution program consisted of a linear gradient from 10 mM NaOH to 5 mM NaOH from 0 to 1.5 min, followed by isocratic elution with 5 mM NaOH from 1.5 to 20 min, and a linear gradient up to 800 mM NaOH from 20 to 43 min.
- Monosaccharides were detected using a pulsed amperometric detector (gold electrode) set on waveform A according to manufacturer's instructions.
- a calibration curve of monosaccharide standards that includes L -Fuc, L -Rha, L -Ara, D -Gal, D -Glc, D -Xyl, D -GalA and D -GlcA (Sigma-Aldrich) was run for verification of response factors.
- Statistical analysis was performed using ANOVA followed by Tukey's test.
- FT-Raman spectroscopy was conducted on CWR of ball-milled mature senesced stems (2 mg) from three independent cultures.
- Raman spectra were collected using a Bruker MultiRAM FT-Raman system equipped with a 1064 nm diode laser (Bruker Optics Inc.). Five spectra were acquired for each sample with spectral resolution of 4 cm ⁇ 1 using a laser power of 50 mW and 256 scans to achieve good signal-to-noise ratio.
- White light correction of the acquired spectra was performed to correct the influence of the optics on the spectrometer. Spectra in the range of 200-3500 cm ⁇ 1 were smoothed and baseline corrected using OPUS software.
- Lignin and polysaccharides (cellulose and hemicellulose) content were determined using integrated intensities measured over the range of 1555-1690 cm ⁇ 1 and 1010-1178 cm ⁇ 1 , respectively.
- analyses were carried out on xylem and interfascicular fibers tissues from 50- ⁇ m thick sections of the basal region of stems of five-week-old plants.
- IRX5:HCHL line 2
- FT-IR spectra were collected from a 50 ⁇ m ⁇ 50 ⁇ m window targeting xylem vessels or interfascicular fibers, and normalization of the data and statistical analysis (Student's t-test) were performed as described (Mouille et al., 2003).
- CEL lignin was purified from wild type and IRX5:HCHL (line 2) plants.
- One gram of ball-milled mature senesced stems was mixed with 50 mM NaCl (30 ml) and incubated overnight at 4° C. After centrifugation (2,800 g, 10 min), the biomass was extracted sequentially by sonication (20 min) with 80% ethanol (three times), acetone (one time), chloroform-methanol (1:1, v/v, one time) and acetone (one time).
- the obtained CWR were ball-milled for 3 h per 500 mg of sample (in 10 min on/10 min off cycles) using a PM100 ball mill (Retsch) vibrating at 600 rpm with zirconium dioxide vessels (50 mL) containing ZrO 2 ball bearings (10 ⁇ 10 mm). Ball-milled walls (490 mg for wild type and 480 mg for IRX5:HCHL) were transferred to centrifuge tubes (50 mL) and digested four times over three days at 30° C. with crude cellulases (Cellulysin; Calbiochem; 60 mg g ⁇ 1 of sample) in NaOAc pH 5.0 buffer (30 mL) under gentle rotation.
- Cellulysin Calbiochem
- CEL was washed 3 times with deionized water and lyophilized overnight. CEL recovered were 131 mg for wild type (27.3%) and 101 mg for IRX5:HCHL (20.6%).
- 1% (w/v) CEL lignin solutions were prepared in analytical-grade 1-methyl-2-pyrrolidinone-DMSO (1:1, v/v) and sonicated for 3 hours at 40° C.
- Ball-milled mature senesced stems (10 mg) were mixed with 340 ⁇ L of water, 340 ⁇ L of H 2 SO 4 (1.2%, w/v), or 340 ⁇ L of NaOH (0.25%, w/v) for hot water, dilute acid, or dilute alkaline pretreatments, respectively, incubated at 30° C. for 30 min, and autoclaved at 120° C. for 1 h. After cooling down at room temperature, samples pretreated with dilute acid and dilute alkaline were neutralized with 5 N NaOH (25 ⁇ L) and 1.25 N HCl (25 ⁇ L), respectively.
- Saccharification was initiated by adding 635 ⁇ L of 100 m M sodium citrate buffer pH 6.2 containing 80 g ml ⁇ 1 tetracycline, 5% w/w cellulase complex NS50013 and 0.5% w/w glucosidase NS50010 (Novozymes). After 72 h of incubation at 50° C. with shacking (800 rpm), samples were centrifuged (20,000 g, 3 min) and 10 ⁇ L of the supernatant was collected for reducing sugar measurement using the DNS assay and glucose solutions as standards (Miller, 1959).
- RNA samples from three independent biological replicates were isolated and separately analyzed. For each biological replicate, RNA from the main inflorescence stem (first two internodes) of three plants were pooled. For each comparison, one technical replication with fluorochrome reversal was performed for each biological replicate (i.e. nine hybridizations per comparison). Reverse transcription of RNA was conducted in the presence of Cy3-dUTP or Cy5-dUTP (PerkinElmer-NEN Life Science Products), and hybridization and scanning of the slides were performed as described in Lurin et al. (2004).
- GSTs gene-specific tags
- Microarray data from this article were deposited at GEO (http://www.ncbi.nlm.nih.gov/geo/) and at CATdb (http://urgv.evry.inra.fr/CATdb/) according to Minimum Information about a Microarray Experiment standards (MIME).
- GEO http://www.ncbi.nlm.nih.gov/geo/
- CATdb http://urgv.evry.inra.fr/CATdb/
- MIME Minimum Information about a Microarray Experiment standards
- tissue specific activity of the IRX5 promoter was verified using the beta-glucuronidase (GUS) as a reporter gene. Gus activity was essentially detected in the xylem vessels of the stem. After prolonged incubations, stem interfascicular fibers also showed strong GUS activity, and more moderate staining was observed in the vascular system of young seedlings, siliques, rosette and cauline leaves. No activity was detected in other organs or tissues except for the style and anthers ( FIG. 9 ).
- GUS beta-glucuronidase
- a codon-optimized sequence encoding HCHL from Pseudomonas fluorescens AN103 was designed and cloned downstream of the IRX5 promoter for preferential expression in lignified tissues of Arabidopsis stems. Presence of HCHL transcripts in the main stem of five independent transformants was verified by RT-PCR in the T1 generation ( FIG. 2A ). Plants homozygous for the IRX5:HCHL construct were identified in the T2 generation, and used to analyze HCHL protein expression and activity in stems. Western blotting analysis using the ‘universal antibody’ allowed detection of HCHL in stem extracts of the five selected transgenic lines ( FIG. 2B ; Eudes et al. 2010).
- HCHL activity could be detected in the stem of these lines, ranging from 0.025 to 0.16 pkat vanillin ⁇ g ⁇ 1 protein using feruloyl-CoA as substrate, whereas no detectable activity was observed in protein extracts of wild type plants (Table I). Two transgenic lines showing the highest and the lowest levels of HCHL activity, and two lines exhibiting intermediate activity level were selected for detailed analysis.
- IRX5:HCHL plants had growth and development characteristics visually similar to the wild type from early rosette stage and until senescence ( FIG. 10 ). However, mature senesced stems from lines IRX5:HCHL (4) and IRX5:HCHL (5) were little bit shorter (22% and 13% reduction) and had lower dry weight yield (30% and 16% reduction) compared to control plants, whereas those from lines IRX5:HCHL (1) and IRX5:HCHL (2) were not significantly different (Table II). Stem tissues of five-week-old IRX5:HCHL plants were inspected using light microscopy.
- HBA content in the IRX5:HCHL lines ranged between 1.59 and 2.49 mg g ⁇ 1 FW, which represents a 113 to 179 fold increase compared to values observed in wild type samples, and indicates that 88-94% of HBA accumulated in transgenic lines is glycosylated.
- Extract-free cell wall residues obtained from mature senesced stems of wild type and IRX5:HCHL plants were subjected to mild alkaline hydrolysis for the release of loosely-bound phenolics. This procedure released from the cell wall samples some HBAld, 3,4-HBAld, Van, 5OH-Van, SyrAld, HBA, VA, and SyrA, which were quantified using LC-MS analysis.
- Line IRX5:HCHL (2) which showed no defective xylem structures and biomass yield similar to wild type plants, was selected for further analyses.
- Fourier transformed Raman (FT-Raman) spectroscopy was used to determine the chemical composition of CWR obtained from senesced stems of IRX5:HCHL plants. Compared to the wild type, data showed that lignin content and amount of polysaccharides (cellulose and hemicellulose) in IRX5:HCHL plants were not significantly different ( FIG. 4A ).
- FT-IR Fourier transformed infrared
- Monosaccharide composition was determined after sulfuric acid hydrolysis of total cell wall polysaccharides from mature senesced stems of line IRX5:HCHL (2) and wild type plants. Although both genotypes had similar amount of total monosaccharides, IRX5:HCHL plants showed reduction in glucose ( ⁇ 12%) and increase in xylose (+22%) and arabinose (+16%) compared to wild type plants (Table VI). Moreover, hemicellulosic monosaccharides released from CWR using trifluoroacetic acid showed that total amount of sugar quantified in this hydrolysate was 23% higher in IRX5:HCHL stems which corresponds to higher xylose (+23%) and arabinose (+22%) contents compared to wild type (Table VI).
- the polydispersity of cellulolytic lignin purified from wild type and IRX5:HCHL (2) stems was determined using size exclusion chromatography (SEC). Elution profiles acquired by monitoring UV-A absorbance (SEC UV-A 300 ) and UV-F fluorescence (SEC UV-F ex 250/ em 450) of the dissolved lignin revealed differences between wild type and IRX5:HCHL plants ( FIG. 6 ). First, total area corresponding to the largest mass peak detected between 7 min and 13.5 min was severely reduced in transgenics due to significant diminution of the largest lignin fragments which elute between 7 min and 9 min.
- HCHL HCHL
- adverse phenotypes such as chlorotic and senescing leaves, stunting, low pollen production, male sterility, collapsed xylem vessels, and reduction of biomass were observed in transgenic tobacco, and sugarcane (Mayer et al., 2001; Merali et al., 2007; McQualter et al., 2005).
- the inventors selected the promoter of a secondary cell wall cellulose synthase to preferentially express HCHL in the lignifying tissues of Arabidopsis stems ( FIG. 9 ).
- IRX5:HCHL constructs were not dwarf or sterile, and young rosette leaves did not show reduced epidermal fluorescence which is symptomatic of alteration in phenylpropanoid-derived soluble phenolic pools.
- two IRX5:HCHL lines showed reduced biomass, and in one case some occasional collapsed xylem vessels caused by stronger HCHL activity and possibly modification of call wall integrity, some other IRX5:HCHL lines were comparable to wild-type plants.
- the transgenic lines show increased amount of soluble C 6 C 1 aldehydes (HBAld, 3,4-DHBAld, and Van), which are produced upon HCHL activity after cleavage of hydroxybenzoyl-CoA, 3,4-dihydroxybenzoyl-CoA, and feruloyl-CoA ( FIG. 11 ).
- HCHL has no activity against sinapoyl-CoA, suggesting that Syrald is a conversion product of Van, which is supported by the identification of the new intermediate 5OH-Van (Mitra et al., 1999; FIG. 11 ).
- soluble C 6 C 1 phenolics predominantly accumulate as conjugates in transgenics since we showed that glucose conjugates (phenolic glucoside and glucose ester) represented around 90% of the HBA soluble pool, presumably for vacuolar storage as previously described for other C 6 C 1 phenolics (Eudes et al., 2008).
- This C 6 C 1 acid glucoside accumulation is in agreement with what was observed in tobacco, sugar beet, datura and sugar cane plants expressing HCHL (Mayer et al., 2001; Mitra et al., 2002; McQualter et al., 2005; Rahman et al., 2009).
- the lignin from plants expressing HCHL shows increased content of C 6 C 1 phenolics.
- analysis of lignin monomers released after thioacidolysis identified two novel units (Vanalc and Syralc) and showed large amounts of Syrald, Van, and SyrA.
- This suggests part of C 6 C 1 aldehydes are converted into alcohols and acids and demonstrates that they are incorporated into the lignin as ⁇ -O-4-linked C 6 C 1 monomer end-groups in lignin ( FIG. 11 ).
- Due to the absence of phenyl propanoid tail these new monolignols when incorporated in lignin end chains, should block further polymerization of the polymer and act as condensation terminator or stopper molecules.
- transgenic plants also show higher content of conventional H-units (+30%), which preferentially distribute as terminal end-groups in lignin and contribute to modifications of lignin size and structure (Lapierre, 2010; Ziebell et al., 2010).
- plants overproducing C 6 C 1 monolignols and with similar lignin content as wild type plants show a lower thioacidolysis release of monolignols, indicating a reduction in the availability of free propanoid tail in lignin end-chain for polymer elongation. It also indicates higher carbon-carbon linkages and increased lignin condensation degree.
- saccharification efficiency of biomass is determined by several characteristics of cell walls, the observed saccharification efficiency improvement after different pretreatments suggests that less ramified lignin would reduce cross-linkages and embedding of cell wall polysaccharides (cellulose and hemicellulose) and would favor their accessibility to hydrolytic enzymes. This hypothesis is supported by the fact that total sugar content is unchanged in cell walls of plants overproducing theses C 6 C 1 monomers.
- lignification “stopper” molecules can be used to modify the lignin structure in order to reduce lignocellulosic biomass recalcitrance. Since this approach does not require any particular genetic background, it should be easily transferable to various energycrops. Restricting the biosynthesis of these lignification “stopper” molecules in supporting lignified tissues (i.e. schlerenchyma fibers) as well as avoiding strong production in conductive tissues (i.e. vessels) should limit the risk of adverse effects on plant development and biomass yield.
- This example illustrates expression of bacterial HCHL in a monocot, rice.
- Rice plants were transformed with the DNA constructs described in Example 1.
- Rice lines were engineered ( FIG. 12 ) that expressed the HCHL gene, as demonstrated by RT-PCR ( FIG. 13 ).
- evaluation of rice lines demonstrated that they accumulated pHBA (para-hydroxybenzoate) ( FIG. 14 ), which is generated from the conversion of p-coumaroyl-CoA by HCHL.
- pHBA para-hydroxybenzoate
- Transcript variant 1 0.00E+0 AT1G77450 ANAC032 (Arabidopsis NAC domain containing protein 32); transcription factor 0.00E ⁇ 0 AT5G63790 ANAC102 (Arabidopsis NAC domain containing protein 102); transcription factor, Transcript variant 2 0.65 1.26E ⁇ 5 AT1G01720 ATAF1 (Arabidopsis NAC domain containing protein 2); transcription factor 0.54 7.23E ⁇ 3 Glycine-rich protein AT2G05380 GRP3S (GLYCINE-RICH PROTEIN 3 SHORT ISOFORM) Transcript variant 1 0.00E+0 AT2G05380 GRP3S (GLYCINE-RICH PROTEIN 3 SHORT ISOFORM) Transcript variant 2 0.00E+0 AT2G05530 glycine-rich protein 0.96 0.00E+0 AT2G05540 glycine-rich protein 0.90 0.00E+0 Auxin metabolism AT3G44300 NIT2 (NITRILASE 2) 0.00E+0 AT3
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
- This application claims benefit of U.S. provisional application No. 61/507,484, filed Jul. 13, 2011, which application is herein incorporated by reference.
- This invention was made with government support under Contract No. DE-AC02-05CH11231 awarded by the U.S. Department of Energy. The government has certain rights in this invention.
- Lignocellulosic plant biomass is utilized as a renewable feedstock in various agro-industrial activities. Lignin is an aromatic and hydrophobic branched polymer incrusted within biomass that negatively affects extraction and hydrolysis of polysaccharides during industrial processes. Engineering the monomer composition of lignin offers attractive potential for reducing its recalcitrance. The present invention offers a new strategy developed in Arabidopsis for the overproduction of rare lignin monomers, which incorporate as end-groups in the polymer and reduce lignin chain extension. Biosynthesis of these lignification stoppers' is achieved by expressing a bacterial hydroxycinnamoyl-CoA hydratase-lyase (HCHL) in lignifying tissues of Arabidopsis inflorescence stems. HCHL cleaves the propanoid side chain of hydroxycinnamoyl-CoA lignin precursors to produce the corresponding hydroxybenzaldehydes. Stems from plants that express HCHL accumulate higher amount of hydroxybenzaldehyde and hydroxybenzoate derivates compared to wild type plants. Part of these C6C1 phenolics are alcohol-extractable from plant tissues and are released from extract-free cell walls upon mild alkaline hydrolysis. Engineered plants with intermediate HCHL activity level show no reduction of total lignin, sugar content and biomass yield compared to wild type plants. However, cell wall characterization by 2D-NMR reveals the presence of new molecules in the aromatic region and the analysis of lignin isolated from these plants revealed an increased amount of C6C1 phenolic end-groups and a reduced molecular mass distribution. In addition, these engineered lines show saccharification improvement of pretreated cell wall biomass. Enhancing the incorporation of C6C1 phenolic end-groups in lignin represents a promising strategy to alter lignin structure and reduce cell wall recalcitrance to enzymatic hydrolysis.
- In the first aspect, the present invention provides an isolated expression cassette comprising a polynucleotide sequence encoding a hydroxycinnamoyl-CoA hydratase-lyase (HCHL) and a heterologous promoter, and the promoter is operably linked to the polynucleotide sequence. In some embodiments, the HCHL is Pseudomonas fluorescens HCHL, which has the amino acid sequence set forth in SEQ ID NO:1. In some embodiments, the promoter used in this expression cassette is a secondary cell wall specific promoter, such as pIRX5, which is within the polynucleotide sequence set forth in SEQ ID NO:3.
- In a second aspect, the present invention provides a method for engineering a plant having reduced lignification. The method includes these steps: (1) introducing the expression cassette described herein into the plant; and (2) culturing the plant under conditions under which the HCHL is expressed, thereby reducing lignification in the plant. In some embodiments, the plant is selected from the group consisting of Arabidopsis, poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, and Brachypodium.
- In a third aspect, the present invention provides a plant that is engineered by the methods described herein, and a plant cell from such a plant, a seed, flower, leaf, or fruit from such a plant, a plant cell that contains the expression cassette described herein, and biomass comprising plant tissue from the plant or part of the plant described herein. Thus, the invention provides an engineered plant comprising a heterologous hydroxycinnamoyl-CoA hydratase-lyase (HCHL) operably linked to a promoter. In some embodiments, the polynucleotide encoding the heterologous HCHL is integrated into a plant genome. In some embodiments, the promoter is heterologous to the plant. In some embodiments, the promoter is an endogenous promoter. In some embodiment, the promoter is a secondary cell wall-specific promoter, such as an IRX5 promoter. In some embodiments, the HCHL is Pseudomonas fluorescens HCHL. The plant may be a monocot or a dicot. In some embodiments, the plant is selected from the group consisting of Arabidopsis, poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, and Brachypodium.
- In further aspects, the invention provide methods of using an engineered plant of the invention, or parts of the plant, or plant biomass comprising material from the plant. In some embodiments, plant material is used in a saccharificatoni reaction, e.g., enzymatic saccharification, to generate soluble sugars at an increased level of efficiency as compared to wild-type plants that have not been modified to express HCHL. In some embodiments, the plants, parts of plants, or plant biomass material are used to increase biomass yield or simplify downstream processing for wood industries (such as paper, pulping, and construction) as compared to wild-type plants. In some embodiments, the plants, parts of plants, or plant biomass material are used to increase the quality of wood for construction purposes. In some embodiments the plants, parts of plants, or plant biomass material can be used in a combustion reaction, gasification, pyrolysis, or polysaccharide hydrolysis (enzymatic or chemical). In some embodiments, the plants, plant parts, or plant biomass material are used as forage that is more readily digested compared to wild-type plants.
-
FIG. 1 . HCHL-mediated conversion of hydroxycinnamoyl-CoAs into hydroxybenzaldehydes. HCHL performs the hydration and cleavage of hydroxycinnamoyl-CoAs (R=H, coumaroyl-CoA; R=OH, caffeoyl-CoA; R=OCH3, feruloyl-CoA) to produce hydroxybenzaldehydes (R=H, 4-hydroxybenzaldehyde; R=OH, 3,4-dihydroxybenzaldehyde; R=OCH3, 4-hydroxy-3-methoxybenzaldehyde) and acetyl-CoA via the formation of the corresponding reaction intermediates 4-hydroxyphenyl-β-hydroxypropionyl-CoAs. -
FIG. 2 . Analysis of HCHL expression in IRX5:HCHL lines. (A) Detection by RT-PCR of HCHL transcripts using mRNA isolated from secondary stems of five independent five-week-old transformants in the T1 generation. cDNA synthesized from mRNA purified from wild type (WT) stems were used as a negative control. Tub8-specific primers were used to assess cDNA quality for each sample. (B) Detection by western blot of HCHL tagged with the AttB2 peptide (approximate size 32 kDa) using the universal antibody and 5 μg of total protein extracted from the primary stem of five independent five-week-old IRX5:HCHL transformants in the T2 generation. A protein extract from wild type stems (WT) was used as a negative control. -
FIG. 3 . Histochemical staining of stem sections from five-week-old Arabidopsis plants. (A) Mäule staining. (B) Phloroglucinol-HCl staining. (C) Toluidine blue O staining. i, interfascicular fibers; x, xylem. Bars represent 50 μm for (A) and (B), and 20 μm for (C). Note the collapsed xylem vessels (yellow arrows) observed for line IRX5:HCHL (4). -
FIG. 4 . Spectral analysis of IRX5:HCHL and wild type plants. (A) Lignin and polysaccharide content in CWR of mature senesced stems from wild type (WT) and line IRX5:HCHL (2) using FT-Raman spectroscopy. Values represent integrated intensities over the range of 1555-1690 cm−1 and 1010-1178 cm−1 for lignin and polysaccharides (cellulose/hemicellulose) quantification, respectively. Values are means of three biological replicates±SE. (B) Comparison of FT-IR spectra obtained from xylem (black line) and interfascicular fibers (grey line) in basal stem sections of wild type and line IRX5:HCHL (2). A Student's t-test was performed on absorbance values of wild type versus transgenic and plotted against wave numbers. At each wavelength, the zone between −2 and +2 corresponds to non-significant differences (p-value<0.05) between the two genotypes tested. Significant positive t-values indicated a higher absorbance value in wild type than in IRX5:HCHL plants. -
FIG. 5 . 2D-HSQC NMR spectra analysis of line IRX5:HCHL plants. 2D-HSQC NMR spectra of lignin from wild type (WT) stems (A) and from IRX5:HCHL (FCA1) stems (B); Difference spectrum (IRX5:HCHL (2)—wild type) showing the presence of new components in the aromatic region (C). -
FIG. 6 . Polydispersity profiles of CEL lignin purified from stems of wild type and line IRX:HCHL (2) plants. SEC chromatograms were obtained using (A) UV-A300 absorbance and (B) UV-Fex250/em450 fluorescence. -
FIG. 7 . Saccharification of biomass from mature senesced stems of IRX5:HCHL and wild type plants. Amount of reducing sugars released from 10 mg of biomass after hot water, dilute alkaline, or dilute acid pretreatment followed by 72-h enzymatic hydrolysis were measured using the DNS assay. Values are means of four biological replicates±SE. -
FIG. 8 . Alignment of amino acid sequences of Pseudomonas fluorescens HCHL (SEQ ID NO:1) and other homologous proteins. -
FIG. 9 . Organ and tissue-specific activity of the IRX5 promoter in Arabidopsis. Line CS70758, which contains a pIRX5:GUS expression cassette, was used to localize the activity of the IRX5 promoter. Young seedlings (A and B), rosettes leaves (C and D), siliques (E and F), cauline leaves (G and H), flowers (I and J), and inflorescence stems (K and L) were incubated in the GUS assay buffer for 1 h and 8 h at 37° C. Gus activity was essentially detected in the stem xylem vessels after a 1-h incubation (K). For longer incubations (8 h), GUS staining was also observed in interfascicular fibers of the stem (L), the vascular system of young seedlings (A), siliques (F) rosette (D) and cauline leaves (H), as well as in the style and anthers (J). x: xylem vessels, if: interfascicular fibers. Scale bars: 2 mm (A-B, E-F), 4 mm (C-D, G-H), 500 μm (I-J), 100 μm (K-L). -
FIG. 10 . Growth and development of IRX5:HCHL and wild type (WT) plants at different stages. (A) Three-week-old rosette (B) Five-week-old flowering stage. (C) Eight-week-old senescing stage. -
FIG. 11 . Synthesis of C6C1 phenolics production upon HCHL activity and probable associated enzymes. The phenylpropanoid pathway (center box) and monolignol pathway (left box) are represented. HCHL converts hydroxycinnamoyl-CoAs into their corresponding hydroxybenzaldehydes. Metabolomic data showed occurrence of hydroxycinnamic acids and alcohols, suggesting involvement of aldehyde dehydrogenases (DH) and reductases (left box). UDP-glucosyltransferases (UGT) are responsible for the formation of C6-C1 phenolic glucose conjugates. Syringaldehyde is possibly derived from vanillin and 5OH-vanillin after successive monooxyenase (Monox) and O-methyltransferase activities (OMT). Asterisks indicate compounds found in higher amount in lignin of Arabidopsis expressing HCHL. Abbreviations for enzymes are: PAL, phenylalanine ammonia lyase; C4H, cinnamate 4-hydroxylase; 4CL, 4-coumarate-CoA ligase; CCR, hydroxycinnamoyl-CoA reductase; CAD, coniferyl alcohol dehydrogenase; HCT, p-hydroxycinnamoyl-CoA:quinate shikimate p-hydroxycinnamoyl-CoA transferase; C3H, p-coumarate 3-hydroxylase; CCoAOMT, caffeoyl-CoA O-methyltransferase; FSH, ferulate 5-hydroxylase (coniferaldehyde 5-hydroxylase); COMT, caffeic acid/5-hydroxyferulic acid O-methyltransferase. -
FIG. 12 . Transgenic rice lines that express pAtIRX5::HCHL. -
FIG. 13 . Expression analysis of HCHL in the engineered rice lines. Results of an RT-PCR using RNA extracted from rice plants and HCHL-specific primers. -
FIG. 14 . Detection of pHBA in stems from the engineered rice lines. - As used herein, the term “hydroxycinnamoyl-CoA hydratase-lyase” or “HCHL” refers to an enzyme that catalyzes the hydration of the double bond of lignin precursor p-coumaroy-CoA, caffeoyl-CoA, or feruloyl-CoA thioester, which is followed by a retro aldol cleavage reaction to produce a corresponding C6C1 hydroxylbenzaldehyde and acetyl-CoA. A typical HCHL within the meaning of this invention is an HCHL from bacterium Pseudomonas fluorescens (EC 4.2.1.101-trans-feruloyl-CoA hydratase), which has the amino acid sequence set forth in
FIG. 11 as SEQ ID NO:1 (GenBank Accession No. CAA73502), encoded by cDNA sequence set forth in GenBank Accession No. Y13067.1 or by a codon-optimized polynucleotide sequence set forth in SEQ ID NO:2 (synthesized by GenScript, Piscatway, N.J.). In this application, the term HCHL includes polymorphic variants, alleles, mutants, and interspecies homologs to the Pseudomonas fluorescens HCHL, some examples of which are provided inFIG. 8 . A nucleic acid that encodes an HCHL refers to a gene, pre-mRNA, mRNA, and the like, including nucleic acids encoding polymorphic variants, alleles, mutants, and interspecies homologs of the particular sequences described herein. Thus, an HCHL nucleic acid (1) has a polynucleotide sequence that has greater than about 50% nucleotide sequence identity, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or higher nucleotide sequence identity, preferably over a region of at least about 10, 15, 20, 25, 50, 100, 200, 500 or more nucleotides or over the length of the entire polynucleotide, to a polynucleotide sequence encoding SEQ ID NO:1 (e.g., SEQ ID NO:2 or the polynucleotide sequence set forth in Y13067.1); or (2) encodes a polypeptide having an amino acid sequence that has greater than about 50% amino acid sequence identity, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or greater amino acid sequence identity, preferably over a region of at least about 25, 50, 100, 200 or more amino acids or over the length of the entire polypeptide, to a polypeptide having the amino acid sequence set forth in SEQ ID NO:1 or to any one of the amino acid sequences shown inFIG. 8 (SEQ ID NOs:4-34). The enzymatic activity of an HCHL within the meaning of this application can be verified by functional assays known in the art or described in the example section of this application, for its ability to convert any one of lignin precursors p-coumaroy-CoA, caffeoyl-CoA, and feruloyl-CoA thioester to a corresponding C6C1 hydroxylbenzaldehyde and acetyl-CoA. - The term “substantially localized,” when used in the context of describing a plant expressing an exogenous HCHL that is substantially localized to a particular tissue, refers to the enzymatic activity and modified monolignols produced therefore in substantially higher amounts in the particular cell or tissue type of interest as compared to other cell or tissue types. In some embodiments, the presence of HCHL and modified monolignols is substantially localized to the secondary cell wall of a plant cell and in the stem of a plant.
- The terms “polynucleotide” and “nucleic acid” are used interchangeably and refer to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5′ to the 3′ end. A nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, nucleic acid analogs may be used that may have alternate backbones, comprising, e.g., phosphoramidate, phosphorothioate, phosphorodithioate, or O-methylphosphoroamidite linkages (see Eckstein, Oligonucleotides and Analogues: A Practical Approach, Oxford University Press); positive backbones; non-ionic backbones, and non-ribose backbones. Thus, nucleic acids or polynucleotides may also include modified nucleotides that permit correct read-through by a polymerase. “Polynucleotide sequence” or “nucleic acid sequence” includes both the sense and antisense strands of a nucleic acid as either individual single strands or in a duplex. As will be appreciated by those in the art, the depiction of a single strand also defines the sequence of the complementary strand; thus the sequences described herein also provide the complement of the sequence. Unless otherwise indicated, a particular nucleic acid sequence also implicitly encompasses variants thereof (e.g., degenerate codon substitutions) and complementary sequences, as well as the sequence explicitly indicated. The nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid may contain combinations of deoxyribo- and ribo-nucleotides, and combinations of bases, including uracil, adenine, thymine, cytosine, guanine, inosine, xanthine hypoxanthine, isocytosine, isoguanine, etc.
- The term “substantially identical,” used in the context of two nucleic acids or polypeptides, refers to a sequence that has at least 50% sequence identity with a reference sequence. Percent identity can be any integer from 50% to 100%. Some embodiments include at least: 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, compared to a reference sequence using the programs described herein; preferably BLAST using standard parameters, as described below. For example, an HCHL may have an amino acid sequence that is at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:1, the amino acid sequence of Pseudomonas fluorescens HCHL.
- Two nucleic acid sequences or polypeptide sequences are said to be “identical” if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The terms “identical” or percent “identity,” in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers & Miller, Computer Applic. Biol. Sci. 4:11-17 (1988) e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif., USA).
- For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.
- A “comparison window,” as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection.
- Algorithms that are suitable for determining percent sequence identity and sequence similarity are the BLAST and BLAST 2.0 algorithms, which are described in Altschul et al. (1990) J. Mol. Biol. 215: 403-410 and Altschul et al. (1977) Nucleic Acids Res. 25: 3389-3402, respectively. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (NCBI) web site. The algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al, supra). These initial neighborhood word hits acts as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatching residues; always <0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses as defaults a word size (W) of 28, an expectation (E) of 10, M=1, N=−2, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a word size (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)).
- The BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.01, more preferably less than about 105, and most preferably less than about 10.
- Nucleic acid or protein sequences that are substantially identical to a reference sequence include “conservatively modified variants.” With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode any given protein. For instance, the codons GCA, GCC, GCG and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded polypeptide. Such nucleic acid variations are “silent variations,” which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes every possible silent variation of the nucleic acid. One of skill will recognize that each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine) can be modified to yield a functionally identical molecule. Accordingly, each silent variation of a nucleic acid which encodes a polypeptide is implicit in each described sequence.
- As to amino acid sequences, one of skill will recognize that individual substitutions, in a nucleic acid, peptide, polypeptide, or protein sequence which alters a single amino acid or a small percentage of amino acids in the encoded sequence is a “conservatively modified variant” where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art.
- The following six groups each contain amino acids that are conservative substitutions for one another:
- 2) Aspartic acid (D), Glutamic acid (E);
- (see, e.g., Creighton, Proteins (1984)).
- Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other, or a third nucleic acid, under stringent conditions. Stringent conditions are sequence dependent and will be different in different circumstances. Generally, stringent conditions are selected to be about 5° C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Typically, stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60° C. For example, stringent conditions for hybridization, such as RNA-DNA hybridizations in a blotting technique are those which include at least one wash in 0.2×SSC at 55° C. for 20 minutes, or equivalent conditions.
- The term “promoter,” refers to a polynucleotide sequence capable of driving transcription of a DNA sequence in a cell. Thus, promoters used in the polynucleotide constructs of the invention include cis- and trans-acting transcriptional control elements, translational control elements (5′UTR: untranslated region) and regulatory sequences that are involved in regulating or modulating the timing and/or rate of transcription of a gene. For example, a promoter can be a cis-acting transcriptional control element, including an enhancer, a promoter, a transcription terminator, an origin of replication, a chromosomal integration sequence, 5′ and 3′ untranslated regions, or an intronic or exonic sequence, which are involved in transcriptional regulation. These cis-acting sequences typically interact with proteins or other biomolecules to carry out (turn on/off, regulate, modulate, etc.) gene transcription. Promoters are located 5′ to the transcribed gene, and as used herein, include the
sequence 5′ from the translation start codon (i.e., including the 5′ untranslated region of the mRNA, typically comprising 50-200 bp). Most often the core promoter sequences lie within 1-3 kb of the translation start site, more often within 1 kbp and often within 500 bp of the translation start site. By convention, the promoter sequence is usually provided as the sequence on the coding strand of the gene it controls. - A “constitutive promoter” is one that is capable of initiating transcription in nearly all cell types, whereas a “cell type-specific promoter” initiates transcription only in one or a few particular cell types or groups of cells forming a tissue. In some embodiments, the promoter is secondary cell wall specific. Secondary cell wall is mainly composed of cellulose, hemicellulose, and lignin and is deposited in some, but not all, tissues of a plant, such as woody tissue. As used herein, a “secondary cell wall specific” promoter refers to a promoter that initiates higher levels of transcription in cell types that have secondary cell walls, e.g., lignified tissues such as vessels and fibers, which may be found in wood and bark cells of a tree, as well as other parts of plants such as the leaf stalk. In some embodiments, a promoter is secondary cell wall specific if the transcription levels initiated by the promoter in secondary cell walls are at least 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 50-fold, 100-fold, 500-fold, 1000-fold higher or more as compared to the transcription levels initiated by the promoter in other tissues, resulting in the encoded protein substantially localized in plant cells that possess secondary cell wall, e.g., the stem of a plant. Non-limiting examples of secondary cell wall specific promoters include the promoters directing expression of genes IRX1, IRX3, IRX5, IRX7, IRX8, IRX9, IRX10, IRX14, NST1, NST2, NST3, MYB46, MYB58, MYB63, MYB83, MYB85, MYB103, PAL1, PAL2, C3H, CcOAMT, CCR1, F5H, LAC4, LAC17, CADc, and CADd. See, e.g., Turner et al 1997; Meyer et al 1998; Jones et al 2001; Franke et al 2002; Ha et al 2002; Rohde et al 2004; Chen et al 2005; Stobout et al 2005; Brown et al 2005; Mitsuda et al 2005; Zhong et al 2006; Mitsuda et al 2007; Zhong et al 2007a, 2007b; Zhou et al 2009; Brown et al 2009; McCarthy et al 2009; Ko et al 2009; Wu et al 2010; Berthet et al 2011. In some embodiments, the promoter is substantially identical to the native promoter sequence directing expression of the IRX5 gene (see, e.g., the promoter and transcriptional regulatory elements for IRX5 are contained in SEQ ID NO:3). Some of the above mentioned secondary cell wall promoter sequences can be found within the polynucleotide sequences provided herein as SEQ ID NOs:36-61. A promoter originated from one plant species may be used to direct gene expression in another plant species.
- A polynucleotide is “heterologous” to an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, when a polynucleotide encoding a polypeptide sequence is said to be operably linked to a heterologous promoter, it means that the polynucleotide sequence encoding the polypeptide is derived from one species whereas the promoter sequence is derived from another, different species; or, if both are derived from the same species, the coding sequence is not naturally associated with the promoter (e.g., is a genetically engineered coding sequence, e.g., from a different gene in the same species, or an allele from a different ecotype or variety).
- The term “operably linked” refers to a functional relationship between two or more polynucleotide (e.g., DNA) segments. Typically, it refers to the functional relationship of a transcriptional regulatory sequence to a transcribed sequence. For example, a promoter or enhancer sequence is operably linked to a DNA or RNA sequence if it stimulates or modulates the transcription of the DNA or RNA sequence in an appropriate host cell or other expression system. Generally, promoter transcriptional regulatory sequences that are operably linked to a transcribed sequence are physically contiguous to the transcribed sequence, i.e., they are cis-acting. However, some transcriptional regulatory sequences, such as enhancers, need not be physically contiguous or located in close proximity to the coding sequences whose transcription they enhance.
- The term “expression cassette” refers to a nucleic acid construct that, when introduced into a host cell, results in transcription and/or translation of an RNA or polypeptide, respectively. Antisense or sense constructs that are not or cannot be translated are expressly included by this definition. In the case of both expression of transgenes and suppression of endogenous genes (e.g., by antisense, RNAi, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only substantially identical to a sequence of the gene from which it was derived. As explained herein, these substantially identical variants are specifically covered by reference to a specific nucleic acid sequence. One example of an expression cassette is a polynucleotide construct that comprises a polynucleotide sequence encoding a HCHL protein operably linked to a promoter that is heterologous to the plant cell into which the expression cassette may be introduced. In some embodiments, an expression cassette comprises a polynucleotide sequence encoding a HCHL protein that is targeted to a position in the genome of a plant such that expression of the HCHL polynucleotide sequence is driven by a promoter that is present in the plant.
- The term “plant,” as used herein, refers to whole plants and includes plants of a variety of a ploidy levels, including aneuploid, polyploid, diploid and haploid. The term “plant part,” as used herein, refers to shoot vegetative organs and/or structures (e.g., leaves, stems and tubers), branches, roots, flowers and floral organs (e.g., bracts, sepals, petals, stamens, carpels, anthers), ovules (including egg and central cells), seed (including zygote, embryo, endosperm, and seed coat), fruit (e.g., the mature ovary), seedlings, and plant tissue (e.g., vascular tissue, ground tissue, and the like), as well as individual plant cells, groups of plant cells (e.g., cultured plant cells), protoplasts, plant extracts, and seeds. The class of plants that can be used in the methods of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, and multicellular algae.
- The term “biomass,” as used herein, refers to plant material that is processed to provide a product, e.g., a biofuel such as ethanol, or livestock feed, or a cellulose for paper and pulp industry products. Such plant material can include whole plants, or parts of plants, e.g., stems, leaves, branches, shoots, roots, tubers, and the like.
- The term “reduced lignification” encompasses both reduced size of a lignin polymer, e.g., a shorter lignin polymer chain due to a smaller number of monolignols being incorporated into the polymer, a reduced degree of branching of the lignin polymer or a reduced space filling (also called a reduced pervaded volume). Typically, a reduced lignin polymer can be shown by detecting a decrease in it molecular weight or a decrease in the number of monolignols by at least 2%, 5%, 10%, 20%, 25%, 30%, 40%, 50%, or more, when compared to the average lignin molecule in a control plant. Methods for detecting reduced lignification are described in detail in the example section of this application.
- As used herein and in the appended claims, the singular “a”, “an” and “the” include the plural reference unless the context clearly dictates otherwise. Thus, for example, reference to a “plant cell” includes a plurality of such plant cells.
- Plant cell walls are constituted by a polysaccharidic network of cellulose microfibrils and hemicellulose embedded in an aromatic polymer known as lignin. This ramified polymer is mainly composed of three phenylpropanoid-derived phenolics (i.e., monolignols) named p-coumaryl, coniferyl, and sinapyl alcohols which represent the p-hydroxyphenyl (H), guaiacyl (G) and syringyl (S) lignin units (Boerjan et al., 2003). Monolignols have a C6C3 carbon skeleton which consists of a phenyl ring (C6) and a propane (C3) side chain. Lignin is crucial for the development of terrestrial plants as it confers recalcitrance to plant cell walls. It also provides mechanical strength for upright growth, confers hydrophobicity to vessels that transport water, and acts as a physical barrier against pathogens that degrade cell walls (Boudet, 2007). Notably, lignin content and composition are finely regulated in response to environmental biotic and abiotic stresses (Moura et al., 2010).
- Economically, lignocellulosic biomass from plant cell walls is widely used as raw material for the production of pulp in paper industry and as ruminant livestock feed. Plant feedstocks also represent a source of fermentable sugars for the production of synthetic molecules such as pharmaceuticals and transportation fuels using engineered microorganisms (Keasling, 2010). However, negative correlations exist between lignin content in plant biomass and pulp yield, forage digestibility, or polysaccharides enzymatic hydrolysis (de Vrije et al., 2002; Reddy et al., 2005; Dien et al., 2006; Chen and Dixon, 2007; Dien et al., 2009; Taboada et al., 2010; Elissetche et al., 2011; Studer et al., 2011). Consequently, reducing lignin recalcitrance in plant feedstocks is a major focus of interest, especially in the lignocellulosic biofuels field for which efficient enzymatic conversion of polysaccharides into monosaccharides is crucial to achieve economically and environmentally sustainable production (Carroll and Somerville, 2009).
- Lignin biosynthesis is well characterized and well conserved across land plants (Weng and Chapple 2010). Genetic modifications such as silencing of genes involved in particular steps of this pathway or its regulation have been employed to reduce lignin content (Simmons et al., 2010; Umezawa, 2010) but this approach often results in undesired phenotypes such as dwarfism, sterility, reduction of plant biomass, and increased susceptibly to environmental stress and pathogens (Bonawitz and Chapple, 2010). These pleiotropic effects are generally the consequences of a loss of secondary cell wall integrity, accumulation of toxic intermediates, constitutive activation of defense responses, or depletion of other phenylpropanoid-derived metabolites which are essential for plant development and defense (Li et al., 2008; Naoumkina et al., 2010, Gallego-Giraldo et al., 2011). Alternatively, changing the recalcitrant structure and physico-chemical properties of lignin can be achieved by modifying its monomer composition. For example, incorporation of coniferyl ferulate into lignin improves enzymatic degradation of cell wall polysaccharides (Grabber et al., 2008). Recently, it has been demonstrated that enrichment in 5-hydroxy-G units and reduction in S units in lignin contribute to enhanced saccharification efficiencies without affecting drastically biomass yields and lignin content (Weng et al., 2010; Dien et al., 2011; Fu et al., 2011).
- In this study, as an alternative strategy to reduce lignin recalcitrance, the inventors developed a dominant approach that uses precursors derived from the lignin biosynthetic pathways to enhance production of non-conventional monolignols, namely C6C1 phenolics. These phenol units lack propane side chain and thus have different polymerization properties compared to classic C6C3 monolignols. Such C6C1 phenolics are usually found in trace amount in some lignins and form the so-called ‘benzyl end-groups’ (Kim et al., 2000; Ralph et al., 2001; Kim et al., 2003; Morreel et al., 2004; Ralph et al., 2008; Kim and Ralph, 2010). The inventors considered increasing C6C1 end-group phenolics in lignin to reduce its polymerization degree and native branched structure. For this purpose, a hydroxycinnamoyl-CoA hydratase-lyase (HCHL, EC 4.2.2.101/EC 4.1.2.41) from Pseudomonas fluorescens was expressed in stems of Arabidopsis. HCHL is an enzyme that catalyzes the hydration of the double bond of the lignin precursor p-coumaroyl-CoA, caffeoyl-CoA, and feruloyl-CoA thioesters, followed by a retro aldol cleavage reaction that produces the corresponding C6C1 hydroxybenzaldehydes and acetyl-CoA (
FIG. 1 ; Mitra et al., 1999). The promoter of a secondary cell wall cellulose synthase gene (Cesa4/IRX5) was used to restrict HCHL expression in lignified tissues of the stem (xylem and interfascicular fibers) and prevent depletion of hydroxycinnamoyl-CoAs in other tissues in which they are precursors of hydroxycinnamate conjugates and other derivates involved in plant defense and development (Gou et al., 2009; Luo et al., 2009; Buer et al., 2010; Milkowski and Strack, 2010). The data disclosed herein show that HCHL expression driven by the IRX5 promoter results for some lines in no significant changes in lignin content, plant development and biomass yields. It has also been demonstrated that C6C1 phenolics accumulate as end-groups in the lignin of HCHL transgenics, which reduces lignin size and renders cell walls less recalcitrant to enzymatic hydrolysis. - A. Modification of Expression of an HCHL Enzyme
- In one aspect, the present invention provides a method for engineering a plant having reduced lignification. This method includes these steps: first, introducing into the plant an expression cassette comprising a polynucleotide sequence encoding an HCHL enzyme and a promoter, with the coding sequence and the promoter being in an operably linked arrangement; and second, culturing the plant under conditions permissible for the expression of a functional HCHL to produce C6C1 phenolics, which can be polymerized with other monolignols and thereby reducing lignification in the plant.
- In particular, the present invention provides methods of engineering a plant having modified lignin polymers, which may have reduced size, molecular weight, and/or altered (especially reduced or less extensive) branching, that are substantially localized to the lignified tissue of the plant. This is achieved by first introducing into the plant an expression cassette as described above but in particular having a secondary cell wall specific promoter, and then culturing the plant under conditions in which the functional HCHL enzyme is expressed. This enzyme converts various hydroxycinnamoyl-coA into their respective hydroxybenzaldehydes that can be either directly incorporated or further modified (e.g., oxidation or reduction of the aldehyde group) by native enzymes prior to their incorporation into the lignin polymer by polymerization with native monolignols.
- The expression cassette as described herein, when introduced into a plant, does not necessarily modify the lignin content. Vessel stays intact indicating that the lignin cell wall structure is still robust to prevent vessel collapse, but the lignin composition and properties are modified to a level that its recalcitrance is reduce.
- One of skill in the art will understand that the HCHL that is introduced into the plant by an expression cassette described herein does not have to be identical to the Pseudomonas fluorescens HCHL, which was used in the experiments detailed in the example section of this disclosure. In some embodiments, the HCHL that is introduced into the plant by an expression cassette is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to the Pseudomonas fluorescens HCHL. For example, a variant HCHL will have at least 80%, 85%, 90%, or 95% sequence identity in its amino acid residues as compared to SEQ ID NO:1, especially within one or more of the 8 highly conserved regions (shown in the 8 boxes in
FIG. 8 ). - 1. Hydroxycinnamoyl-CoA Hydratase-Lyase (HCHL)
- In some embodiments, the expression cassette of this invention comprises a polynucleotide encoding an enzyme that produces modified monoligols that can cause reduced lignification. An example of such an enzyme is the Pseudomonas fluorescens HCHL, having the amino acid sequence set forth in SEQ ID NO:1. Additional examples of such HCHL suitable for use in the present invention include those shown in
FIG. 8 . Also appropriate for use in the present invention are variants HCHL, which may be naturally occurring or recombinantly engineered, provided the variants possess (1) substantially amino acid sequence identity to an exemplary HCHL (e.g., SEQ ID NO:1) and (2) the enzymatic activity to convert at least one lignin precursor p-coumaroy-CoA, caffeoyl-CoA, or feruloyl-CoA thioester into a corresponding C6C1 hydroxylbenzaldehyde, as determined by an HCHL enzymatic assay known in the art by way of various scientific publications or described herein. - Examples of naturally occurring HCHL that can be used to practice the present invention includes, p-hydroxycinnamoyl CoA hydratase/lyase (HCHL), Enoyl-CoA hydratase/isomarase (ECH), Feruloyl-CoA hydratase/lyase (FCA, FerA), as well as those named in
FIG. 8 , the amino acid sequences for which are provided in SEQ ID NOs:4-34. - 2. Secondary Cell Wall-Specific Promoters
- In some embodiments, the polynucleotide encoding the HCHL is operably linked to a secondary cell wall-specific promoter. The secondary cell wall-specific promoter is heterologous to the polynucleotide encoding the HCHL, in other words, the promoter and the HCHL coding sequence are derived from two different species. A promoter is suitable for use as a secondary cell wall-specific promoter if the promoter is expressed strongly in the secondary cell wall, e.g., in vessel and fiber cells of the plant, but is expressed at a much lower level or not expressed in cells without the secondary cell wall.
- In some embodiments, the promoter is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to the native promoter of a gene encoding a secondary cell wall cellulose synthase Cesa4/IRX5, polynucleotide sequence set forth in Genebank Accession No.
AF458083 —1 and SEQ ID NO:35, and the promoter pIRX5 is contained in SEQ ID NO:3. - In some embodiments, the secondary cell wall-specific promoter comprises SEQ ID NO:3. In some embodiments, the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 or a variant thereof. In some embodiments, the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 comprising about 50 to about 1000 or more contiguous nucleotides of SEQ ID NO:3. In some embodiments, the secondary cell wall-specific promoter comprises a subsequence of SEQ ID NO:3 comprising 50 to 1000, 50 to 900, 50 to 800, 50 to 700, 50 to 600, 50 to 500, 50 to 400, 50 to 300, 50 to 200, 50 to 100; 75 to 1000, 75 to 900, 75 to 800, 75 to 700, 75 to 600, 75 to 500, 75 to 400, 75 to 300, 75 to 200; 100 to 1000, 100 to 900, 100 to 800, 100 to 700, 100 to 600, 100 to 500, 100 to 400, 100 to 300, or 100 to 200 contiguous nucleotides of SEQ ID NO:3.
- Secondary cell wall-specific promoters are also described in the art. See, for example, Mitsuda et al 2005 Plant Cell; Mitsuda et al 2007 Plant Cell; Zhou et al 2009 plant cell; Ohtani et al 2011 Plant Journal. They are contained the polynucleotide sequences provided in this application as SEQ ID NO:36-61.
- It will be appreciated by one of skill in the art that a promoter region can tolerate considerable variation without diminution of activity. Thus, in some embodiments, the secondary cell wall-specific promoter is substantially identical (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical) to SEQ ID NO:3. The effectiveness of a secondary cell wall-specific promoter may be confirmed by an reporter gene (e.g., β-glucuronidase or GUS) assay known in the art or as described in the example section of this application.
- B. Preparation of Recombinant Expression Vectors
- Once the promoter sequence and the coding sequence for the gene of interest (e.g., a Pseudomonas fluorescens HCHL or any other HCHL as shown in
FIG. 8 ) are obtained, the sequences can be used to prepare an expression cassette for expressing the gene of interest in a transgenic plant. Typically, plant transformation vectors include one or more cloned plant coding sequences (genomic or cDNA) under the transcriptional control of 5′ and 3′ regulatory sequences and a selectable marker. Such plant transformation vectors may also contain a promoter (e.g., a secondary cell wall-specific promoter as described herein), a transcription initiation start site, an RNA processing signal (such as intron splice sites), a transcription termination site, and/or a polyadenylation signal. - The plant expression vectors may include RNA processing signals that may be positioned within, upstream, or downstream of the coding sequence. In addition, the expression vectors may include regulatory sequences taken from the 3′-untranslated region of plant genes, e.g., a 3′ terminator region to increase mRNA stability of the mRNA, such as the PI-II terminator region of potato or the octopine or
nopaline synthase 3′ terminator regions. - Plant expression vectors routinely also include selectable marker genes to allow for the ready selection of transformants. Such genes include those encoding antibiotic resistance genes (e.g., resistance to hygromycin, kanamycin, bleomycin, G418, streptomycin or spectinomycin), herbicide resistance genes (e.g., phosphinothricin acetyltransferase), and genes encoding positive selection enzymes (e.g. mannose isomerase).
- Once an expression cassette comprising a polynucleotide encoding the HCHL and operably linked to a promoter (especially a secondary cell wall specific promoter) has been constructed, standard techniques may be used to introduce the polynucleotide into a plant in order to express the HCHL and effectuate reduced lignification. See, e.g., protocols described in Ammirato et al. (1984) Handbook of Plant Cell Culture—Crop Species. Macmillan Publ. Co. Shimamoto et al. (1989) Nature 338:274-276; Fromm et al. (1990) Bio/Technology 8:833-839; and Vasil et al. (1990) Bio/Technology 8:429-434.
- Transformation and regeneration of plants is known in the art, and the selection of the most appropriate transformation technique will be determined by the practitioner. Suitable methods may include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG) mediated transformation; transformation using viruses; micro-injection of plant cells; micro-projectile bombardment of plant cells; vacuum infiltration; and Agrobacterium tumeficiens mediated transformation. Transformation means introducing a nucleotide sequence in a plant in a manner to cause stable or transient expression of the sequence. Examples of these methods in various plants include: U.S. Pat. Nos. 5,571,706; 5,677,175; 5,510,471; 5,750,386; 5,597,945; 5,589,615; 5,750,871; 5,268,526; 5,780,708; 5,538,880; 5,773,269; 5,736,369 and 5,610,042.
- Following transformation, plants can be selected using a selectable marker incorporated into the transformation vector. Typically, such a marker will confer antibiotic or herbicide resistance on the transformed plants or the ability to grow on a specific substrate, and selection of transformants can be accomplished by exposing the plants to appropriate concentrations of the antibiotic, herbicide, or substrate.
- The polynucleotide sequence coding for an HCHL, as well as the polynucleotide sequence comprising a promoter (e.g., a secondary cell wall-specific promoter), can be obtained according to any method known in the art. Such methods can involve amplification reactions such as polymerase chain reaction (PCR) and other hybridization-based reactions or can be directly synthesized.
- C. Plants in which Lignification can be Reduced
- An expression cassette comprising a polynucleotide encoding an HCHL operably linked to a promoter, especially a secondary cell wall specific promoter, as described herein, can be expressed in various kinds of plants. The plant may be a monocotyledonous plant or a dicotyledonous plant. In some embodiments of the invention, the plant is a green field plant. In some embodiments, the plant is a gymnosperm or conifer.
- In some embodiments, the plant is a plant that is suitable for generating biomass. Examples of suitable plants include, but are not limited to, Arabidopsis, poplar, eucalyptus, rice, corn, switchgrass, sorghum, millet, miscanthus, sugarcane, pine, alfalfa, wheat, soy, barley, turfgrass, tobacco, hemp, bamboo, rape, sunflower, willow, Jatropha, and Brachypodium.
- In some embodiments, the plant into which the expression cassette of this invention is introduced is the same species of plant as the one from which the promoter is derived. In some embodiments, the plant into which the expression cassette is introduced is a different species of plant from the plant species the promoter is derived from.
- D. Screening for Plants Having Reduced Lignification
- After transformed plants are selected, the plants or parts of the plants may be evaluated to determine whether expression of the exogenous HCHL can be detected, e.g., by evaluating the level of RNA or protein, by measuring enzymatic activity of the HCHL, as well as by evaluating the size, molecular weight, content, or degree of branching in the lignin molecules found in the plants. These analyses can be performed using any number of methods known in the art.
- In some embodiments, plants are screened by evaluating the level of RNA or protein. Methods of measuring RNA expression are known in the art and include, for example, PCR, northern analysis, reverse-transcriptase polymerase chain reaction (RT-PCR), and microarrays. Methods of measuring protein levels are also known in the art and include, for example, mass spectroscopy or antibody-based techniques such as ELISA, Western blotting, flow cytometry, immunofluorescence, and immunohistochemistry.
- In some embodiments, plants are screened by assessing HCHL activity, and also by evaluating lignin size and composition. The enzymatic assays for HCHL are well known in the art and are described in this application. Lignin molecules can be assessed, for example, by nuclear magnetic resonance (NMR), spectrophotometry, microscopy, klason lignin assays, acetyl-bromide reagent or by histochemical staining (e.g., with phloroglucinol).
- Plants, parts of plants, or plant biomass material from plants having reduced lignification due to the expression of an exogenous HCHL in the secondary cell wall can be used for a variety of methods. In some embodiments, the plants, parts of plants, or plant biomass material generate less recalcitrant biomass for use in a conversion reaction as compared to wild-type plants. In some embodiments, the plants, parts of plants, or plant biomass material are used in a saccharification reaction, e.g., enzymatic saccharification, to generate soluble sugars at an increased level of efficiency as compared to wild-type plants. In some embodiments, the plants, parts of plants, or plant biomass material are used to increase biomass yield or simplify downstream processing for wood industries (such as paper, pulping, and construction) as compared to wild-type plants. In some embodiments, the plants, parts of plants, or plant biomass material are used to increase the quality of wood for construction purposes. In some embodiments the plants, parts of plants, or plant biomass material can be used in a combustion reaction, gasification, pyrolysis, or polysaccharide hydrolysis (enzymatic or chemical). In further embodiments, the plants, parts of plants, or plant biomass is used as a forage crop and exhibit improved digestibility compared to wild-type plants.
- Methods of conversion, for example biomass gasification, are known in the art. Briefly, in gasification plants or plant biomass material (e.g., leaves and stems) are ground into small particles and enter the gasifier along with a controlled amount of air or oxygen and steam. The heat and pressure of the reaction break apart the chemical bonds of the biomass, forming syngas, which is subsequently cleaned to remove impurities such as sulfur, mercury, particulates, and trace materials. Syngas can then be converted to products such as ethanol or other biofuels.
- Methods of enzymatic saccharification are also known in the art. Briefly, plants or plant biomass material (e.g., leaves and stems) are optionally pre-treated with hot water, dilute alkaline, AFEX (Ammonia Fiber Explosion), ionic liquid or dilute acid, followed by enzymatic saccharification using a mixture of cell wall hydrolytic enzymes (such as hemicellulases, cellulases and beta-glucosidases) in buffer and incubation of the plants or plant biomass material with the enzymatic mixture. Following incubation, the yield of the saccharification reaction can be readily determined by measuring the amount of reducing sugar released, using a standard method for sugar detection, e.g. the dinitrosalicylic acid method well known to those skilled in the art. Plants engineered in accordance with the invention provide a higher saccharification efficiency as compared to wild-type plants, while the plants growth, development, or disease resistance is not negatively impacted.
- Sugars generated from a saccharification reaction using plant biomass of the invention can be used for producing any product for which the sugars can serve as a carbon source. Examples of products include, but are not limited to, alcohols (e.g., ethanol, methanol, butanol); organic acids (e.g., citric acid, acetic acid, itaconic acid, lactic acid, gluconic acid); ketones (e.g., acetone); amino acids (e.g., glutamic acid); gases (e.g., H2 and CO2); antibiotics (e.g., penicillin and tetracycline); vitamins (e.g., riboflavin, B12, beta-carotene), fatty acids and fatty acid derivatives (as described, e.g., in PCT/US2008/068833); isoprenyl alkanoates (as described, e.g., PCT/US2008/068756, methyl butenol (as described, e.g., PCT/US2008/068831; fatty acid esters (as described, e.g., in PCT/US2010/033299), isoprenoid-based alternative diesel fuels (as described, e.g., in PCT/US2011/059784; a polyketide synthesized by a polyketide synthase, such as a diacid (see, e.g., PCT/US2011/061900), biofuels (see, e.g., PCT/US2009/042132) and alpha-olefins (see, e.g., PCT/US2011/053787).
- The following examples are provided to illustrate but not to limit the claimed invention.
- Arabidopsis thaliana (ecotype Columbia, Col-0) seeds were germinated directly on soil. Growing conditions were 14 h of light per day at 100 mmol m−2 s−1, 22° C., 55% humidity. Selection of T1 and T2 homozygote transgenic plants was made on solid Murashige and Skoog vitamin medium (PhytoTechnology Laboratories) supplemented with 1% sucrose, 1.5% agar (Sigma-Aldrich) adjusted to pH 5.6-5.8, and containing 50 μg mL−1 kanamycin.
- 4-Hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, vanillic acid, 4-hydroxybenzaldehyde, vanillin, 5-hydroxyvanillin, 4-hydroxybenzyl alcohol, vanillyl alcohol, and 1-methyl-2-pyrrolidinone were purchased from Sigma-Aldrich. Vanillic acid, syringic acid, 3,4-dihydroxybenzaldehyde, syringaldehyde, and sinapyl alcohol were purchased from Alfa Aesar. 5-Hydroxyvanillic acid was obtained from Chromadex, and 3,4-dihydroxybenzyl alcohol from TCI America.
- pIRX5:GUS Line and GUS Staining
- Arabidopsis line CS70758 (ecotype Columbia, Col-2) was obtained from the Arabidopsis Biological Resource Center (ABRC). This line has a pMLBART plasmid containing an expression cassette consisting of the genomic fragment located upstream of the CESA4 start codon fused to the GUS gene. Histochemical GUS activity was performed as previously described (Eudes et al., 2006). Various organs of soil-grown line CS70758 were incubated for 1 h or 8 h at 37° C. in the GUS assay buffer using 5-bromo-4-chloro-3-indolyl-D-glucuronic acid (Indofine Chemical Company, Inc.) as a substrate. After staining, stem samples (1 cm) were cross-sectioned (80 μm) using a vibratome before observation under the microscope (Leica).
- For HCHL expression in Arabidopsis, the binary vector pTKan which is derived from pPZP212 was used (Hajdukiewicz et al., 2004). A Gateway cloning cassette (Invitrogen) was inserted between XhoI and PstI restriction sites to produce a pTKan-GW vector. The nucleotide sequence of the IRX5 promoter was amplified by PCR from Arabidopsis (ecotype Columbia, Col-0) genomic
DNA using oligonucleotides 5′-CCCGGCGGCCGCATGAAGCCATCCTCTACCTCGGAAA-3′ and 5′-CCCGGCTAGCGGCGAGGTACACTGAGCTCTCGGAA-3′ (NotI and NheI restriction sites underlined), and inserted between the ApaI and SpeI restriction sites of pTKan-GW to produce a pTKan-pIRX5-GW expression vector. A codon-optimized nucleotide sequence encoding the HCHL enzyme from Pseudomonas fluorescens AN103 (accession number CAA73502) for expression in Arabidopsis was synthesized without stop codon (Genescript) and amplified byPCR using oligonucleotides 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGTCTACTTACGAGGGAAGATG G-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTCTCTCTTGTAAGCCTGGAGTCC-3′ (attb1 and attb2 sites underlined) for cloning into the Gateway pDONR221-f1 entry vector (Lalonde et al 2010). A sequence-verified HCHL entry clone was LR recombined with the pTKan-pIRX5-GW vector to generate the final IRX5:HCHL construct. The construct was introduced into wild type Arabidopsis plants (ecotype Col0) via Agrobacterium tumefaciens-mediated transformation (Bechtold and Pelletier, 1998). - Total RNA (1 μg) extracted from inflorescence stems of IRX5:HCHL T1 transformants and wild type plants using the Plant RNeasy extraction kit (Qiagen) was reverse-transcribed using the Transcriptor First Strand cDNA Synthesis Kit (Roche applied Science). The obtained cDNA preparation was quality-controlled for PCR using tub8-specific oligonucleotides (5′-GGGCTAAAGGACACTACACTG-3′/5′-CCTCCTGCACTTCCACTTCGTCTTC-3′).
Oligonucleotides 5′-ATGTCTACTTACGAGGGAAGATGG-3′ and 5′-TCTCTTGTAAGCCTGGAGTCC-3′ were used for the detection of HCHL expression by PCR. - For protein extraction, inflorescence stems of IRX5:HCHL T2 transformants and wild type plants were ground in liquid nitrogen, and 0.25 g of the resulting powder was homogenized with the extraction buffer [100 mM Tris-HCl pH 6.5, 2% (w/v) polyvinylpyrrolidone, 2% (v/v) β-mercaptoethanol, 1% (w/v) SDS] at 1400 rpm for 30 min. The mixture was centrifuged at 20,000 g for 5 min and the supernatant collected for protein quantification using the Bradford method (Bradford, 1976) and bovine serum albumin as a standard. For electrophoresis, soluble protein (5 μg) were mixed with 0.2 M Tris-HCl, pH 6.5, 8% (w/v) SDS, 8% (v/v) β-mercaptoethanol, 40% (v/v) glycerol, and 0.04% (w/v) bromophenol blue and incubated at 40° C. for 30 min. Proteins were separated by SDS-PAGE using 8-16% (w/v) polyacrylamide gradient gels (Invitrogen) and electrotransferred (100 volts, 45 min) onto PVDF membranes (Thermo Fisher Scientific). Blotted membranes were incubated 1 h in TBS-T (20 m
M Tris-HCl, 150 mM NaCl, 0.1% (v/v)Tween 20, pH 7.6) containing 2% (w/v) non-fat milk powder, and incubated overnight with the universal antibody (1:20000) in TBS-T containing 2% (w/v) non-fat milk powder. Membranes were then washed in TBS-T for 30 min and incubated for 1 h with an anti-rabbit secondary antibody conjugated to horseradish peroxidase (1:20000; Sigma-Aldrich) in TBS-T containing 2% (w/v) non-fat milk powder. Membranes were then washed in TBS-T for 30 min, and detection was performed by chemiluminescence using the SuperSignal West Dura Extended Duration Substrate (Thermo Fisher Scientific). - For protein extraction, inflorescence stems of IRX5:HCHL T2 transformants and wild type plants were ground in liquid nitrogen, and 0.25 g of the resulting powder was homogenized with 25 mg of polyvinylpolypyrrolidone and 1.25 mL of extraction buffer (EB; 100 mM Tris-HCl, pH 8.5, 20 mM DTT, and 10 mM Na2EDTA). Extracts were shaken at 1400 rpm for 15 min at 4° C., and centrifuged for 30 min at 20,000 g at 4° C. Supernatants were collected, adjusted to 2.5 mL with EB, and applied to PD10 columns (GE healthcare) pre-equilibrated with 25 mL of EB. Proteins were eluted with 3.5 mL of EB and quantified using the Bradford method (Bradford, 1976) and bovine serum albumin as a standard.
- For HCHL activity, 5 μL of protein extract was incubated for 15 min at 30° C. with 150 μM feruloyl-CoA in 100 m
M Tris-HCl pH 8.5 in a total volume of 50 μL. Total amounts of protein per reaction varied from 4 to 6.5 μg. Reactions were stopped with 50 μL of cold acidified methanol (12% glacial acetic acid/88% methanol, v/v) and stored at −70° C. until LC-MS analysis. - For biomass measurements, IRX5:HCHL and wild type plants were grown until senescence and dried stems were collected without roots, leaves and siliques before weighing. Statistical analysis was performed using ANOVA followed by Scheffe post hoc test.
- Five-week-old plants were use for microscopy. Stem segments cut between the first and second internodes were embedded in 4% agarose. Stem semi-thin sections (100-μm thickness) were obtained using a vibratome (Leica). For toluidine blue O (TBO) staining, sections were incubated in a 0.05% (w/v) solution of TBO (Sigma-Aldrich) in water for 30 sec and rinsed with water. For Wiesner lignin staining, sections were incubated for 3 min in phloroglucinol-HCl reagent (VWR International) and rinsed with water. For Mäulne lignin staining, sections were incubated in 4% KMnO4 for 5 min, rinsed with water, incubated in 37% HCl/H2O (1:1, v/v) for 2 min, and observed after addition of a drop of aqueous ammonia. Sections were immediately observed using bright field light microscopy (Leica DM4000 B).
- For extraction of methanol soluble phenolics, approximately 200 mg of frozen stem powder was mixed with 1 mL of 80% (v/v) methanol-water and shaken for 1 h at 1400 rpm. Extracts were cleared by centrifugation (5 min, 20,000 g), mixed with 400 μL of analytical grade water and filtered using Amicon Ultra centrifugal filters (3,000 Da MW cutoff regenerated cellulose membrane; Millipore) prior to LC-MS analysis. Alternatively, an aliquot of the filtered extracts was dried under vacuum, resuspended with 1
N HCl and incubated at 95° C. for 3 h for acid hydrolysis. The mixture was subjected to three ethyl acetate partitioning steps. Ethyl acetate fractions were pooled, dried in vacuo, and resuspended in 50% (v/v) methanol-water prior to LC-MS analysis. - For extraction of cell-wall bound phenolics, mature senesced stems were collected without the leaves and siliques, and ball-milled to a fine powder using a Mixer Mill MM 400 (Retsch) and stainless steel balls for 2 min at 30 s−1. Extract-free cell wall residues (CWR) were obtained by sequentially washing 60 mg of ball-milled stems with 1 ml of 96% ethanol at 95° C. twice for 30 min, and vortexing with 1 mL of 70% ethanol twice for 30 sec. The resulting CWR were dried in vacuo overnight at 30° C. Approximately 6 mg of CWR was mixed with 500 μL of 2 M NaOH and shaken at 1400 rpm for 24 h at 30° C. The mixture was acidified with 100 μL of concentrated HCl, and subjected to three ethyl acetate partitioning steps. Ethyl acetate fractions were pooled, dried in vacuo, and suspended in 50% (v/v) methanol-water prior to LC-MS analysis.
- Separation of C6C1 phenolic acids and aldehydes was conducted on a Poroshell-120 column (150 mm length, 3 mm internal diameter, 2.7 μm particle size) using a 1200 Series HPLC system (Agilent Technologies Inc.). Analytes were separated using a gradient elution with mobile phase composition of 0.1% formic acid in water as solvent A, and 0.1% formic acid in acetonitrile-water (98:2, v/v) as solvent B. The elution gradient was 0-5 min 13% B, 5-7
min 50% B, 7-8min 50% B, and 8-11 min 13% B, using a flow rate of 0.55 mL min−1. The HPLC system was coupled to an Agilent 6210 time-of-flight (TOF) mass spectrometer (MS) via a 1:7 post-column split. Analyses were conducted using Electrospray ionization (ESI) in the positive ion mode. Detection of [M+H]+ ions was carried out in full scan mode at 0.85 spectra sec and a cycle time of 1.176 sec spectrum−1 using the following parameters: capillary voltage 3500 V, fragmentor 165 V, skimmer 50 V and OCT RF 170 V, drying gas flow rate 9 L min−1,nebulizer pressure 15 psig, drying gas temperature 325° C. Separation of C6C1 phenolic alcohols was conducted on the same HPLC and MS system using the same HPLC column. Analytes were separated using gradient elution with a mobile phase composition of 0.1% formic acid in water as solvent A, and 0.1% formic acid in methanol-water (98:2, v/v) as solvent B. Elution conditions were the same as described above. Analyses were conducted using atmospheric pressure chemical ionization (APCI) in the positive ion mode. Detection of [M−H2O+H]+ ions was carried as described above except for the following parameters: capillary voltage 3200 V, corona current 4 μA, drying gas flow rate 12 L min−1,nebulizer pressure 30 psig,vaporizer temperature 350° C. Quantification of compounds was made by comparison with standard curves of authentic compounds prepared in 50% (v/v) methanol-water. - Extract-free samples (CWR) of ball-milled mature senesced stems were prepared using a Soxhlet apparatus by sequentially extracting the ground material with toluene:ethanol (2:1, v/v), ethanol, and water (Sluiter et al., 2008). The determination of lignin content using the standard Klason procedure (Dente, 1992) and the thioacidolysis procedure (Lapierre et al., 1995; 1999) were carried out on CWR. The lignin-derived monomers were identified by GC-MS as their trimethyl-silylated derivatives. All the lignin analyses were performed in duplicate.
- For total sugar hydrolysis, CWR of ball-milled mature senesced stems (50 mg) were swelled in 500 μL H2SO4 (72%, w/v) at 30° C. for 60 min, and autoclaved at 120° C. for 1 h in dilute H2SO4 (4%, w/v) after addition of deionized water (14 mL). Samples were cooled down at room temperature and filtered using pre-weighted GF/C glass microfiber filters (Whatman). Filtrates were collected and diluted 100 times with deionized water prior to HPAEC-PAD analysis. For hemicellulose hydrolysis, CWR of ball-milled mature dried stems (5 mg) were hydrolyzed in 1 ml of 2 M trifluoroacetic acid (TFA) for 1 h at 120° C. TFA was removed by drying under vacuum and the residue suspended in deionized water (1 mL) prior to HPAEC-PAD analysis.
- Monosaccharide composition was determined by HPAEC-PAD of hydrolyzed material. Chromatography was performed on a PA20 column (Dionex) at a flow rate of 0.5 mL min−1. Before injection of each sample (20 μL) the column was washed with 200 mM NaOH for 10 min, then equilibrated with 10 mM NaOH for 10 min. The elution program consisted of a linear gradient from 10 mM NaOH to 5 mM NaOH from 0 to 1.5 min, followed by isocratic elution with 5 mM NaOH from 1.5 to 20 min, and a linear gradient up to 800 mM NaOH from 20 to 43 min. Monosaccharides were detected using a pulsed amperometric detector (gold electrode) set on waveform A according to manufacturer's instructions. A calibration curve of monosaccharide standards that includes
L -Fuc,L -Rha,L -Ara,D -Gal,D -Glc,D -Xyl,D -GalA andD -GlcA (Sigma-Aldrich) was run for verification of response factors. Statistical analysis was performed using ANOVA followed by Tukey's test. - FT-Raman spectroscopy was conducted on CWR of ball-milled mature senesced stems (2 mg) from three independent cultures. Raman spectra were collected using a Bruker MultiRAM FT-Raman system equipped with a 1064 nm diode laser (Bruker Optics Inc.). Five spectra were acquired for each sample with spectral resolution of 4 cm−1 using a laser power of 50 mW and 256 scans to achieve good signal-to-noise ratio. White light correction of the acquired spectra was performed to correct the influence of the optics on the spectrometer. Spectra in the range of 200-3500 cm−1 were smoothed and baseline corrected using OPUS software. Lignin and polysaccharides (cellulose and hemicellulose) content were determined using integrated intensities measured over the range of 1555-1690 cm−1 and 1010-1178 cm−1, respectively. For FT-IR spectroscopy, analyses were carried out on xylem and interfascicular fibers tissues from 50-μm thick sections of the basal region of stems of five-week-old plants. For both wild type and IRX5:HCHL (line 2), five to six sections from three different plants were analyzed. FT-IR spectra were collected from a 50 μm×50 μm window targeting xylem vessels or interfascicular fibers, and normalization of the data and statistical analysis (Student's t-test) were performed as described (Mouille et al., 2003).
- CEL lignin was purified from wild type and IRX5:HCHL (line 2) plants. One gram of ball-milled mature senesced stems was mixed with 50 mM NaCl (30 ml) and incubated overnight at 4° C. After centrifugation (2,800 g, 10 min), the biomass was extracted sequentially by sonication (20 min) with 80% ethanol (three times), acetone (one time), chloroform-methanol (1:1, v/v, one time) and acetone (one time). The obtained CWR were ball-milled for 3 h per 500 mg of sample (in 10 min on/10 min off cycles) using a PM100 ball mill (Retsch) vibrating at 600 rpm with zirconium dioxide vessels (50 mL) containing ZrO2 ball bearings (10×10 mm). Ball-milled walls (490 mg for wild type and 480 mg for IRX5:HCHL) were transferred to centrifuge tubes (50 mL) and digested four times over three days at 30° C. with crude cellulases (Cellulysin; Calbiochem; 60 mg g−1 of sample) in NaOAc pH 5.0 buffer (30 mL) under gentle rotation. The obtained CEL was washed 3 times with deionized water and lyophilized overnight. CEL recovered were 131 mg for wild type (27.3%) and 101 mg for IRX5:HCHL (20.6%). For SEC analysis, 1% (w/v) CEL lignin solutions were prepared in analytical-grade 1-methyl-2-pyrrolidinone-DMSO (1:1, v/v) and sonicated for 3 hours at 40° C.
- Polydispersity of dissolved lignin was determined using analytical techniques SEC UV-F and SEC UV-A as described elsewhere (George et al., 2011, submitted). An Agilent 1200 series binary LC system (G1312B) equipped with FL (G1321A) and DA (G1315D) detectors was used. Separation was achieved with a Mixed-D column (5 mm particle size, 300 mm×7.5 mm i.d., linear molecular weight range of 200 to 400,000 u, Polymer Laboratories) at 80° C. using a mobile phase of NMP at a flow rate of 0.5 mL min−1. Absorbance of material eluting from the column was detected at 300 nm (UV-A).
Excitation 250 nm and emission 450 nm were used for UV-F detection. Intensities were area normalized and molecular mass estimates were determined after calibration of the system with polystyrene standards. - Ball-milled mature senesced stems (10 mg) were mixed with 340 μL of water, 340 μL of H2SO4 (1.2%, w/v), or 340 μL of NaOH (0.25%, w/v) for hot water, dilute acid, or dilute alkaline pretreatments, respectively, incubated at 30° C. for 30 min, and autoclaved at 120° C. for 1 h. After cooling down at room temperature, samples pretreated with dilute acid and dilute alkaline were neutralized with 5
N NaOH (25 μL) and 1.25N HCl (25 μL), respectively. Saccharification was initiated by adding 635 μL of 100 mM sodium citrate buffer pH 6.2 containing 80 g ml−1 tetracycline, 5% w/w cellulase complex NS50013 and 0.5% w/w glucosidase NS50010 (Novozymes). After 72 h of incubation at 50° C. with shacking (800 rpm), samples were centrifuged (20,000 g, 3 min) and 10 μL of the supernatant was collected for reducing sugar measurement using the DNS assay and glucose solutions as standards (Miller, 1959). - Microarray analysis was performed on complete Arabidopsis thaliana transcriptome microarrays containing 24,576 gene-specific tags (GSTs) corresponding to 22,089 genes from Arabidopsis (Crowe et al., 2003; Hilson et al., 2004). RNA samples from three independent biological replicates were isolated and separately analyzed. For each biological replicate, RNA from the main inflorescence stem (first two internodes) of three plants were pooled. For each comparison, one technical replication with fluorochrome reversal was performed for each biological replicate (i.e. nine hybridizations per comparison). Reverse transcription of RNA was conducted in the presence of Cy3-dUTP or Cy5-dUTP (PerkinElmer-NEN Life Science Products), and hybridization and scanning of the slides were performed as described in Lurin et al. (2004).
- Statistical analysis was performed with normalization based on dye swapping (i.e., four arrays, each containing 24,576 GSTs and 384 controls) as previously described (Gagnot et al., 2008). For the identification of differentially expressed genes, we performed a paired t test on log ratios, assuming that the variance of the log ratios was similar for all genes. Spots with extreme variances (too small or too large) were excluded. The raw P values were adjusted by the Bonferroni method, which controls the family-wise error rate (with a type I error equal to 5%) to minimize the number of false positives in a multiple-comparison context (Ge et al., 2003). Genes with a Bonferroni P value ≦0.05 were considered to be differentially expressed, as previously described (Gagnot et al., 2008).
- Microarray data from this article were deposited at GEO (http://www.ncbi.nlm.nih.gov/geo/) and at CATdb (http://urgv.evry.inra.fr/CATdb/) according to Minimum Information about a Microarray Experiment standards (MIME).
- The tissue specific activity of the IRX5 promoter was verified using the beta-glucuronidase (GUS) as a reporter gene. Gus activity was essentially detected in the xylem vessels of the stem. After prolonged incubations, stem interfascicular fibers also showed strong GUS activity, and more moderate staining was observed in the vascular system of young seedlings, siliques, rosette and cauline leaves. No activity was detected in other organs or tissues except for the style and anthers (
FIG. 9 ). A codon-optimized sequence encoding HCHL from Pseudomonas fluorescens AN103 was designed and cloned downstream of the IRX5 promoter for preferential expression in lignified tissues of Arabidopsis stems. Presence of HCHL transcripts in the main stem of five independent transformants was verified by RT-PCR in the T1 generation (FIG. 2A ). Plants homozygous for the IRX5:HCHL construct were identified in the T2 generation, and used to analyze HCHL protein expression and activity in stems. Western blotting analysis using the ‘universal antibody’ allowed detection of HCHL in stem extracts of the five selected transgenic lines (FIG. 2B ; Eudes et al. 2010). Furthermore, HCHL activity could be detected in the stem of these lines, ranging from 0.025 to 0.16 pkat vanillin μg−1 protein using feruloyl-CoA as substrate, whereas no detectable activity was observed in protein extracts of wild type plants (Table I). Two transgenic lines showing the highest and the lowest levels of HCHL activity, and two lines exhibiting intermediate activity level were selected for detailed analysis. - IRX5:HCHL plants had growth and development characteristics visually similar to the wild type from early rosette stage and until senescence (
FIG. 10 ). However, mature senesced stems from lines IRX5:HCHL (4) and IRX5:HCHL (5) were little bit shorter (22% and 13% reduction) and had lower dry weight yield (30% and 16% reduction) compared to control plants, whereas those from lines IRX5:HCHL (1) and IRX5:HCHL (2) were not significantly different (Table II). Stem tissues of five-week-old IRX5:HCHL plants were inspected using light microscopy. Transverse stem cross-sections stained with Mäule and phloroglucinol-HCl reagents, which are indicative of S-units and hydroxycinnamaldehyde units in lignin, respectively, showed similar patterns between transgenic and wild type plants (FIGS. 3A and 3B ). Similarly, lignin in stem sections stained with toluidine blue O did not revealed any quantitative differences between genotypes (FIG. 3C ). A few collapsed xylem structures were, however, occasionally observed on some stem cross-sections of line IRX5:HCHL (4), but were absent in sections from other lines (FIG. 3C ). Overall, these data suggest that lignin content is not drastically reduced in IRX5:HCHL plants. - Methanol soluble fractions from stems of five-week-old wild type and IRX5:HCHL plants were extracted and analyzed by LC-MS. Analysis was performed to focus on hydroxybenzaldehydes, direct products of HCHL activity, and possible derivatives such as hydroxybenzoyl alcohols and hydroxybenzoic acids and their glucose conjugates. Trace amounts of 4-hydroxybenzaldehyde (HBAld), 3,4-dihydroxybenzaldehyde (3,4-DHBAld), and 4-hydroxybenzoic acid (HBA) were detected in IRX5:HCHL stem soluble extracts but not in wild type (Table III). Notably, much larger quantities of 4-hydroxybenzoic acid glucoside (HBAGlc) and 4-hydroxybenzoic acid glucose ester (HBAGE) were detected in IRX5:HCHL plant soluble extracts (ranging from 0.48 to 0.57 mg g−1 FW for HBAGlc, and from 0.96 to 1.65 mg g−1 FW for HBAGE), whereas trace amounts of these HBA-glucose conjugates were present in wild type extracts (Table III).
- Considering that other soluble C6C1 phenolics could be glycosylated, acid hydrolysis of the soluble fractions was performed to release aglycones from conjugated forms. This procedure brought down HBAGE and HBAG pools to undetectable levels, and concomitantly increased free HBA content in samples (Table IV). HBA content in the IRX5:HCHL lines ranged between 1.59 and 2.49 mg g−1 FW, which represents a 113 to 179 fold increase compared to values observed in wild type samples, and indicates that 88-94% of HBA accumulated in transgenic lines is glycosylated. In addition to HBA, other C6C1 phenolics quantified in acid-treated extracts include vanillin (Van), 5-hydroxyvanillin (5OH-Van), syringaldehyde (Syrald), 5-hydroxyvanillic acid (5OH-VA), and syringic acid (SyrA), which are only detected in IRX5:HCHL extracts, as well as HBAld, 3,4-DHBAld, 3,4-dihydroxybenzoic acid (3,4-DHBA), and vanillic acid (VA), which are on average 14, 119, 1.6, and 40 times more abundant in IRX5: HCHL extracts compared to wild type, respectively (Table IV).
- Extract-free cell wall residues (CWR) obtained from mature senesced stems of wild type and IRX5:HCHL plants were subjected to mild alkaline hydrolysis for the release of loosely-bound phenolics. This procedure released from the cell wall samples some HBAld, 3,4-HBAld, Van, 5OH-Van, SyrAld, HBA, VA, and SyrA, which were quantified using LC-MS analysis. 5OH-Van, undetectable in wild type cell wall, was present in that of IRX5:HCHL samples and HBAld, SyrAld, HBA, VA, and SyrA were increased on average by
approx - Line IRX5:HCHL (2), which showed no defective xylem structures and biomass yield similar to wild type plants, was selected for further analyses. Fourier transformed Raman (FT-Raman) spectroscopy was used to determine the chemical composition of CWR obtained from senesced stems of IRX5:HCHL plants. Compared to the wild type, data showed that lignin content and amount of polysaccharides (cellulose and hemicellulose) in IRX5:HCHL plants were not significantly different (
FIG. 4A ). Moreover, Fourier transformed infrared (FT-IR) spectral analysis conducted on lignified tissues (xylem and interfascicular fibers) of transverse stem sections of five-week-old IRX5:HCHL and wild type plants revealed differences between the two genotypes (FIG. 4B ). In particular, significant changes in spectra were observed for bands assigned to different bending or stretching of lignin (Agarwal and Atalla, 2010, Fackler et al., 2010). For example, absorptions at wavelengths 1589 cm−1 and 1506 cm−1 (aryl ring stretching), 1464 cm−1 (C—H group deformation), 1425 cm−1 (methoxyl C—H group deformation), 1379 cm−1 (aromatic skeletal vibrations combined with C—H group in plane deformation), and 1268 cm−1 (aryl ring breathing with C=O group stretch) were modified in fibers, whereas the most significant difference for xylem cell walls was observed at band 1367 cm−1 (methoxyl C—H group deformation). Overall, spectral analyses suggested compositional modifications of lignin in plants expressing HCHL. - Monosaccharide composition was determined after sulfuric acid hydrolysis of total cell wall polysaccharides from mature senesced stems of line IRX5:HCHL (2) and wild type plants. Although both genotypes had similar amount of total monosaccharides, IRX5:HCHL plants showed reduction in glucose (−12%) and increase in xylose (+22%) and arabinose (+16%) compared to wild type plants (Table VI). Moreover, hemicellulosic monosaccharides released from CWR using trifluoroacetic acid showed that total amount of sugar quantified in this hydrolysate was 23% higher in IRX5:HCHL stems which corresponds to higher xylose (+23%) and arabinose (+22%) contents compared to wild type (Table VI).
- Incorporation of Unusual C6C1 Monomers into the Lignin of IRX5:HCHL Plants
- Lignin content and monomeric composition in mature senesced stems from wild type and IRX5:HCHL (2) plants was determined on CWR. In two independent cultures, klason lignin (KL) was identical and accounted for about 20% of the CWR for both wild type and IRX5:HCHL plants (Table VII). Lignin monomer composition was evaluated by thioacidolysis, a chemical degradative method that generates thioethylated monomers from lignin units involved in labile β-O-4 bonds. Data showed that total amount of conventional H, O, and S monomers released from CWR after thioacidolysis (or total yield) was reduced by 25% and 16% in the two independent cultures of IRX5:HCHL plants compared to the wild type, indicating that fewer of these three monolignols are crosslinked as β-O-4 bond in transgenics (Table VII). Considering identical KL values for both wild type and IRX5:HCHL CWR, these data indicate higher frequency of thioacidolysis-resistant bonds between lignin monomers in transgenic plants. The relative amount of G and S units recovered from this lignin fraction was unchanged, both wild type and transgenic samples showing an S/G ratio ranging between 0.34-0.36, however, molar frequency of H units was significantly higher in IRX5:HCHL plants (Table VII). Furthermore, the content of non-conventional units such as Van, Syrald, and SyrA released by thioacidolysis showed on average a 1.44-, 20.8-, and 1.65-fold increase in IRX5:HCHL plants compared to wild type plants, respectively. Interestingly, two new lignin units were released from the lignin of transgenics plants, which were identified as C6C1 vanillyl alcohol (Vanalc) and syringyl alcohol (Syralc) (Table VIII). On the other hand, the content of coniferaldehyde end-groups (Cald) and VA was unchanged between the two genotypes (Table VIII). Overall, these data showed higher amount of C6C1 phenolic end-groups among monomers released by thioacidolysis from IRX5:HCHL stem cell walls compared to wild type.
- The polydispersity of cellulolytic lignin purified from wild type and IRX5:HCHL (2) stems was determined using size exclusion chromatography (SEC). Elution profiles acquired by monitoring UV-A absorbance (SEC UV-A300) and UV-F fluorescence (SEC UV-
F ex250/em450) of the dissolved lignin revealed differences between wild type and IRX5:HCHL plants (FIG. 6 ). First, total area corresponding to the largest mass peak detected between 7 min and 13.5 min was severely reduced in transgenics due to significant diminution of the largest lignin fragments which elute between 7 min and 9 min. Similarly, smaller molecular mass material which elutes later in a second peak between 13.5 min and 19.5 min was more abundant (increased by 27% and 16% using UV-A and UV-F detections) in IRX5:HCHL samples. Finally, the amount of the smallest lignin fragments detected between 19.5 min and 26.5 min using UV-F is increased by 55% in transgenics (FIG. 6 ). These results demonstrate smaller chains and reduced polymerization degree in lignin purified from IRX5:HCHL plants. - To examine impact lignin size reduction on cell wall digestibility caused by the expression of the HCHL enzyme in lignifying tissues, saccharification assays were conducted biomass derived from mature senesced stems pretreated with hot water, dilute alkaline, and dilute acid. After a 72-h incubation with cellulase and glucosidase, pretreated biomass of IRX5 HCHL plants released more reducing sugars compared to wild type (
FIG. 7 ). In particular, improvement of saccharification efficiency observed for the different IRX5:HCHL lines ranged from 34% to 77% after hot water, from 43% to 71% after dilute alkaline, and from 15% to 31% after dilute acid pretreatments (FIG. 7 ). - Expression of HCHL in plants has originally been considered for in planta production of valuable and soluble compounds such as Van and HBA. Due to strong ectopic HCHL expression, however, adverse phenotypes such as chlorotic and senescing leaves, stunting, low pollen production, male sterility, collapsed xylem vessels, and reduction of biomass were observed in transgenic tobacco, and sugarcane (Mayer et al., 2001; Merali et al., 2007; McQualter et al., 2005). In this study, the inventors selected the promoter of a secondary cell wall cellulose synthase to preferentially express HCHL in the lignifying tissues of Arabidopsis stems (
FIG. 9 ). Successfully, plants transformed with the IRX5:HCHL construct were not dwarf or sterile, and young rosette leaves did not show reduced epidermal fluorescence which is symptomatic of alteration in phenylpropanoid-derived soluble phenolic pools. Although two IRX5:HCHL lines showed reduced biomass, and in one case some occasional collapsed xylem vessels caused by stronger HCHL activity and possibly modification of call wall integrity, some other IRX5:HCHL lines were comparable to wild-type plants. - As expected, the transgenic lines show increased amount of soluble C6C1 aldehydes (HBAld, 3,4-DHBAld, and Van), which are produced upon HCHL activity after cleavage of hydroxybenzoyl-CoA, 3,4-dihydroxybenzoyl-CoA, and feruloyl-CoA (
FIG. 11 ). HCHL has no activity against sinapoyl-CoA, suggesting that Syrald is a conversion product of Van, which is supported by the identification of the new intermediate 5OH-Van (Mitra et al., 1999;FIG. 11 ). Similarly, the data presented herein cannot exclude that some of the 3,4-DHBald and Van accumulated in transgenics derive from HBAld after successive hydroxylation and methoxylation on the C-3 position of the phenyl ring. Interestingly, several genes encoding monooxygenases are upregulated in plants expressing HCHL, but no known or predicted O-methyltransferase showed altered expression level (Table IX). Analysis of soluble aromatics in transgenics also shows that C6-C1 aldehydes are oxidized into their respective acid forms. This conversion could be a response to reduce the amount of these chemically reactive compounds since several genes from the short-chain dehydrogenase/reductase (SDR), aldo-keto reductase (AKR), and aldehyde dehydrogenase (ALDH) families are upregulated in plants expressing HCHL, (FIG. 11 ; Kirch et al., 2004; Kavanagh et al., 2008). In particular, AKR4C9 (At3g37770) encodes an enzyme known to metabolize a range of hydroxybenzaldehydes (Simpson et al., 2009). In addition, soluble C6C1 phenolics predominantly accumulate as conjugates in transgenics since we showed that glucose conjugates (phenolic glucoside and glucose ester) represented around 90% of the HBA soluble pool, presumably for vacuolar storage as previously described for other C6C1 phenolics (Eudes et al., 2008). This C6C1 acid glucoside accumulation is in agreement with what was observed in tobacco, sugar beet, datura and sugar cane plants expressing HCHL (Mayer et al., 2001; Mitra et al., 2002; McQualter et al., 2005; Rahman et al., 2009). Interestingly, expression analysis of HCHL plants revealed seven up-regulated genes of the UDP-glucosyltranferase (UGT) family and among them UGT75B1 and UGT73B4 were previously shown to catalyze glucose esterification and phenolic glucosylation of benzoates (Table IX; Lim et al, 2002; Eudes et al., 2008). - Furthermore, this study showed that some C6C1 phenolics are released from extract-free cell wall fractions of senesced stems upon mild alkaline hydrolysis. Higher amounts of HBAld, 5OH-Van, SyrAld, HBA, VA, and SyrA were measured in the ‘loosely wall-bound’ fraction of IRX5:HCHL lines compared to wild type. Although the type of linkages involved is unclear, loosely attached C6C1 phenolics were previously extracted from cell walls of Arabidopsis leaves and roots (Tan et al., 2004; Forcat et al., 2010).
- The lignin from plants expressing HCHL shows increased content of C6C1 phenolics. Notably, analysis of lignin monomers released after thioacidolysis identified two novel units (Vanalc and Syralc) and showed large amounts of Syrald, Van, and SyrA. This suggests part of C6C1 aldehydes are converted into alcohols and acids and demonstrates that they are incorporated into the lignin as β-O-4-linked C6C1 monomer end-groups in lignin (
FIG. 11 ). Due to the absence of phenyl propanoid tail, these new monolignols when incorporated in lignin end chains, should block further polymerization of the polymer and act as condensation terminator or stopper molecules. Interestingly, transgenic plants also show higher content of conventional H-units (+30%), which preferentially distribute as terminal end-groups in lignin and contribute to modifications of lignin size and structure (Lapierre, 2010; Ziebell et al., 2010). In addition, plants overproducing C6C1 monolignols and with similar lignin content as wild type plants show a lower thioacidolysis release of monolignols, indicating a reduction in the availability of free propanoid tail in lignin end-chain for polymer elongation. It also indicates higher carbon-carbon linkages and increased lignin condensation degree. - It was postulated that higher incorporation of end-group units in lignin would hinder more frequently chain elongation and ultimately reduce lignin branching and polymerization degree. This hypothesis is further supported by the analysis the polydispersity of lignin in plants overproducing theses “stopper” molecules, which shows significant reduction of high molecular masses and significant increase of low molecular masses, hence supporting smaller lignin chain length. These observations are relevant for understanding the higher susceptibility of the biomass from HCHL lines to polysaccharide enzymatic hydrolysis. Although saccharification efficiency of biomass is determined by several characteristics of cell walls, the observed saccharification efficiency improvement after different pretreatments suggests that less ramified lignin would reduce cross-linkages and embedding of cell wall polysaccharides (cellulose and hemicellulose) and would favor their accessibility to hydrolytic enzymes. This hypothesis is supported by the fact that total sugar content is unchanged in cell walls of plants overproducing theses C6C1 monomers.
- it is concluded that in planta the over-production of lignification “stopper” molecules can be used to modify the lignin structure in order to reduce lignocellulosic biomass recalcitrance. Since this approach does not require any particular genetic background, it should be easily transferable to various energycrops. Restricting the biosynthesis of these lignification “stopper” molecules in supporting lignified tissues (i.e. schlerenchyma fibers) as well as avoiding strong production in conductive tissues (i.e. vessels) should limit the risk of adverse effects on plant development and biomass yield.
- This example illustrates expression of bacterial HCHL in a monocot, rice. Rice plants were transformed with the DNA constructs described in Example 1. Rice lines were engineered (
FIG. 12 ) that expressed the HCHL gene, as demonstrated by RT-PCR (FIG. 13 ). Furthermore, evaluation of rice lines demonstrated that they accumulated pHBA (para-hydroxybenzoate) (FIG. 14 ), which is generated from the conversion of p-coumaroyl-CoA by HCHL. - This experiment additionally demonstrated that a secondary wall promoter, pIRX5, from a dicot (Arabidopsis in this example), can be used in a monocot (rice in this example).
- It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, accession numbers, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.
-
- Agarwal U P and Aralla R H (2010) Vibrational spectroscopy. In C Heitner, D Dimmel, J Schmidt eds. Lignin and Lignans: Advances in Chemistry. CRC Press, Boca Raton, pp 103-136
- Bechtold N, Pelletier G (1998) In planta Agrobacterium-mediated transformation of adult Arabidopsis thaliana plants by vacuum infiltration. Methods Mol Biol 82: 259-266
- Berthet et al. Disruption of LACCASE4 and 17 results in tissue-specific alterations to lignification of Arabidopsis thaliana stems. The Plant cell (2011) vol. 23 (3) pp. 1124-37
- Boerjan W, Ralph J, Baucher M (2003) Lignin biosynthesis. Annu Rev Plant Biol 54: 519-546
- Bonawitz N D, Chapple C (2010) The genetics of lignin biosynthesis: connecting genotype to phenotype. Annu Rev Genet 44: 337-363
- Boudet A M (2007) Evolution and current status of research in phenolic compounds. Phytochemistry 68: 2722-2735
- Bradford M M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
- Brown et al. Identification of novel genes in Arabidopsis involved in secondary cell wall formation using expression profiling and reverse genetics. Plant Cell (2005) vol. 17 (8) pp. 2281-95
- Brown et al. Characterization of IRX10 and IRX10-like reveals an essential role in glucuronoxylan biosynthesis in Arabidopsis. Plant J (2009) vol. 57 (4) pp. 732-46
- Buer C S, Imin N, Djordjevic M A (2010) Flavonoids: new roles for old molecules. J Integr Plant Biol 52: 98-111
- Carroll A, Somerville C (2009) Cellulosic biofuels. Annu Rev Plant Biol 60: 165-182
- Chen et al. Disruption of the cellulose synthase gene, AtCesA8/IRX1, enhances drought and osmotic stress tolerance in Arabidopsis. Plant J (2005) vol. 43 (2) pp. 273-83
- Chen F, Dixon R A (2007) Lignin modification improves fermentable sugar yields for biofuel production. Nat Biotechnol 25: 759-761
- Crowe M L, Serizet C, Thareau V, Aubourg S, Rouze P, Hilson P, Beynon J, Weisbeek P, van Hummelen P, Reymond P, Paz-Ares J, Nietfeld W, Trick M (2003) CATMA: a complete Arabidopsis GST database. Nucleic Acids Res 31: 156-158
- Dence C (1992) Lignin determination. In C Dence, S Lin, eds, Methods in Lignin Chemistry. Springer-Verlag, Berlin, pp 33-61
- de Vrije T, de Haas G G, Tan G B, Keijsers E R, Claassen P A (2002) Pretreatment of Miscanthus for hydrogen production by Thermotoga elfii. Int J Hydrogen Energy 27: 1381-1390
- Dien B S, Jung H-JG, Vogel K P, Casler M D, Lamb J F S, Iten L, Mitchell R B, Sarath G (2006) Chemical composition and response to dilute-acid pretreatment and enzymatic saccharification of alfalfa, reed canarygrass, and switchgrass. Biomass Bioenergy 30: 880-891
- Dien B S, Sarath G, Pedersen J F, Satler S E, Chen H, Funnell-Harris D L, Nichols N N, Cotta M A (2009) Improved sugar conversion and ethanol yield for forage sorghum (Sorghum bicolor (L.) Moench) lines with reduced lignin contents. Bioenerg Res 2: 153-164
- Dien B S, Miller D J, Hector R E, Dixon R A, Chen F, McCaslin M, Reisen P, Sarath G, Cotta M A (2011) Enhancing alfalfa conversion efficiencies for sugar recovery and ethanol production by altering lignin composition. Bioresour Technol 102: 6479-6486
- Elissetche J P, Valenzuela S, García R, Norambuena M, Iturra C, Rodríguez J, Teixeira Mendonça R, Balocchi C (2011) Transcript abundance of enzymes involved in lignin biosynthesis of Eucalyptus globulus genotypes with contrasting levels of pulp yield and wood density. Tree Genet Gen DOI: 10.1007/s11295-011-0367-5
- Eudes A, Pollet B, Sibout R, Do C T, Séguin A, Lapierre C, Jouanin L (2006) Evidence for a role of
AtCAD 1 in lignification of elongating stems of Arabidopsis thaliana. Planta 225: 23-39 - Eudes A, Baidoo E E, Yang F, Surd H, Hadi M Z, Collins F W, Keasling J D, Loqué D (2011) Production of tranilast [N-(3′,4′-dimethoxycinnamoyl)-anthranilic acid] and its analogs in yeast Saccharomyces cerevisiae. Appl Microbiol Biotechnol 89: 989-1000
- Eudes A, Bozzo G G, Waller J C, Naponelli V, Lim E K, Bowles D J, Gregory J F 3rd, Hanson A D (2008) Metabolism of the folate precursor p-aminobenzoate in plants: glucose ester formation and vacuolar storage. J Biol Chem 283: 15451-15459
- Fackler K, Stevanic J S, Ters T, Hinterstoisser B, Schwanninger M, Salmén L (2010) Localisation and characterisation of incipient brown-rot decay within spruce wood cell walls using FT-IR imaging microscopy. Enzyme Microb Technol 47: 257-267
- Forcat S, Bennett M, Grant M, Mansfield J W (2010) Rapid linkage of indole carboxylic acid to the plant cell wall identified as a component of basal defence in Arabidopsis against hrp mutant bacteria. Phytochemistry 71: 870-876
- Franke et al. The Arabidopsis REF8 gene encodes the 3-hydroxylase of phenylpropanoid metabolism. Plant J (2002) vol. 30 (1) pp. 33-45
- Fu C, Mielenz J R, Xiao X, Ge Y, Hamilton C Y, Rodriguez M Jr, Chen F, Foston M, Ragauskas A, Bouton J, Dixon R A, Wang Z Y (2011) Genetic manipulation of lignin reduces recalcitrance and improves ethanol production from switchgrass. Proc Natl Acad Sci USA 108: 3803-3808
- Gagnot S, Tamby J P, Martin-Magniette M L, Bitton F, Taconnat L, Balzergue S, Aubourg S, Renou J-P, Lecharny A, Brunaud V (2008) CATdb: a public access to Arabidopsis transcriptome data from the URGV-CATMA platform. Nucleic Acids Res 36 (database issue): D986-990
- Gallego-Giraldo L, Jikumaru Y, Kamiya Y, Tang Y, Dixon R A (2011) Selective lignin downregulation leads to constitutive defense response expression in alfalfa (Medicago sativa L.). New Phytol 190: 627-639
- Gasson M J, Kitamura Y, McLauchlan W R, Narbad A, Parr A J, Parsons E L, Payne J, Rhodes M J, Walton N J (1998) Metabolism of ferulic acid to vanillin. A bacterial gene of the enoyl-SCoA hydratase/isomerase superfamily encodes an enzyme for the hydration and cleavage of a hydroxycinnamic acid SCoA thioester. J Biol Chem 273: 4163-4170
- Ge Y C, Dudoit S, Speed T P (2003) Resampling-based multiple testing for microarray data analysis. Test 12: 1-77
- George A, Tran K, Morgan T J, Benke P I, Berrueco C, Lorente E, Wu B C, Simmons B A and Holmes B M (2011) The effect of ionic liquid cation and anion combinations on the macromolecular structure of lignins. Green Chemistry. (Submitted)
- Gou J Y, Yu X H, Liu C J (2009) A hydroxycinnamoyltransferase responsible for synthesizing suberin aromatics in Arabidopsis. Proc Natl Acad Sci USA 106: 18855-18860
- Grabber J H, Hatfield R D, Lu F, Ralph J (2008) Coniferyl ferulate incorporation into lignin enhances the alkaline delignification and enzymatic degradation of cell walls. Biomacromolecules 9: 2510-2516
- Ha et al. Structure of cellulose-deficient secondary cell walls from the irx3 mutant of Arabidopsis thaliana. Phytochemistry (2002) vol. 61 (1) pp. 7-14
- Hajdukiewicz P, Svab Z, Maliga P (1994) The small, versatile pPZP family of Agrobacterium binary vectors for plant transformation. Plant Mol Biol 25: 989-994
- Hilson P, Allemeersch J, Altmann T, Aubourg S, Avon A, Beynon J, Bhalerao R P, Bitton F, Caboche M, Cannoot B, Chardakov V, Cognet-Holliger C, Colot V, Crowe M, Darimont C, Durinck S, Eickhoff H, de Longevialle A F, Farmer E E, Grant M, Kuiper M T, Lehrach H, Leon C, Leyva A, Lundeberg J, Lurin C, Moreau Y, Nietfeld W, Paz-Ares J, Reymond P, Rouze P, Sandberg G, Segura M D, Serizet C, Tabrett A, Taconnat L, Thareau V, Van Hummelen P, Vercruysse S, Vuylsteke M, Weingartner M, Weisbeek P J, Wirta V, Wittink F R, Zabeau M, Small I (2004) Versatile gene-specific sequence tags for Arabidopsis functional genomics: transcript profiling and reverse genetics applications. Genome Res 14: 2176-2189
- Jones et al. Cloning and characterization of irregular xylem4 (irx4): a severely lignin-deficient mutant of Arabidopsis. Plant J (2001) vol. 26 (2) pp. 205-16
- Kavanagh K L, Jörnvall H, Persson B, Oppermann U (2008) Medium- and short-chain dehydrogenase/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci 65: 3895-3906
- Keasling J D (2010) Manufacturing molecules through metabolic engineering. Science 330: 1355-1358
- Kim H, Ralph J, Yahiaoui N, Pean M, Boudet A M (2000) Cross-coupling of hydroxycinnamyl aldehydes into lignins. Org Lett 2: 2197-2200
- Kim H, Ralph J, Lu F, Ralph S A, Boudet A M, MacKay J J, Sederoff R R, Ito T, Kawai S, Ohashi H, Higuchi T (2003) NMR analysis of lignins in CAD-deficient plants.
Part 1. Incorporation of hydroxycinnamaldehydes and hydroxybenzaldehydes into lignins. Org Biomol Chem 1: 268-281 - Kim H, Ralph J (2010) Solution-state 2D NMR of ball-milled plant cell wall gels in DMSO-d(6)/pyridine-d(5). Org Biomol Chem 8: 576-591
- Kirch H H, Bartels D, Wei Y, Schnable P S, Wood A J (2004) The ALDH gene superfamily of Arabidopsis. Trends Plant Sci 9: 371-377
- Ko et al. Ectopic expression of MYB46 identifies transcriptional regulatory genes involved in secondary wall biosynthesis in Arabidopsis. The Plant journal: for cell and molecular biology (2009) vol. 60 (4) pp. 649-65
- Lalonde S, Sero A, Pratelli R, Pilot G, Chen J, Sardi M I, Parsa S A, Kim D Y, Acharya B R, Stein E V, Hu H C, Villiers F, Takeda K, Yang, Y, Han Y S, Schwacke R, Chiang W, Kato N, Loqué D, Assmann S M, Kwak J M, Schroeder J, Rhee S Y and Frommer W B (2010) A membrane protein/signaling protein interaction network for Arabidopsis version AMPv2, Frontiers in Plant Physiology doi: 10.3389/fphys.2010.00024
- Lapierre C, Pollet B, Rolando R (1995) New insights into the molecular architecture of hardwood lignins by chemical degradation methods. Res Chem Intermed 21: 397-412
- Lapierre C, Pollet B, Petit-Conil M, Toval G, Romero J, Pilate G, Leple J C, Boerjan W, Ferret V V, De Nadai V, Jouanin L (1999) Structural alterations of lignins in transgenic poplars with depressed cinnamyl alcohol dehydrogenase or caffeic acid O-methyltransferase activity have an opposite impact on the efficiency of industrial kraft pulping. Plant Physiol 119: 153-164
- Lapierre C (2010) Determining [sic] lignin structure by chemical degradations. In C Heitner, D Dimmel, J Schmidt eds. Lignin and Lignans: Advances in Chemistry. CRC Press, Boca Raton, pp 11-48
- Lim E K, Doucet C J, Li Y, Elias L, Worrall D, Spencer S P, Ross J, Bowles D J (2002) The activity of Arabidopsis glycosyltransferases toward salicylic acid, 4-hydroxybenzoic acid, and other benzoates. J Biol Chem 277: 586-592
- Li X, Weng J K, Chapple C (2008) Improvement of biomass through lignin modification. Plant J 54: 569-581
- Luo J, Fuell C, Parr A, Hill L, Bailey P, Elliott K, Fairhurst S A, Martin C, Michael A J (2009) A novel polyamine acyltransferase responsible for the accumulation of spermidine conjugates in Arabidopsis seed. Plant Cell 21: 318-333.
- Lurin C, Andres C, Aubourg S, Bellaoui M, Bitton F, Bruyere C, Caboche M, Debast C, Gualberto J, Hoffmann B, Lecharny A, Le Ret M, Martin-Magniette M L, Mireau H, Peeters N, Renou J P, Szurek B, Taconnat L, Small I (2004) Genome-wide analysis of Arabidopsis pentatricopeptide repeat proteins reveals their essential role in organelle biogenesis. Plant Cell 16: 2089-2103
- Mayer M J, Narbad A, Parr A J, Parker M L, Walton N J, Mellon F A, Michael A J (2001) Rerouting the plant phenylpropanoid pathway by expression of a novel bacterial enoyl-CoA hydratase/lyase enzyme function. Plant Cell 13: 1669-1682
- McCarthy et al. MYB83 is a direct target of SND1 and acts redundantly with MYB46 in the regulation of secondary cell wall biosynthesis in Arabidopsis. Plant Cell Physiol (2009) vol. 50 (11) pp. 1950-64
- McQualter R B, Chong B F, Meyer K, Van Dyk D E, O'Shea M G, Walton N J, Viitanen P V, Brumbley S M (2005) Initial evaluation of sugarcane as a production platform for p-hydroxybenzoic acid. Plant Biotechnol J 3: 29-41
- Merali Z, Mayer M J, Parker M L, Michael A J, Smith A C, Waldron K W (2007) Metabolic diversion of the phenylpropanoid pathway causes cell wall and morphological changes in transgenic tobacco stems. Planta 225: 1165-1178
- Meyer et al. Lignin monomer composition is determined by the expression of a cytochrome P450-dependent monooxygenase in Arabidopsis. Proc Natl Acad Sci USA (1998) vol. 95 (12) pp. 6619-23
- Milkowski C, Strack D (2010) Sinapate esters in brassicaceous plants: biochemistry, molecular biology, evolution and metabolic engineering. Planta 232: 19-35
- Miller G L (1959) Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 31: 426-428
- Mitra A, Kitamura Y, Gasson M J, Narbad A, Parr A J, Payne J, Rhodes M J, Sewter C, Walton N J (1999) 4-hydroxycinnamoyl-CoA hydratase/lyase (HCHL)—An enzyme of phenylpropanoid chain cleavage from Pseudomonas. Arch Biochem Biophys 365: 10-16
- Mitra A, Mayer M J, Mellon F A, Michael A J, Narbad A, Parr A J, Waldron K W, Walton N J (2002) 4-Hydroxycinnamoyl-CoA hydratase/lyase, an enzyme of phenylpropanoid cleavage from Pseudomonas, causes formation of C(6)-C(1) acid and alcohol glucose conjugates when expressed in hairy roots of Datura stramonium L. Planta 215: 79-89
- Mitsuda et al. The NAC transcription factors NST1 and NST2 of Arabidopsis regulate secondary wall thickenings and are required for anther dehiscence. Plant Cell (2005) vol. 17 (11) pp. 2993-3006
- Mitsuda et al. NAC transcription factors, NST1 and NST3, are key regulators of the formation of secondary walls in woody tissues of Arabidopsis. Plant Cell (2007) vol. 19 (1) pp. 270-80
- Mouille G, Robin S, Lecomte M, Pagant S, Hofte H (2003) Classification and identification of Arabidopsis cell wall mutants using Fourier-Transform InfraRed (FT-IR) microspectroscopy. Plant J 35: 393-404
- Moura J C, Bonine C A, de Oliveira Fernandes Viana J, Dornelas M C, Mazzafera P (2010) Abiotic and biotic stresses and changes in the lignin content and composition in plants. J Integr Plant Biol 52: 360-376
- Morreel K, Ralph J, Lu F, Goeminne G, Busson R, Herdewijn P, Goeman J L, Van der Eycken J, Boerjan W, Messens E (2004) Phenolic profiling of caffeic acid O-methyltransferase-deficient poplar reveals novel benzodioxane oligolignols. Plant Physiol 136: 4023-4036
- Naoumkina M A, Zhao Q, Gallego-Giraldo L, Dai X, Zhao P X, Dixon R A (2010) Genome-wide analysis of phenylpropanoid defence pathways. Mol Plant Pathol 11: 829-846
- Rahman L, Kouno H, Hashiguchi Y, Yamamoto H, Narbad A, Parr A, Walton N, Ikenaga T, Kitamura Y (2009) HCHL expression in hairy roots of Beta vulgaris yields a high accumulation of p-hydroxybenzoic acid (pHBA) glucose ester, and linkage of pHBA into cell walls. Bioresour Technol 100: 4836-4842
- Ralph J, Lapierre C, Marita J M, Kim H, Lu F, Hatfield R D, Ralph S, Chapple C, Franke R, Hemm M R, Van Doorsselaere J, Sederoff R R, O'Malley D M, Scott J T, MacKay J J, Yahiaoui N, Boudet A, Pean M, Pilate G, Jouanin L, Boerjan W (2001) Elucidation of new structures in lignins of CAD- and COMT-deficient plants by NMR. Phytochemistry 57: 993-1003
- Ralph J, Kim H, Lu F, Grabber J H, Leple J C, Berrio-Sierra J, Derikvand M M, Jouanin L, Boerjan W, Lapierre C (2008) Identification of the structure and origin of a thioacidolysis marker compound for ferulic acid incorporation into angiosperm lignins (and an indicator for cinnamoyl CoA reductase deficiency). Plant J 53: 368-379
- Reddy M S, Chen F, Shadle G, Jackson L, Aljoe H, Dixon R A (2005) Targeted downregulation of cytochrome P450 enzymes for forage quality improvement in alfalfa (Medicago sativa L.). Proc Natl Acad Sci USA 102: 16573-16578
- Rohde et al. Molecular phenotyping of the pall and pall mutants of Arabidopsis thaliana reveals far-reaching consequences on phenylpropanoid, amino acid, and carbohydrate metabolism. Plant Cell (2004) vol. 16 (10) pp. 2749-71
- Sibout et al. CINNAMYL ALCOHOL DEHYDROGENASE-C and -D are the primary genes involved in lignin biosynthesis in the floral stem of Arabidopsis. Plant Cell (2005) vol. 17 (7) pp. 2059-76
- Simmons B A, Loqué D, Ralph J (2010) Advances in modifying lignin for enhanced biofuel production. Curr Opin Plant Biol 13: 313-320
- Simpson P J, Tantitadipatak C, Reed A M, Mather O C, Bunce C M, White S A, Ride J P (2009) Characterization of two novel aldo-keto reductases from Arabidopsis: Expression patterns, broad substrate specificity, and an open active-site structure suggest a role in toxicant metabolism following stress. J Mol Biol 392: 465-480
- Sluiter A, Crocker D, Hames B, Ruiz R, Scarlata C, Sluiter J, Templeton, D (2008) Determination of Structural Carbohydrates and Lignin in Biomass NREL/TP-510-42618. Laboratory Analytical Procedure, National Renewable Energy Laboratory, Golden, Colo., USA
- Studer M H, Demartini J D, Davis M F, Sykes R W, Davison B, Keller M, Tuskan G A, Wyman C E (2011) Lignin content in natural Populus variants affects sugar release. Proc Natl Acad Sci USA 108: 6300-6305
- Taboada A, Novo-Uzal E, Flores G, Loureda M, Ros Barceló A, Masa A, Pomar F (2010) Digestibility of silages in relation to their hydroxycinnamic acid content and lignin composition. J Sci Food Agric 90: 1155-1162.
- Tan J, Bednarek P, Liu J, Schneider B, Svatos A, Hahlbrock K (2004) Universally occurring phenylpropanoid and species-specific indolic metabolites in infected and uninfected Arabidopsis thaliana roots and leaves. Phytochemistry 65: 691-699
- Turner and Somerville. Collapsed xylem phenotype of Arabidopsis identifies mutants deficient in cellulose deposition in the secondary cell wall. Plant Cell (1997) vol. 9 (5) pp. 689-701
- Umezawa T (2010) The cinnamate/monolignol pathway. Phytochem rev 9: 1-17
- Weng J K, Chapple C (2010) The origin and evolution of lignin biosynthesis. New Phytologist 187:273-285
- Weng J K, Mo H, Chapple C (2010) Over-expression of F5H in COMT-deficient Arabidopsis leads to enrichment of an unusual lignin and disruption of pollen wall formation. Plant J 64: 898-911
- Wu et al. Analysis of the Arabidopsis IRX9/IRX9-L and IRX14/IRX14-L pairs of glycosyltransferase genes reveals critical contributions to biosynthesis of the hemicellulose glucuronoxylan. Plant Physiol (2010) vol. 153 (2) pp. 542-54
- Zhong et al. SND1, a NAC domain transcription factor, is a key regulator of secondary wall synthesis in fibers of Arabidopsis. Plant Cell (2006) vol. 18 (11) pp. 3158-70
- Zhong et al. The MYB46 transcription factor is a direct target of SND1 and regulates secondary wall biosynthesis in Arabidopsis. Plant Cell (2007) vol. 19 (9) pp. 2776-92
- Zhong and Ye. Regulation of cell wall biosynthesis. Curr Opin Plant Biol (2007) vol. 10 (6) pp. 564-72
- Zhou et al. MYB58 and MYB63 are transcriptional activators of the lignin biosynthetic pathway during secondary cell wall formation in Arabidopsis. Plant Cell (2009) vol. 21 (1) pp. 248-66
- Ziebell A, Gracom K, Katahira R, Chen F, Pu Y, Ragauskas A, Dixon R A, Davis M (2010) Increase in 4-coumaryl alcohol units during lignification in alfalfa (Medicago sativa) alters the extractability and molecular weight of lignin. J Biol Chem 285:38961
-
ILLUSTRATIVE SEQUENCES SEQ ID NO: 1 Amino acid sequence for Pseudomonas fluorscens HCHL (GenBank Accession No. CAA73502) MSTYEGRWKTVKVEIEDGIAFVILNRPEKRNAMSPTLNREMIDVLETLEQDPAA GVLVLTGAGEAWTAGMDLKEYFREVDAGPEILQEKIRREASQWQWKLLRMYAKP TIAMVNGWCFGGGFSPLVACDLAICADEATFGLSEINWGIPPGNLVSKAMADTV GHRQSLYYIMTGKTFGGQKAAEMGLVNESVPLAQLREVTIELARNLLEKNPVVL RAAKHGFKRCRELTWEQNEDYLYAKLDQSRLLDTEGGREQGMKQFLDDKSIKPG LQAYKR SEQ ID NO: 2 Polynucleotide sequence encoding SEQ ID NO: 1 (codon-optimized by GenScript) ATGTCTACTTACGAGGGAAGATGGAAGACTGTTAAGGTTGAGATCGAGGATGGA ATCGCTTTCGTTATCCTCAACAGACCTGAGAAGAGAAACGCTATGTCTCCTACT CTCAACAGAGAGATGATCGATGTTCTCGAGACTCTCGAGCAGGATCCTGCTGCT GGAGTTCTCGTTCTCACTGGAGCTGGAGAGGCTTGGACTGCTGGTATGGATCTC AAGGAGTACTTCAGAGAGGTTGATGCTGGACCTGAGATCCTCCAGGAGAAGATC AGAAGAGAGGCTTCTCAGTGGCAGTGGAAGCTCCTCAGAATGTACGCTAAGCCT ACTATCGCTATGGTTAACGGATGGTGCTTCGGAGGAGGATTCTCTCCTCTCGTT GCTTGCGATCTCGCTATCTGCGCTGATGAGGCTACTTTCGGACTCTCTGAGATC AACTGGGGAATCCCTCCTGGAAACCTCGTTTCTAAGGCTATGGCTGATACTGTT GGACATAGACAGTCTCTCTACTACATCATGACTGGAAAGACTTTCGGAGGACAG AAGGCTGCTGAGATGGGACTCGTTAACGAGTCTGTTCCTCTCGCTCAGCTCAGA GAGGTTACTATCGAGCTCGCTAGAAACCTCCTCGAGAAGAACCCTGTTGTTCTC AGAGCTGCTAAGCATGGATTCAAGAGATGCAGAGAGCTCACTTGGGAGCAGAAC GAGGATTACCTCTACGCTAAGCTCGATCAGTCTAGACTCCTCGATACTGAGGGA GGAAGAGAGCAGGGTATGAAGCAGTTCCTCGATGATAAGTCTATCAAGCCTGGA CTCCAGGCTTACAAGAGA SEQ ID NO: 3 Polynucleotide sequence containing IRX5 promoter (pIRX5) ATGAAGCCATCCTCTACCTCGGAAAAACTTGTTGCGAGAAGAAGACATGCGATG GCATGGATGCTTGGATCTTTGACATTGATGACACTCTTCTCTCAACCATTCCTT ACCACAAGAGCAACGGTTGTTTCGGGTAAATAAACTAAACTTAACCATATACAT TAGCCTTGATTCGGTTTTTGGTTTGATTTATGGATATTAAAGATCCGAATTATA TTTGAACAAAAAAAAATGATTATGTCACATAAAAAAAAATTGGCTTGAATTTTG GTTTAGATGGGTTTAAATGTCTACCTCTAATCATTTCATTTGTTTTCTGGTTAG CTTTAATTCGGTTTAGAATGAAACCGGGATTGACATGTTACATTGATTTGAAAC AGTGGTGAGCAACTGAACACGACCAAGTTCGAGGAATGGCAAAATTCGGGCAAG GCACCAGCGGTTCCACACATGGTGAAGTTGTACCATGAGATCAGAGAGAGAGGT TTCAAGATCTTTTTGATCTCTTCTCGTAAAGAGTATCTCAGATCTGCCACCGTC GAAAATCTTATTGAAGCCGGTTACCACAGCTGGTCTAACCTCCTTCTGAGGTTC GAATCATATTTAATAACCGCATTAAACCGAAATTTAAATTCTAATTTCACCAAA TCAAAAAGTAAAACTAGAACACTTCAGATAAATTTTGTCGTTCTGTTGACTTCA TTTATTCTCTAAACACAAAGAACTATAGACCATAATCGAAATAAAAACCCTAAA AACCAAATTTATCTATTTAAAACAAACATTAGCTATTTGAGTTTCTTTTAGGTA AGTTATTTAAGGTTTTGGAGACTTTAAGATGTTTTCAGCATTTATGGTTGTGTC ATTAATTTGTTTAGTTTAGTAAAGAAAGAAAAGATAGTAATTAAAGAGTTGGTT GTGAAATCATATTTAAAACATTAATAGGTATTTATGTCTAATTTGGGGACAAAA TAGTGGAATTCTTTATCATATCTAGCTAGTTCTTATCGAGTTTGAACTCGGGTT ATGATTATGTTACATGCATTGGTCCATATAAATCTATGAGCAATCAATATAATT CCGAGCATTTTGGTATAACATAATGAGCAAGTATAACAAAAGTATCAAACCTAT GCAGGGGAGAAGATGATGAAAAGAAGAGTGTGAGCCAATACAAAGCAGATTTGA GGACATGGCTTACAAGTCTTGGGTACAGAGTTTGGGGAGTGATGGGTGCACAAT GGAACAGCTTCTCTGGTTGTCCAGTTCCCAAGAGAACCTTCAAGCTCCCTAACT CCATCTACTATGTCGCCTGATTAAATCTTATTTACTAACAAAACAATAAGATCA GAGTTTCATTCTGATTCTTGAGTCTTTTTTTTCTCTCTCCCTCTTTTCATTTCT GGTTTATATAACCAATTCAAATGCTTATGATCCATGCATGAACCATGATCATCT TTGTGTTTTTTTTTCCTTCTGTATTACCATTTTGGGCCTTTGTGAAATTGATTT TGGGCTTTTGTTATATAATCTCCTCTTTCTCTTTCTCTACCTGATTGGATTCAA GAACATAGCCAGATTTGGTAAAGTTTATAAGATACAAAATATTAAGTAAGACTA AAGTAGAAATACATAATAACTTGAAAGCTACTCTAAGTTATACAAATTCTAAAG AACTCAAAAGAATAACAAACAGTAGAAGTTGGAAGCTCAAGCAATTAAATTATA TAAAAACACTAACTACACTGAGCTGTCTCCTTCTTCCACCAAATCTTGTTGCTG TCTCTTGAAGCTTTCTTATGACACAAACCTTAGACCCAATTTCACTCACAGTTT GGTACAACCTCAGTTTTCTTCACAACAAATTCAAACATCTTACCCTTATATTAC CTCTTTATCTCTTCAATCATCAAAACACATAGTCACATACATTTCTCTACCCCA CCTTCTGCTCTGCTTCCGAGAGCTCAGTGTACCTCGCC SEQ ID NO: 4 Sagittula_stellata_E-37__ZP_01746375 (amino acid sequence) MTATEATLPANDPDLSGDNVAVAFEDGIAWVKLNRPEKRNAMSVSLAEDMNVVLD KLEIDDRCGVLVLTGEGSAFSAGMDLKDFFRATDGVSDVERMRAYRSTRAWQWRT LMHYSKPTIAMVNGWCFGGAFTPLICCDLAISSDDAVYGLSEINWGIIPGGVVSK AISTLMSDRQALYYVMTGEQFGGQEAVKLGLVNESVPADKLRERTVELCKVLLEK NPTTMRQARMAYKYIREMTWEESAEYLTAKGDQTVFVDKEKGREQGLKQFLDDKT YRPGLGAYKR SEQ ID NO: 5 Saccharopolyspora_erythraea_NRRL_2338_YP_001105000 (amino acid sequence) MSTPTTDPGTTTTPWGDTVLVDFDDGIAWVTLNRPEKRNAMNPAMNDEMVRTLDA LEADPRCRVMVLTGAGESFSAGMDLKEYFREVDQTADPSVQIRVRRASAEWQWKR LAHWSKPTIAMVNGWCFGGAFTPLVACDLAISDEEARYGLSEINWGIPPGGVVSR ALAAAVSQRDALYFIMTGETFDGRRAEGMRLVNEAVPAERLRERTRELALKLAST NPVVLRAAKVGYKIAREMPWEQAEDYLYAKLEQSQFLDAERGREKGMAQFLDDKS YRPGLSAYSTD SEQ ID NO: 6 Solibacter_usitatus_Ellin6076_YP_821552 (amino acid sequence) MDQYEEKWQTVKVEVDAEGIAWVIFNRPAKRNAMSPTLNREMAQVLETLELDAAA KVLVLTGAGESWSAGMDLKEYFREVDGQPESHQEKIRREASLWQWKLLRMYAKPT IAMVNGWCFGGAFSPLVACDLAIADEKAVFGLSEINWGIPPGNLVSKAVADTMGH RKALHYIMTGETFTGAQAAEMGLVNAAVPTSELREATRTLALKLASKNPVILRAA KHGFKRCRELTWEQNEDYLYAKLDQALHRDPEDARAEGMKQFLDEKSIKPGLQSY KRS SEQ ID NO: 7 Ralstonia_solanacearum_GMI1000_NP_521786 (amino acid sequence) MATYEGRWNTVKVDVEDGIAWVTLNRPDKRNAMSPTLNREMIDVLETLELDGDAQ VLVLTGAGESWSAGMDLKEYFRETDGQPEIMQERIRRDCSQWQWKLLRFYSKPTI AMVNGWCFGGAFSPLVACDLAIAADDAVFGLSEINWGIPPGNLVSKAVADTMGHR AALHYIMTGETFTGREAAEMGLVNRSVPRERLREAVTELAGKLLAKNPVVLRYAK HGFKRCRELSWEQNEDYLYAKVDQSNHRDPEKGRQHGLKQFLDDKTIKPGLQTYK RA SEQ ID NO: 8 Xanthomonas_albilineans_YP_003377516 (amino acid sequence) MSNYQDRWQTVQVQIDAGVAWVTLNRPEKRNAMSPTLNREMIDVLETLELDSAAE VLVLTGAGESWSAGMDLKEYFREIDGKEEIVQERMRRDCSQWQWRLLRFYSKPTI AAVNGWCFGGAFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAVADTMGHR NAMLYIMTGRTFTGTEAAQMGLVNASVPRAQLRAEVTKLAQELQQKNPVVLRFAK HGFKRCRELTWEQNEDYLYAKVDQSNHRDPEKGRQQGLKULDDKTIKPGLQTYKR SEQ ID NO: 9 Acinetobacter_baumannii_ATCC_17978_YP_001084143 (amino acid sequence) MKMSYENRWETVDVKVEDGIAWVTLNRPEKKNAMSPTLNREMIDVLETLELDQNA KVLVLTGAGDSWTAGMDLKEYFREVDTQPEIFQERIRRDSCRWQWQLLRMYSKPT IAMVNGWCFGGGESPLVACDLAIAADEATEGLSEINWGIPPGNLVSKAMADTVGH RASLYYIMTGKTFSGKEAETMGLVNKSVPLAQLKAEVTELANCLLEKNPVVLRTA KNGFKRCRELTWDQNEDYLYAKLDQCIHRDTENGRQEGLKQFLDEKSIKPGLQSY KRTG SEQ ID NO: 10 Acinetobacter_sp._ADP1_YP_046390 (amino acid sequence) MTYDKRWETVDVQVEHGIAWVTLNRPHKKNAMSPTLNREMIDVLETLELDSEAKV LVLTGAGDSWTAGMDLKEYFREVDAQPEIFQERIRRDSCRWQWQLLRMYSKPTIA MVNGWCFGGGFSPLVACDLAIAADEATFGLSEINWGIPPGNLVSKAMADTVGHRA SLYYIMTGKTFTGKEAEAMGLINKSVPLAQLKAEVTELAQCLVEKNPVVLRTAKN GEKRCRELTWDQNEDYLYAKLDQCNHRDTEGGRQEGLKQFLDEKSIKPGLQSYKR TG SEQ ID NO: 11 Chromohalobacter_salexigens_DSM_3043_YP_572340 (amino acid sequence) MSDYTNRWQTVKVDVEDGIAWVTLNRPEKRNAMSPTLNREMIDVLETIELDQDAH VLVLTGEGESFSAGMDLKEYFREIDASPEIVQVKVRRDASTWQWKLLRHYAKPTI AMVNGWCFGGAFSPLVACDLAIAADESVFGLSEINWGIPPGNLVSKAMADTVGHR QALYYIMTGETFTGPQAADMGLVNQSVPRAELRETTHKLAATLRDKNPVVLRAAK TGFKMCRELTWEQNEEYLYAKLDQAQQLDPEHGREQGLKQFLDDKSIKPGLESYR R SEQ ID NO: 12 Burkholderia_cenocepacia_AU_1054_ZP_04942909 (amino acid sequence) MSKYDNRWQTVEVKVEAGIAWVTLNRPEKRNAMSPTLNREMLEVLDAVEFDDEA KVLVLTGAGAAWTAGMDLKEYFREIDGGSDALQEKVRRDASEWQWRRLRMYNKP TIAMVNGWCFGGGFSPLVACDLAIAADDAVFGLSEINWGIPPGNLVSKAMADTV GHRRALHYIMTGDTFTGAEAAEMGLVNSSVPLAELRDATIALAARLMDKNPVVL RAAKHGFKRSRELTWEQCEDYLYAKLDQAQLRDPERGREQGLKQFLDDKTIKPG LQAYKR SEQ ID NO: 13 Burkholderia_ambifaria_MC40-6_YP_776799 (amino acid sequence) MSKYDNRWQTVEVNVEAGIAWVTLNRPDKRNAMSPTLNQEMLQVLDAIEFDDDA KVLVLTGAGSAWTAGMDLKEYFREIDGGSDALQEKVRRDASEWQWRRLRMYNKP TIAMVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTV GHRRALHYIMTGDTFTGVEAAEMGLVNSSVPLAGLRDATIALAARLMDKNPVVL RAAKHGFKRSRELTWEQCEDYLYAKLDQAQLRDPERGREQGLKQFLDDKAIKPG LQAYKR SEQ ID NO: 14 Burkholderia_cepacia_AMMD_YP_776799 (amino acid sequence) MSKYDNRWQTVEVNVEAGIAWVTLNRPDKRNAMSPTLNQEMLQVLDAIEFDDDA KVLVLTGAGSAWTAGMDLKEYFREIDGGSDALQEKVRRDASEWQWRRLRMYNKP TIAMVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTV GHRRALHYIMTGDTFTGVEAAEMGLVNSSVPLAGLRDATIALAARLMDKNPVVL RAAKHGFKRSRELTWEQCEDYLYAKLDQAQLRDPERGREQGLKQFLDDKAIKPG LQAYKR SEQ ID NO: 15 Burkholderia_thailandensis_MSMB43_ZP_02468311 (amino acid sequence) MSKYDNRWQTVEVKVEAGIAWVTLNRPDKRNAMSPTLNQEMLQVLDAIEFDDDA KVLVLTGAGTAWTAGMDLKEYFREIDGGPDALQEKVRRDASEWQWRRLRMYGKP TIAMVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTV GHRCALHYIMTGDTFTGVEAADMGLVNRSVPLAELRDATIALAARLIDKNPVVL RAAKHGFKRSRELTWEQCEDYLYAKLDQAQLRDPERGREQGLKQFLDDKAIKPG LQAYKR SEQ ID NO: 16 Burkholderia_ubonensis_Bu_ZP_02382374 (amino acid sequence) MSKYENRWQTVEVKVEAGIAWVTLNRPDKRNAMSPTLNQEMLQVLDAIEFDDDA KVLVLTGAGAAWTAGMDLKEYFREIDGGPDALQEKVRRDASEWQWRRLRMYGKP TIAMVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTV GHRRALHYIMTGDTFTGVEAADMGLVNRSVPLAELRDATIALAARLIDKNPVVL RAAKHGFKRSRELTWEQCEDYLYAKLDQAQLRDPERGREQGLKQFLDDKAIKPG LQAYKR SEQ ID NO: 17 Azotobacter_vinelandii_AvOP_YP_002798614 (amino acid sequence) MNKYEGRWKTVIVEIEGGIAWVTLNRPDKRNAMSPTLNREMRDVLETLEQDPAAR VLVLTGAGSAWTAGMDLKEYFREVDAGPEILQEKIRREACEWQWKLLRMYAKPTV AMVNGWCFGGGFSPLVACDLAICADEATFGLSEINWGIPPGNLVSKAMADTVGHR QALYYIMTGKTFDGRQAAEMGLVNQSVPLAQLRETVATLCQDLLDKNPVVLRAAK NGFKRCRELTWEQNEDYLYAKLDQSRLLDEEGGREEGMRQFLDEKSIKPGLQAYK R SEQ ID NO: 18 Pseudomonas_putida_KT2440_NP_745498 (amino acid sequence) MSKYEGRWTTVKVELEAGIAWVTLNRPEKRNAMSPTLNREMVDVLETLEQDADAG VLVLTGAGESWTAGMDLKEYFREVDAGPEILQEKIRREASQWQWKLLRLYAKPTI AMVNGWCFGGGFSPLVACDLAICANEATFGLSEINWGIPPGNLVSKAMADTVGHR QSLYYIMTGKTFDGRKAAEMGLVNDSVPLAELRETTRELALNLLEKNPVVLRAAK NGFKRCRELTWEQNEDYLYAKLDQSRLLDTTGGREQGMKQFLDDKSIKPGLQAYK R SEQ ID NO: 19 Pseudomonas_fluorescens_SBW25_YP_002872871 (amino acid sequence) MSNYEGRWTTVKVEIEEGIAWVILNRPEKRNAMSPTLNREMIDVLETLEQDPAAG VLVLTGAGEAWTAGMDLKEYFREVDAGPEILQEKIRREASQWQWKLLRMYAKPTI AMVNGWCFGGGFSPLVACDLAICADEATFGLSEINWGIPPGNLVSKAMADTVGHR QSLYYIMTGKTFGGQKAAEMGLVNESVPLAQLREVTIELARNLLEKNPVVLRAAK HGFKRCRELTWEQNEDYLYAKLDQSRLLDTEGGREQGMKQFLDDKSIKPGLQAYK R SEQ ID NO: 20 Pseudomonas_syringae_NP_792742 (amino acid sequence) MSKYEGRWTTVKVEIEQGIAWVILNRPEKRNAMSPTLNREMIDVLETLEQDPEAG VLVLTGAGEAWTAGMDLKEYFREVDAGPEILQEKIRREASQWQWKLLRMYAKPTI AMVNGWCFGGGFSPLVACDLAICADEATFGLSEINWGIPPGNLVSKAMADTVGHR QSLYYIMTGKTFDGKKAAEMGLVNESVPLAQLRQVTIDLALNLLEKNPVVLRAAK HGFKRCRELTWEQNEDYLYAKLDQSRLLDKEGGREQGMKQFLDDKSIKPGLEAYK R SEQ ID NO: 21 Ralstonia_eutropha_JMP134_YP_299062 (amino acid sequence) MANYEGRWKTVKVSVEEGIAWVMFNRPEKRNAMSPTLNSEMIQVLEALELDADAR VVVLTGAGDAWTAGMDLKEYFREVDAGPEILQEKIRRDACQWQWKLLRMYAKPTI AMVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTVGHR QALHYIMTGDTFTGQQAAAMGLVNKSVPRSQLREHVLELAGKLLEKNPVVLRAAK HGFKRSRELTWEQNEDYLYAKLDQAQLRDPEHGREQGLKQFLDDKSIKPGLQAYK RA SEQ ID NO: 22 Burkholderia_glumae_BGR1_YP_002908688 (amino acid sequence) MSYEGRWTTVKVTVEAGIGWVVLNRPEKRNAMSPTLNKEMIDVLETLELDDEAQV LVLTGEGDAWTAGMDLKEYFREVDAASDVVQERIRRDASRWQWQLLRMYSKPTIA MVNGWCFGGGESPLVACDLAIAADEATFGLSEINWGIPPGNLVSKAMADTVGHRQ ALYYIMTGDTFTGKQAAQMGLVNQSVPRAALREATVALAAKLLDKNPVVLRNAKH GFKRSRELTWEQNEDYLYAKLDQANYRDKEGGREKGLKQELDDKSIKPGLQAYKR SEQ ID NO: 23 Burkholderia_phytofirmans_PsJN_YP_001887778 (amino acid sequence) MSYEGRWKTVKVDVAEGIAWVSFNRPEKRNAMSPTLNKEMIEVLEAVELDAEAQV LVLTGEGDAWTAGMDLKEYFREVDAGPEILQEKIRRDACRWQWQLLRMYSKPTIA MVNGWCFGGGFSPLVACDLAIAADEATFGLSEINWGIPPGNLVSKAMADTVGHRQ ALYYIMTGETFTGQEAAQMGLVNKSVPRAELREATRALAGKLLEKNPVVLRAAKH GFKRCRELTWDQNEDYLYAKLDQAQLRDPEGGREQGLKQFLDDKAIKPGLQTYKR SEQ ID NO: 24 Burkholderia_mallei_ATC_23344_YP_105383 (amino acid sequence) MSYEGRWKTVEVIVDGAIAWVTLNRPDKRNAMSPTLNAEMIDVLEAIELDPEARVL VLTGEGEAWTAGMDLKEYFREIDAGPEILQEKIRRDASRWQWQLLRMYAKPTIAMV NGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTVGHRQALY YIMTGETFTGAQAAQMGLVNRSVPRAQLRDAVRALAAKLLDKNPVVLRNAKHGFKR CRELTWEQNEDYLYAKLDQAQLRDPEHGREQGLKQFLDDKTIKPGLQAYRR SEQ ID NO: 25 Burkholderia_pseudomallei_Pasteur_ZP_01765668 (amino acid sequence) MSYEGRWKTVEVIVDGAIAWVTLNRPDKRNAMSPTLNAEMIDVLEAVELDPEARV LVLTGEGEAWTAGMDLKEYFREVDAGPEILQEKIRRDASRWQWQLLRMYAKPTIA MVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTVGHRQ ALYYIMTGETFTGAQAAQMGLVNRSVPRAQLRDAVRALAAKLLDKNPVVLRNAKH GEKRCRELTWEQNEDYLYAKLDQAQLRDPEHGREQGLKQFLDDKTIKPGLQAYRR SEQ ID NO: 26 Burkholderia_multivorans_ATCC_17616_YP_001583186 (amino acid sequence) MSYEGRWKTVKVAVEGGIAWVTLNRPEKRNAMSPTLNAEMIDVLEAIELDPEAQV LVLTGEGDAWTAGMDLKEYFREVDAGPEILQEKIRRDASRWQWQLLRMYAKPTIA MVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTVGHRQ ALYYIMTGDTFTGQQAAQMGLVNKSVPRAQLRDEVRALAAKLLDKNPVVIRNAKH GFKRCRELTWEQNEDYLYAKLDQANYRDPEGGREQGLKQFLDEKSIKPGLQAYKR SEQ ID NO: 27 Burkholderia_vietnamiensis_G4_YP_001116289 (amino acid sequence) MGYEGRWKTVKVEVAGGIAWVTLNRPEKRNAMSPTLNTEMIDVLEAIELDADAQV LVLTGEGDAWTAGMDLKEYFREIDAGPEILQEKIRRDASRWQWQLLRMYAKPTIA MVNGWCFGGGFSPLVACDLAIAADEAVFGLSEINWGIPPGNLVSKAMADTVGHRE ALYYIMTGDTFTGQQAARMGLVNKSVPRAQLRDEVRALAAKLLDKNPVVIRNAKH GFKRCRELTWEQNEDYLYAKLDQANYRDPEGGREQGLKQFLDDKSIKPGLQAYKR SEQ ID NO: 28 Sphingobium_japonicum_UT26S_YP_003543683 (amino acid sequence) MSEYLTEGPDLSRTCVDVMFDEGIAWVTLNRPEKRNAMSPTLNSEMLAILEQLELD PRCGVVVLTGAGDSFSAGMDLKEYFRETDGLPPAQVRRIRQTAQAWQWRTLQHFGK PTIAMVNGWCFGGAFTPLVACDLAIAANEAVEGLSEINWGIIPGGNVTKAIQERLR PQDAALYIMTGRNFTGEKAAQMGLVAEAVPLTDLRDHTRALALELLSKNPVVLNAA KIALKKVADMTWDVAEDYLVAKGAQTRVADKTDGRNKGITQFLDEKSYKPGLEGYR RDK SEQ ID NO: 29 Xanthomonas_axonopodis_NP_641235 (amino acid sequence) MNEHDVVSVRIENRIAWVKFARPDKRNAMSPALNRRMMDVLDELEFDDNVGVLV LGGEGTAWSAGMDLKEYFRETEAQGLRGVRRSQRESYGWERRLRWYQKPTIAMV NGWCFGGGFGPLFACDLAIAADEAQFGLSEINWGILPGGGVTKVAVELLSMRDA MWMTLTGEMVDGKKAAEWRLVNESVPLERLEARTREVAELLLRKNPVALKYAKD AVRRVGTMTYDEAEDYLVRMQEAANSFDNNARKEGIRQFIDEKSYKPGLGEYDL SKHSA SEQ ID NO: 30 Xanthomonas_campestris_ATCC_33913_NP_636201 (amino acid sequence) MNEHDVVSVHVENRIAWVKFARPDKRNAMSPALNRRMLDVLDELEFDDNVGVLVL GGEGTAWSAGMDLKEYFRETEAQGLRGVRRSQRESYGWFRRLRWYQKPTIAMVNG WCFGGGEGPLFACDLAIAADEAQFGLSEINWGILPGGGVTKVAVELLSMRDAMWM TLTGELVDGRKAAEWRLVNESVPLERLETRTREVAELLLKKNPVALKYAKDAVRR VGTMTYDEAEDYLVRMQEAANSFDNNARKEGIRQFIDEKRYKPGLGAYEPDAGTN SEQ ID NO: 31 Azospirillum_sp._B510_YP_003451575 (amino acid sequence) MTQQQAAARTGTAEDVVTVELDNGVAWVTLNRPDKRNAMNPALNARMHGVLDD LEVDDRCQVLVLTGAGESFSAGMDLKEYFRETEAKGHMATRRAQRDSYGWWRR LRWFEKPSIAMVNGWCFGGAFSPLFACDLAVAADEAQFGLSEINWGIIPGGNV TKVVADLMSQREAMYYILTGETFDGRKAAEMKLVNFSVPHAELRAKVRAIADN LLEKNPQTLKAAKDAFKRVVEMPFDAAEDYLVVRQESLNYLDKSEGRKQGIKQ FIDDKTYRPGLGAYKR SEQ ID NO: 32 Agrobacterium_vitis_S4_YP_002549228 (amino acid sequence) MTVAEKSDADTVLVDIEDRIAFVTFNRPEKRNAMNPALNIRMAEVLEELEADDRC GVLVLRGAGTSWSAGMDLQQYFRDNDDKPRHATLKSRRQSGGWWQRLTYFEKPTI AMVNGWCFGGAFNPLVACDLAIAANEATFGLSEINWGILPGGNVTRAVAEVMNHR DSLYYIMTGEPFGGEKARDMGLVNESVPLEELETRVRKLCASLLEKNPVTMKAAK DTFKRVRNMPWELADDYIYAKLEQMLLLDKTRGRDEGLKQFLDDKTYRPGLGAYK RK SEQ ID NO: 33 Rhizobium_etli_Brasil_5_YP_001985541 (amino acid sequence) MTENTSPVLVEFDGGIAFVTLNRPEKRNAMNPALNARMLEVLDELEGDERCGVLV LRGAGQSWSAGMDLKEYFRDNDDKPRDATLKARRQSGGWWGRLMYFEKPTIAMVN GWCFGGAFTPLVSCDLAIAAEEANFGLSEINWGILPGGNVTRAVAEVMRHRDALY YIMTGELFGGRKAAEMGLVNEAVPLVDLETRVRKICASLLEKNPVTLKAAKDTYK RVRNLPWDLADDYIYAKLEQMLFLDKTKGRDEGLKQFLDDKTYQPGLGAYKRGR SEQ ID NO: 34 Rhizobium_leguminosarum_bv_trifolii_WSM1325_YP_002973001 (amino acid sequence) MTEDKSPVLVEFDSGIAFVTLNRPEKRNAMNPALNIRMLEVLDELEGDERCGVL VLRGAGESWSAGMDLKEYFRDNDDKPRDVTLKARRQSGNWWGRLMYFEKPTIAM VNGWCFGGAFTPLVSCDLAIAAEEANFGLSEINWGILPGGNVTRAVAEVMRHRD ALYYIMTGELFGGRKAAEMGLVNEAVPLAELEPRVRKICASLLEKNPVTLKAAK DTYKRVRNLPWDLADDYIYAKLEQMLFLDKTKGRDEGLKQFLDDKTYQPGLGAY KRGR SEQ ID NO: 35 Amino acid sequence for IRX5 (GenBank Accession No. AF458083_1) MEPNTMASFDDEHRHSSFSAKICKVCGDEVKDDDNGQTFVACHVCVYPVCKPCYE YERSNGNKCCPQCNTLYKRHKGSPKIAGDEENNGPDDSDDELNIKYRQDGSSIHQ NFAYGSENGDYNSKQQCRPNGRAFSSTGSVLGKDFEAERDGYTDAEWKERVDKWK ARQEKRGLVTKGEQTNEDKEDDEEEELLDAEARQPLWRKVPISSSKISPYRIVIV LRLVILVFFFRFRILTPAKDAYPLWLISVICEIWFALSWILDQFPKWFPINRETY LDRLSMRFERDGEKNKLAPVDVFVSTVDPLKEPPIITANTILSILAVDYPVNKVS CYVSDDGASMLLFDTLSETSEFARRWVPFCKKYNVEPRAPEFYFSEKIDYLKDKV QTTFVKDRRAMKREYEEFKVRINALVAKAQKKPEEGWVMQDGTPWPGNNTRDHPG MIQVYLGKEGAFDIDGNELPRLVYVSREKRPGYAHHKKAGAMNAMVRVSAVLTNA PFMLNLDCDHYINNSKAIRESMCFLMDPQLGKKLCYVQFPQRFDGIDHNDRYANR NIVFFDINMRGLDGIQGPVYVGTGCVFNRPALYGYEPPVSEKRKKMTCDCWPSWI CCCCGGGNRNHHKSKSSDSSSKKKSGIKSLLSKLKKKNKKKSDDKTMSSYSRKRS ATEAIFDLEDIEEGLEGYDELEKSSLMSQKNFEKRFGMSPVFIASTLMENGGLPE ATNTSSLIKEAIHVISCGYEEKTEWGKEIGWIYGSVTEDILTGFRMHCRGWKSVY CMPKRPAFKGSAPINLSDRLHQVLRWALGSVEIFFSRHCPLWYAWGGKLKILERL AYINTIVYPFTSIPLLAYCTIPAVCLLTGKFIIPTINNFASIWFLALFLSIIATA ILELRWSGVSINDLWRNEQFWVIGGVSAHLFAVFQGLLKVLFGVDTNFTVTSKGA SDEADEFGDLYLFKWTTLLIPPTTLIILNMVGVVAGVSDAINNGYGSWGPLFGKL FFAFWVIVHLYPFLKGLMGRQNRTPTIVVLWSILLASIF SLVWVRIDPFLPKQTGPLLKQCGVDC SEQ ID NO: 36 Polynucleotide sequence PATCESA7_PATIRX3 TGGGAACTTTCGGTACATTTTCCAATAAAATCTATATACTATAAGATATTAAAT ATACACAAATATATCTAAGTGAATCATACAAATTATGTAGGCACACAGGAAGAG GCTGCTGAGGCTTATGACATTGCAGCCATTAAATTCAGAGGATTAAGCGCAGTG ACTAACTTCGACATGAACAGATACAATGTTAAAGCAATCCTCGAGAGCCCGAGT CTACCTATTGGTAGTTCTGCGAAACGTCTCAAGGACGTTAATAATCCGGTTCCA GCTATGATGATTAGTAATAACGTTTCAGAGAGTGCAAATAATGTTAGCGGTTGG CAAAACACTGCGTTTCAGCATCATCAGGGAATGGATTTGAGCTTATTGCAGCAA CAGCAGGAGAGGTACGTTGGTTATTACAATGGAGGAAACTTGTCTACCGAGAGT ACTAGGGTTTGTTTCAAACAAGAGGAGGAACAACAACACTTCTTGAGAAACTCG CCGAGTCACATGACTAATGTTGATCATCATAGCTCGACCTCTGATGATTCTGTT ACCGTTTGTGGAAATGTTGTTAGTTATGGTGGTTATCAAGGATTCGCAATCCCT GTTGGAACATCGGTTAATTACGATCCCTTTACTGCTGCTGAGATTGCTTACAAC GCAAGAAATCATTATTACTATGCTCAGCATCAGCAACAACAGCAGATTCAGCAG TCGCCGGGAGGAGATTTTCCGGTGGCGATTTCGAATAACCATAGCTCTAACATG TACTTTCACGGGGAAGGTGGTGGAGAAGGGGCTCCAACGTTTTCAGTTTGGAAC GACACTTAGAAAAATAAGTAAAAGATCTTTTAGTTGTTTGCTTTGTATGTTGCG AACAGTTTGATTCTGTTTTTCTTTTTCCTTTTTTTGGGTAATTTTCTTATAACT TTTTTCATAGTTTCGATTATTTGGATAAAATTTTCAGATTGAGGATCATTTTAT TTATTTATTAGTGTAGTCDTAATTTAGTTGTATAACTATAAAATTGTTGTTTGT TTCCGAATCATAAGTTTTTTTTTTTTTTGGTTTTGTATTGATAGGTGCAAGAGA CTCAAAATTCTGGTTTCGATGTTAACAGAATTCAAGTAGCTGCCCACTTGATTC GATTTGTTTTGTATTTGGAAACAACCATGGCTGGTCAAGGCCCAGCCCGTTGTG CTTCTGAACCTGCCTAGTCCCATGGACTAGATCTTTATCCGCAGACTCCAAAAG AAAAAGGATTGGCGCAGAGGAATTGTCATGGAAACAGAATGAACAAGAAAGGGT GAAGAAGATCAAAGGCATATATGATCTTTACATTCTCTTTAGCTTATGTATGCA GAAAATTCACCTAATTAAGGACAGGGAACGTAACTTGGCTTGCACTCCTCTCAC CAAACCTTACCCCCTAACTAATTTTAATTCAAAATTACTAGTATTTTGGCCGAT CACTTTATATAATAAGATACCAGATTTATTATATTTACGAATTATCAGCATGCA TATACTGTATATAGTTTTTTTTTTGTTAAAGGGTAAAATAATAGGATCCTTTTG AATAAAATGAACATATATAATTAGTATAATGAAAACAGAAGGAAATGAGATTAG GACAGTAAGTAAAATGAGAGAGACCTGCAAAGGATAAAAAAGAGAAGCTTAAGG AAACCGCGACGATGAAAGAAAGACATGTCATCAGCTGATGGATGTGAGTGATGA GTTTGTTGCAGTTGTGTAGAAATTTTTACTAAAACAGTTGTTTTTACAAAAAAG AAATAATATAAAACGAAAGCTTAGCTTGAAGGCAATGGAGACTCTACAACAAAC TATGTACCATACAGAGAGAGAAACTAAAAGCTTTTCACACATAAAAACCAAACT TATTCGTCTCTCATTGATCACCGTTTTGTTCTCTCAAGATCGCTGCTAATCTCC GGCCGTCCCT SEQ ID NO: 37 Polynucleotide sequence PATCESA8_PATIRX1 TTTAGTGCAGTCTAGGAAGACGGATCCAAAGGAGATAAACAGAGTTCAAGAAGCT CTTAACTACTATACAATCGAATCGTCAGCCGCGCTTTTTGTTTCGTTCATGATCA ATTTGTTTGTAACTGCGGTTTTCGCGAAAGGGTTTTATGGAACCAAACAAGCTGA TAGTATAGGACTGGTTAACGCGGGATATTACCTACAAGAGAAATATGGCGGTGGT GTTTTCCCGATACTATACATTTGGGGGATTGGTTTATTAGCTGCTGGACAAAGCA GTACTATAACCGGGACTTATGCTGGACAGTTTATAATGGAAGGGTTCTTAGATCT TCAAATGGAACAATGGCTATCAGCTTTTATAACGAGAAGCTTTGCTATTGTACCT ACTATGTTTGTTGCTATTATGTTTAACACATCCGAGGGCTCGCTCGATGTTTTAA ACGAATGGCTTAACATTCTTCAGTCGATGCAGATTCCTTTCGCGGTTATTCCTCT TTTGACTATGGTTTCTAATGAACATATCATGGGTGTCTTCAAGATCGGACCTTCG CTTGAGGTAAAGCAATTTTTTGTCATCTCTCTTTATTGTTATGTGCTTTTGATTG TAACGAGTTAGTTGGGATCTTTGCAGAAGCTAGCTTGGACTGTGGCGGTGTTTGT GATGATGATAAATGGGTATCTTCTTCTAGATTTCTTCATGGCTGAAGTGGAAGGG TTTCTTGTTGGGTTTCTGGTTTTTGGTGGAGTAGTTGGATACATCAGTTTCATCA TCTATCTTGTTTCTTATAGAAGCTCACAATCTTCTTCCTGGTCGAGTTTAGAAAT GTCAGAGAGAGTTGTTTCCACAGAGACGTAGAAACCCATAACTTTAGTATTCTTC AACCCTTACAACTTATCTGAGCAAAATCAGAAGGTCGAATTTGATGGATGGTTTT GCTGTATTTGGTCAACGGTTTTATTTGAGACAGTAGACCAGAGGAAACTCAGATG TGATGATGCAAAGACTGAATTGGTTAAGAGTGTAGATTGATTTGTTCTAACATTG CAAATGTAGAGTAGAATTATGCAAAAAACGTTAATGAACAGAGAAGTGATTAAGC AGAAACAAAATTAGAGAAGTGATATTATATCTCAAAATTTATTTTTGGTACAGCT AAAGCTCAAATTGTTATAGAGATTAGAGATATTAAACCAAATGACGAGTGTTTTC TTTAGTAGTAAACGGTGAAAATTCTCTTCTGACAAAGACAATTAAAATTTTAGGT TTAAGACTTTAATATTTGTCACAAATTGTCATTTACCTAAATAAAAAAAAAACTA AATATTTTTTTTAGATACATATGTGTCTTATAATTTTAACTATAAATTTTAATTT TATGTCTTAAATAATTGTTTACACTATAAATTTAAATATTTTAATGCTAAAATTA ATTTGATTCAAAAAAGTGATTTTAATTCTTATTTTTCTTATAGAAAGTTGGTGAT TGAAAAGATTTACTTAAAAATTATAACAACTTCAATGGTGAATAACCCGACCCGA ATAAACCGGATATAACAACTTCAATGTTAGCTTGATATAGAAAGTACGGTGACGC TTAGGAGGCAAGCAAGCTAGTATCTGCCGCTGGTTAGAGACAAAGAACATGTGTC ACTCCTCTCAACTAAAACTTTCCTTCACTTTCCCGCAAAATCATTTCAAAAAAGC TCCAAATTTAGCTTACCCATCAGCTTTCTCAGAAAACCAGTGAAAGAAACTTCTC AACTTCCGATTTTTCACAATCCACCAAACTTTTTTTAATAACTTTTTTTCCTCTT ATTACAAAACCTCCACTCTCATGGCTTCTCAAACTTGTTATCCATCCAAATCTCA ATCCCTAATTAGGGTTCATTTCTCTGTTTCTCCAAACAGGGGAATTCGAAG SEQ ID NO: 38 Polynucleotide sequence PATNST1 GTTTGTAGAGTTGGATCAGCATCCAGATTTAAACCCTTATTTTTGTTTTTGCCAA GCATCCAGACTTAATCCTATATTAGATACTGTATATGCATCTTGATGGAATATAG ACTATATAGAAAGACCAAAAATGGAAGAGTACGAATAAAAATGCATAATATACCT TGGAAATTATTCTTGGTTATTGTGAAACTTAAAACATTTCAACGAAGTCATATAC TATTATTTAATCATTGATTTAAAATTGCTAATCAAATCACGTGTTGTTGTTATAT ATGGATAAAGAGTTAAACTATAACACAACTGAGAAAAAAATAAAGTTATCAATTT TGTTAAGAATCAATGAAGGTTTCACAAGACTGGGAAGAAAAAAAAATAGATATAT GGAGTACATAAAACATTAAAATTTTGCTAAATTTTACTTTTGAACTCTATTGATT CGGGTTGACATGATGATAATGTTACATTCGTACAATTTCACAATGAAAAAAACGA GTACTAAATATTGTCAATCAAACATATGAATGTACAAAAATCCATAAACTCTACC AAAATAGAATGAAGATTCTGAAATCAAACCTACTTTTTCTTTTTAATTATAAATT CAACTATATTATAAATTTATTTATCACAAATAATAGAGGAGTGAGAATATTTTAG ACAACGCAAATTTCTTTTATTTAGTTCTTATACTTTATTTTTTACCAAACGTTAA TTAAAAAAATCACACATACATAATTTCTAAAAAAAATGTATTCTTCAAGTAATAT ATCTTTCTGAGTACTAGTTTATCTATTTATCTCCGTATTTAATAATCAAAAGTTA CGTTTAAAATAGAAACAACTTTTATCAAACAAAATATATTAGAAAACGCATGGTA CTGGCTACTGGAAAGAATCATGACCTGTAAATTTCTACAGTTTTCCCGTTTTATA TAGTACTTAGAAACTTTGGATTTTCATAGCGCAACCAATAAACACATGGACTTAA GACACAAAAAAAGTTGGGTGCAATGTCATTAATCAAACTAAAAAAATAATGATTA AAAGCATGGAATTCCGAAAACGCAACAAAATGATTCTGTGTTTAGACAAATGCAG AAAGGCCTCTTAACTAATCTTAAATAAAGTCTTAGTTCCAACCACATAAACACTC CTTAGCTCCATTAATTTTGGTTTTCTTAATTACGTTTCTACACAAGTACACGTAC TTACACATACAATTCCACAGTCTAAATGATAAAACTATGTGGTTTTTGACGTCAT CGTTACCTTTCTGTCGTCTCACCTTTATATAGTGTCTCTAACAGAACGTAACAAC CAAATGTTTAAAAAAATAAAAACAGCACCCCTTAATTAGGCTCATTCGTTTTGCA CTAACCATACTACAAATCATCTCGAACGATCGAGCAAAGATTTGAAAAATAAATA AACGTATAACTCTAGAGATTTTCATTAGCTAAGAAAAGTGAAATCGATTGTTAAT CCTATTTCAGACGGGACAGGAACACTCATTACCCAACTCTATCATCTCTCGAACA CCAAACTATATCTACCGTTTGGGGCATTATTTCCCACTTTCTTTCGAAGACAATT TCCCATATATAACATATACACATTATTACTAATATATTTTTATAAATTTTCGTCA CATCCCAAAAAAAAACACTCTTTGTCACATCAACTAGTTTTTTTGTAACGATCAA ACCTTTTCGTTTAAAAAAAAAAAACTTTTGTAGTGTAAACGTTTATTTATCGATG AAAAAAGCCACATCTTCCGGAGGGAAACTTTTTAAGACACCCTATTTCGACTTTA TTTTGTAAATACAGTGTGCATGTGCATATAAAGAGAGATATCATTTGTATAAATA TCAAGAATTAGAAGAGAAAAAGAGAGAAGAAGACAATCTATTACTATTACGATGT GTGGGTTGTTAATTTGTTTAAAGGGAGCTTTTCTATAGAGATTTTTAAGGTCAAG GGTCATCGTTCGATGTGGGCTTGCTTCCTACAATCTAGTTGCCTTACGGGGCCTA CTCTTTTTCTTTTGATAACTACATCACCTTTTTTTTCTCCGACAACTATATATCA CTTTTTTTATGTTTTCCTTTTTTTCTTCACAATAATTCTTTACTCGTTGCAAATG TAAAGATACACAAAGTTACTTATTTTGTTTACGATGGTTCTTAGTAGTTTAAAGA ATTAATGAATAAGATAAACCTAAACTTTGAAAAGACTAAAAAAAATGTATAACAA CATACATTATACGTATTTGAAATAGTCCAAGTGATATTATGTCATTGATATTAGC ACAAATAATTACGATGCCTGATATTGTCACATTTGATGATTTTAAGTTCTTGTAA AAGATAAGTGTAACTAAATCACTATAGTGAGGCCCACGTTTTAATTTCTAAACTA ATTACAATGACAATAAAATAGCAAAACTATTTAAAACTAGACGCCAAAAAAAATT GAAACTAATAATTGTGAAAAAAGAACAAGAGAATAATAATCATTAATAATTGACA AGTGAAATTAATATATTGCTCTTGGAGGGTTATATTTTAATTTTCAAACTAAATA ATGAATACAAATGGAAAAGCTAATGATAAGAGTTGAATTTTAATAATTAAGAAAA ACAAAAAAAGGTGTACAAGGAGACACATGCGTTTTCCTCATGCATCTTGTTTTTA TACAACAATATATATATATATATTGAGTCATTCTCTGCTAGCTCTCTCATCTCCA ACTTTCAGTATGATATATAGTTACAATTAAATAAACCTCACATGCTCTATTCTTG CTTGATTTTTGAGTTAATCTTGAATCTCTTTG SEQ ID NO: 39 Polynucleotide sequence PATCESA4_PATIRX5 ATGAAGCCATCCTCTACCTCGGAAAAACTTGTTGCGAGAAGAAGACATGCGATG GCATGGATGCTTGGATCTTTGACATTGATGACACTCTTCTCTCAACCATTCCTT ACCACAAGAGCAACGGTTGTTTCGGGTAAATAAACTAAACTTAACCATATACAT TAGCCTTGATTCGGTTTTTGGTTTGATTTATGGATATTAAAGATCCGAATTATA TTTGAACAAAAAAAAATGATTATGTCACATAAAAAAAAATTGGCTTGAATTTTG GTTTAGATGGGTTTAAATGTCTACCTCTAATCATTTCATTTGTTTTCTGGTTAG CTTTAATTCGGTTTAGAATGAAACCGGGATTGACATGTTACATTGATTTGAAAC AGTGGTGAGCAACTGAACACGACCAAGTTCGAGGAATGGCAAAATTCGGGCAAG GCACCAGCGGTTCCACACATGGTGAAGTTGTACCATGAGATCAGAGAGAGAGGT TTCAAGATCTTTTTGATCTCTTCTCGTAAAGAGTATCTCAGATCTGCCACCGTC GAAAATCTTATTGAAGCCGGTTACCACAGCTGGTCTAACCTCCTTCTGAGGTTC GAATCATATTTAATAACCGCATTAAACCGAAATTTAAATTCTAATTTCACCAAA TCAAAAAGTAAAACTAGAACACTTCAGATAAATTTTGTCGTTCTGTTGACTTCA TTTATTCTCTAAACACAAAGAACTATAGACCATAATCGAAATAAAAACCCTAAA AACCAAATTTATCTATTTAAAACAAACATTAGCTATTTGAGTTTCTTTTAGGTA AGTTATTTAAGGTTTTGGAGACTTTAAGATGTTTTCAGCATTTATGGTTGTGTC ATTAATTTGTTTAGTTTAGTAAAGAAAGAAAAGATAGTAATTAAAGAGTTGGTT GTGAAATCATATTTAAAACATTAATAGGTATTTATGTCTAATTTGGGGACAAAA TAGTGGAATTCTTTATCATATCTAGCTAGTTCTTATCGAGTTTGAACTCGGGTT ATGATTATGTTACATGCATTGGTCCATATAAATCTATGAGCAATCAATATAATT CGAGCATTTTGGTATAACATAATGAGCCAAGTATAACAAAAGTATCAAACCTAT GCAGGGGAGAAGATGATGAAAAGAAGAGTGTGAGCCAATACAAAGCAGATTTGA GGACATGGCTTACAAGTCTTGGGTACAGAGTTTGGGGAGTGATGGGTGCACAAT GGAACAGCTTCTCTGGTTGTCCAGTTCCCAAGAGAACCTTCAAGCTCCCTAACT CCATCTACTATGTCGCCTGATTAAATCTTATTTACTAACAAAACAATAAGATCA GAGTTTCATTCTGATTCTTGAGTCTTTTTTTTTCTCTCTCCCTCTTTTCATTTC TGGTTTATATAACCAATTCAAATGCTTATGATCCATGCATGAACCATGATCATC TTTGTGTTTTTTTTTCCTTCTGTATTACCATTTTGGGCCTTTGTGAAATTGATT TTGGGCTTTTGTTATATAATCTCCTCTTTCTCTTTCTCTACCTGATTGGATTCA ATATTAAGTAAGACTAAAGTAGAAATACATAATAACTTGAAAGCTACTCTAAGT TAGAACATAGCCAGATTTGGTAAAGTTTATAAGATACAAAATACAAATTCTAAA GAACTCAAAAGAATAACAAACAGTAGAAGTTGGAAGCTCAAGCAATTAAATTAT ATAAAAACACTAACTACACTGAGCTGTCTCCTTCTTCCACCAAATCTTGTTGCT GTCTCTTGAAGCTTTCTTATGACACAAACCTTAGACCCAATTTCACTCACAGTT TGGTACAACCTCAGTTTTCTTCACAACAAATTCAAACATCTTACCCTTATATTA CCTCTTTATCTCTTCAATCATCAAAACACATAGTCACATACATTTCTCTACCCC ACCTTCTGCTCTGCTTCCGAGAGCTCAGTGTACCTCGCCT SEQ ID NO: 40 Polynucleotide sequence PATGAUT8_PATIRX8 ACGAGCTGACTTGTACCGATGAGCTGGCTCTTCTGGGCGAGCTGGCTGATCTTGA CGAGCAGACTTCTCCCGACGAGCTGACTTGTGTCGATGAGCTGGCTCTTCTGGGC GAGTTGGCTGATCTTGACGAGCAGACTTCTCCCGACGAGCTGACTTGTGTCGATG AGCTGGCTCTTCTGGGCGAACTGGCTGATCTTGACGAGCAGACTTCTCCCGACGA GCTGACTTGTGCTATCCTTTCTCCAGGTCTCGAAAAAGTCCCCTTTCCCGAGACT TTCTATTCCTTATTTATACCCGTCCGTATAGTAGGGTACGCAAGGTGAATTCTCG AGAGTGCCCCTTTTCTACGCAGCCGAACTCACATCCTGACCAGGCCGGGCTTCGG CCTGGTGGGCCGGCTCGAGTTCTAAAGTGATGGTCGGGGCTGGGTCGTTATTCCT TGAAATGGGCCGGTTGATCACTGAGGCCCAATTGATGTATCAACATGTGGTTTTT ATAAAAAGAGTCGTGAGAAGAGTTTTCTCTAAAAATCCCTTGTGTTTGGTAATCA AACTTCATTCAACCAACGAATTCCAAAAAAACAACTAAATTGTTCGGGTATATAA AATGATTGGTAATGATATATCCCATAGAGGCCGTAGACATAGGCCCAAAAAGTTT CCATAACTAGCAGAAATTGAAACTTGCAAGTTGCAAATATTATTACACTGGAAAG GCAACAAGTCTTGAAGTACAAACTACAAAGACTTCTTGTTTGGATGGGGACGACT GACGAGTTTGAATAACTTAAGAGAAAAGGGTCGCAATCGAAATTAGACAAGAAAT TAGTCCTCAAAAAGTAAATTCTGAAGTTGAAGCTCCAATGTCTTTGTTCAAAGAC TTTATTTAGATGTAAAGTTATGTCTTGTAACCACCAAACAGCTCCTTTTCATCTA CACTCCCAATTTTTTTAACATCTATGTTTTGCATTGCCTTTGACTTGTCTTTCTC TCTCCAACTTCTCTCCTTCAACATAAAGCCAAATCCTAAATCCAAATCCCTTAAA CCGAACCGAATTAAACCGAAGCTGTTGAACTATCGCAAAATTTCAGATCTTACTA ATCATAAACATGTGACGTTTAATTCATTTTAAGAGTTTCATGATTTGCACTGAAT GGTATTCCGAGTCCACCGGAAAAAAACTTTTCCTACAAGTAGAAAAAGGATAACC CCATAAATCCAAATAACCTAACCGATCAAACATATACCAATATAAACCAAAACAA GATTCAGATTCATCGGTTTAGTAATCGAAGTAATGTACTAATGTGTAATATTGAT TCCACCACCAGCTTAGAGATTCGAACCAAAAACCGAATAGCGCATAACCGAGAAA ACCCAAAGCTTCCTAACAAATACATAAAACCGTGGTGTTTCTAATTCTAACCAAC ACACGTTTCCTTTTTATTCACAAGAAACATCAGAGTTATGATCTGCCATTAATAA CCTAAACACAAAGCAAGGTTAGGTAAATGATATGGACCCCTAATGAATAATCATA CAATACATAACAACGTAAGATCCAGTTTCCCTCTTCG SEQ ID NO: 41 Polynucleotide sequence PATNST2 AACGGTGGCGTGATGGAGCTTCATCCTCCCATCTTCGCCGAATTCATCACCAACG AATTTCCCGGCCATGTCATCCACGACTCTTTAAGCCTCCGCCACTCATCTCCACC GCTTCTCCACGGCGAAGAACTCTTTCCCGGTAACATCTACTACCTCCTTCCTCTT TCTTCTTCCGCAGCCGCGACCGCTCAACTGGATTCCTCCGACCAACTATCAACGC CGTACAGAATGTCTTTCGGGAAGACGCCGATAATGGCGGCTTTGAGTGGCGGTGG TTGTGGAGTGTGGAAGGTGAGGCTTGTGATAAGTCCGGAGCAGTTGGCGGAAATT CTTGCGGAGGATGTGGAAACGGAAGCGTTGGTGGAAAGTGTGAGGACGGTGGCGA AGTGTGGCGGTTACGGCTGCGGCGGAGGAGTTCATTCGAGAGCGAATTCAGACCA GCTAAGCGTTACGAGTAGCTTTAAAGGGAAATTGTGGTAAAATTTCGAATTATGA ATAAACTACGTTTATGTTTTAATCTGTTTCACGATTTAAGCATTTAAATTAGTAT GTTGATTTCCGTATTCATTGAAGACTTGGAACGATTATATAAGTTTATCAACGTA GATATATTTGAAATATCATTGTTATCTCTCATGAAACAATTAATTTATGAAGTCG TAGACTCGTAGTTAGAGATTATTTAATCTTCCCTATTCAATGCCAAAAGTCTAGA AGAGCAAAACAAAAGGGAGAAACTCTTTTATTTCAGGCCCAATGACACAAAGCTG GCCAGAAACAGTTTAAGATTAGGCTAAAGTTATAAGTCCGACAAGCACGAGTGCT AATATATATAGTTATATGACGTCTCACCATTAAGGGTTTAATAAATTTTGAAACA CCTCAAATTAAGATTGCTTCCCATGCAAACTTCCTTCATCTTCTAGAAAAATTAC GATTTGTAATACTTCAATTATATCATTTTAGTTTTTTGTCACTAATTATCATCAA TTTATCATAGCTCCGTGCCGCAACAACGTTCGTTTTAATCAGATTATATATTACT CTGCTATAAACTCAGAACCATGTTAGAAAAATGAAAAAGACATTTCAGAATATTC ATTAACTCAAAATTTTAATCTCATGATTTAATTTTTTATTAACAATGTTATCCTA TAGCACATGGCAAATTTGAACGGCCCTTGCGTATTAATCTATTATAATCTCAAAA CCATGTGTAAGAAAAAGGAAATTCAGAAAATAACCTTTTGTAAATAGGCCCCCAC AAAATCTACAACATACGTAGATACCTCCTCGCTTACAGTTGTAAACAACTGTTCA TCTAGATTCATGCCGTCATTCAAGTTTAAATTAATACAATAATTTAAAATTTTAA TTTGGATGAATCGAATCCACCGTCGTTTCCTGAATACCAGATAGGTTAACTTTAT GATTAGTTCGAGTGAACCACATGCACAATATTCGAATCTTAGACATTCGTTGCAA TGTTAACTTCACATATATTTGATAAACGCTTCTTGAATCAGATCTTAATCTCTTT CTTTCTCTCCATCTTCTAAGGAGGTTGTGGATTATCATGTAGTATATCATTATCT TCGCATCACCTTCAACAAGAACAAGCTACGAGCTTTAAAGTCGTATTTAACACAA TAATGTATAAAGTCTTTCTTCATCACATCACATACATTTTTTGTTGCCATCACCC TTCATTCACTTTTTTTGTTAACACTATTCGTTTCTATATAAAATAAAAATAAAAT GAGGAATGTCTTGTCCATAGAGATTTTTAAGGTCGAGGGTCATCGGAGCGATGTG GGCTTGCTTCCTACATTATAGTTGATATGTGGATCCCGCGTGGACCATATTTTTA CCCAATAGCTACGTGCATGGTCCCACCGCTCTCTCTCACGCACTATTCCGAAATT GCCATAAACAATTTCACCGGACAAAAAGAGCAAATAATTTCGATGTTTAATAAAG AGACCATTAGTATATTTGACCCAAAAAAAAATAAAAAAAAAAGAGAGACATTACT ATAACTTTTATTAGATGAAATATTGCAACATTGTATTTATAACGGATCTAATTTA CTGAATCATATTTTTTTTCTTTGTTAAAGAGATACTGAATCATGCAGAAAAATAG ATAGATTTTTAAATACTAGGTGAACTCATGACGAATCAACCATTACGAGAGATTT CTGGATAAAAGCAAAAACAAAACAAAACTAACATGCTAATCTAGGCAATTAGTAG AGCGAAAAGTCGGCAAAACCAAAGGCCGAAGAAGCTTGATCGATATACTTTTTTT TTTTTGTTTTGGCTGGATATACTTGGTATGAACTAAGAATTAAGTAAAAACTCAT AGGGAGTAATTTTTCGAGAAGTGCATTCACTATGAGTATAAAACAGACATTTTCA AATTATTAAAACAAGCTCTTAGAGGCTCATATGTTTAATTGTAAGTGGCGGCTCA TGCGAACTTATAATGAAAACATCAAATATTCGGAAAAATAATACTCCACTGTTAA AAAGAAAACTTAACAAAGGAATTAAAAATATGAGAGCAAAAGAACACATGCATTT TCTCATGCATGTACTATTATTTATTTTTTTGCAGAGTTGATGTAAAAAATATACA CATATATATAGACATACTTTGGTTAGTTATAAACTCGTTCTATTTTCTTCTCCTT TTTCTATCTTTAGCA SEQ ID NO: 42 Polynucleotide sequence PATNST3 ATTCTACACATTCACAAAGTTTACTACACTATATATAATTTACCCAACAAACACT TATTTTACTGCATTATTCAGTATATTATCTTACCTATAAATGTGTATCATCATCA TCAATAACGCGATTATTTGTGCTGAAGGATTATATATTCAAAATGATCTAGTTAT ATATGTCACATGATTGCCGTTAACAAGACACATTTGAAGAAGCTAAGCAAGAAAA ACGGACACTITTGCGACTTGTTACATAATTTAACTTATAGGTCAAAAGAATTTGA TTAGTCATTGCAACTACGTGTGGATGTCACTTTCTATTCAACCAAAACTCACAAT ATTATATGATCTAGTTTTGTCGTATTACTGATTTGTATTATAAAATGTTATTTAA TTTGAATTCTACGTAGATATTGCTCATGCATGATAGTATGTATCTAAACTATTCA AATAACTAACTACGTGGATATTTTATAATCCAAGTAAAAAGCAGAAAGTGGGTAA CTACGTCAGTATGACTATACTTTTATCGGAATTGCTTGACATCCAAACTTTTGCT ATGCTTCACCAACCAATGCAGTTTCACTTAATTATTAACTATTGACTATGTCTTA TTAAGTTAGCACTAATTCGTTAATCATTCAAAACGTTATTTGATTGAATTACATA TTACACTCTCTTTCTGCATCACCACTCACACCATATGCAACTATAACCAACTCAT ATTCAAATGTATTAATTGGATTTTGGTGCGAGATTAAAAATTGAAAGGAAACAAC ACAATATGATAATGGGATAAAATCTTGAACGGAAACTCAAACTAATCCTCATAAG GTATAACAAAATAACAATTTAAGCTAAGCACAACAACATACAAGTTCGACCTTTT CCTTTGATGATCCAGCCCAACAGTTCTCTTATATCTCAAACCATTCGACCATTTG AGCCAAACTAGCTAAACCTGCAGGAATCAAAACCAACAAAGATTCAGATTAGCTA AACCGGTTTCATCCCTTTGTCACATGACTCACATCCGTCTTCTACATAACGATTT CTAATGATGTGAGCTCTTAACTTGCTCCAGCAAGATCATCAACTTTGGAGCACCT TCAATGATTTAGTTAACATGTTAGATAAATTAAATATTCTTGTTTCAATATATAT CAACTTTAGTGTAAAAGCCTTAACATTCTCTTGAATATTTAATTTATTTCTCCTT ATTTCGATTTAATGACAAATGTGAATTAATTTTTGTGATATTTTTGTTCGAAATT AGTTTTCAGTTAATAACATACATGTGAGCATGGGACACACATGATTTAACAAAAG GGAATGACGAAATGATATATCAAAATATTAGTATGGGAACAAATTACGAGGTGAA ACTTCACACTCAACTCAATTAAAACTAGAATAAAGAAATGGAAAAAGTGAAAGAA TGAGAGGTCAAATGTGGTTAATCATTATGTGGTATTAGTTAATCCATCAATTGTG TACCCAAAAGCATGATTAAGCATAGAATTTAGAGAAACAAAACATCATTATTAAT GTTGAAACACAAAGATCCCATCAACAGACAAATGATAAGTACAGTGCATGTAGGG TAACAACTTTTATGTACATGTTATATACTTATATTATATAATAAGAAAACGATTA AAGTGTCATTGCTCCAGCCTCTATTTGTAAATCATATTATATCAGTATGCTTAAT TCCAATAATTAAGTCCATAACTAAAATATATACACATATATGTATGTTAAATGGT TGAATATATACATATATTTTCATAAACAAATATTGCTAATTAATTCAGTTATTTG TGTACATAATCCAACTATCACCTTTTTAGCTGGAAGTGGATATTCCAACATGTCA GTCTGTCACTCCCACATTCATACTCTCTATTCTTTTTAGCTATTTCAATATCTAC GGTTAAATATTAATGGCTATATAGCCTTACCCTTCATTTTAGTTTTTTTTTGGTA TTCGCATAACCATCGAATACTCAAACTTACTATGTAAGATGGTCTGAATAACTAT TTCCGATTTAAGATGAATAGCTAGATTGAAATATACATGCACTAATTGGACATGC ACTAAAGGCAGAGGTGAATTAAATGATGAAATGAAGATGAAGTGTCACACTTGTG CAAAAAGCATGTCCCCTGCTCTTCTCCGCTTGTTTCAATTTCTTTGACTTTCATC ACGTTTTTGTCACTTAAATACACCAAAAAATATAGTACAATTAAACATCGAAAAT CGTCCAAAAAGAAGAAAAAAAATCATGGAAAGTTCTTTCGTTAATGTTACACACA TTATCTTGATTAGGTGACACCAGATATTAGAATAAAAATGATAGATTATGAAAAG AAAAAAAAAATTGATGTATTTTTAGGATACATCGAAAGGAATGAACATACCAAAA ACATGGGAAAAAATAGATAACTAATTAACATGGTAGAATGTAGATGACGTAGATC ATGAAACGAGTGTGTGATATATTAATGAAAATTATTTTAATATACGTAGCTATAT TAGAAAATAATTTACATTTATTTTCTTCTAAACAAATCTATACTTTATATTTACA TACATTAGTAAAGACCAAAACACATGGAATTCAAATTCTGCAATAAGTAATTGCA AGAAAACACAAAGATTAATCCCCCACTAAACCCGTTTATTTACGTTAGTATTTTT CCGTTTTATACATTACACATGACATGACATTACACGTCAAAAGAAATATGTCTTA CGTCAGAACTTACGTATGATCAAACTCGATTTAAACATAGAAACATCTGTTTACT AAATTATACTAATTTCATAAAGACACTTTAATGCATGAACTTCTTTGTTTAAATA ACAATTTCCCCCTTTTGGGGGCTATGTCTCGTCGAGTCCTACCACCATTATAAAT TATCTCATCGTTTGCTTTCTTTTTTTTAAGTTGTAACCATTTCCACTCGTAATCA TACAACTTCTCTACTCTTCTAGAGCAAAAACCCAAAAATATATTGCTATCTTCGT TA SEQ ID NO: 43 Polynucleotide sequence PATFRA8_PATIRX7 CTTCAAATCTCTTGTATCATTAAATAGTAACGTTTTAAATATTTTCTGGATAAGCA TAAGTTTCTTTGAAAACTATTTTGTATATATTCCTACTTCTCCATTTTTCTAAATT ATTTTATATTATACATAGTTTTCCAAATTATCAAACATTTTTACATGTTTTGACTA ATAAATAAACATATTACTGCGAATTAATTAAAAATAAATATTCCACACAATAATTA CCTTACAAGCGAATAAACTTTTACTATGTTTTCGATGTAAATTTTTCTTACATATT TGTAACTGAAATTTCTAACTTGTTGTTTCATAAGTTTTAAAATTTATTATCTAATT ATCTACTTTTATGTGTTCTAGAGCAAAGTGCTAAATGTATATATACTTAGATGTTG TGTTGTAATCCAATGTCAATATAATCAATGATTTAGCTATTTGTAAACATACTAAA TAGTATTCCACCAAAAAAAAAACATACTAAACAGTAAACAAACAGCAAAAACAAAA TCCACATGTCCTAAAAGATAGTCTGATTTTCGTTCATAATGCTCTGGTTTTTGAAA GATAATAATTGTGTTGTATGAGTGTATGACAAATATTCATTGGTTTGAGAAGTTAA CAAAATTTGGTGGCTACAAATGGTTTCCTATTCGAGTTGGGTCCATTATCCCTTGG CGTGTACGGAAATAATACCTACCCATCATAATCTGATCAAAGATGAGGTAGTCTTT AAATAAATTTTGCGGCTTATATCAATCTTTATGTACTATAAACTGTGAACTTTTTG TTCTTCAGGACTTCCACATCATTGCCCAATCCGGTTATACCTTCGCTAGTTAATAT GTTAATTAACATTAAATTAAAGAGCTAACATTTCTTAGGTAGTAAAATAGAAGTTT TGAACTACTATACTACTAACATGTGAAAATACTTTAGTCACAAATATGACAATATA CAAATTTATTGGAATGCAAATTCTTGAATTTCAATTGTTTGAAAATTATATATTTC TACATAACAATTCTTTATAAACTAAAAATATTAATTTTCCATGGCTATGCGTTATA CGTATATGTCAAATATTTTTATTATTTATATAATTTTACGATAAATTAGTACTCCT ACTTTACTATATTACTCAACACTAAAAGACCTCTTTAACTCCGCCTAACAAGATAT GTTTTCTTTTGAATGTTTCGGTTAAACATGACAGAGATTTGTITTCTTGCTTTCGC TCAATACATATTTGTGCTCCTTTAGAAAAGTAGTATTTCCTAACAATCCAACATTT TCATATTTATTATATCTTTTAAATATTATCATGGTTCTTTTTCTTTCGTCATGTTT GGCCTCTTTAAAATAATTCTTGAATTGTATGAGCATTAATCCAATAACGTCCTGAT CCCAAAAACCTCATATTAGGTTTGAGAGTCCGAAAATATACTTTTCACATAAAGCA CCTAAGGTGTCATACTTTAACAACTTCACAAAATATGCAAAATTTGTCATTGTCAC TTTGAGATGTAAGTTTTTTTTTACATGCAAATAGATTGAGTCTCTTTACGTGTAAA TTCATTTAATAAAATTGTATGGAATATCTATTTATATCATATATTTCTAACATATA TATAAATATCTATACAAAAATACGACTTTTTGGCACATGTAATTAGAAAAATCCAC AAGAAACAGAAAAAAGAAACACCAAATACAACGAAATGAAGAAATTATTATAAATT TGAATGGCTTAACATCTCTTAAGAGTCAACAAGGTAAAGGATTAATTAGTAGTCTT CATCAATCTTTCTCCACCTTCTTCTATTCCTTAATCTCCACTTTATCTCCCAAACC CGAAAACTCCTCTICACCAACTTAAACCCTATTAACTAATCCCAACAATCAGATGT TTCGAATTCAACAACCAGCTCAGGCCATAAGATTCATCCCGGAGAAACAAGAACG SEQ ID NO: 44 Polynucleotide sequence PATIRX9 CGGGTTTTCGGTTCGACCCGGACTCGAAACGGGTCTAGATGAAGAAAACCTCATCT CTTTTTGTGTCTAAGGATTTTTTGGTACTGAAACTCTCACTCTTTTTTTTGGTTCC TCTGGTCCCTCTCTATATGATTCAGATCGAACACTGTGGTTTTATATTTTTTAATG TTTTGTTATGTTCACACGTTGGGTTCAGAAAAATTGACGGCCGAGATCTTTTCTAT AAGAGGAAATCGGTGGTTCTACTTAGCTAATCCTTTTTACTAGAAAAGTTTAACAT TTTGTACTTTTTGTCTGTATGCTCTCTAGTTGTTTGTTGAGATCTCTTGCTGCTAG ATTCACTTTTTGGGACACATTGCTTTGTATTTGAAGCTAGAAAGTTTATATCAACA TGATCTAAAAAAGTATTTTAAGAGAACTACATTGAGGTAGTTATTTCTTTTCCTAA ATTAGTCATTGGTAAATTACATCGTGACATTTATAGAACATTGCAGAGCATAAAAG ATTGAAAAAAAAATGAGCTGAGATTTGTATGTATATAAAGAAAACGTATTAGCATA GCTTTCTTTCAGATTTAACGGTGGAAATCATACAAAACTTTCTTGCAGAACAATGA GTATATATATGAAGGACTCGTTAACGAAAATATTAGTTTAAATCTAGATATCTTCC AGTAAAATATGAGTTTCGCCTTCGTATATGATACGGCAATAACTTTGGGACCAACT AATTTGCATATCACATGTTGATATCTCTTTCAGTTCTACTCATTCTTTTTTTTTGA AAACAACAAATTATTGGCTGCAAATGTTTTTTGGTTTAACTAGTGCTTCTCTAATT GTCAAGTATCTTAGTCTAGAGTTAATTACTTAAATACTAAAAGGCTGTCGACAAAA TCAAGCTTGAATCTCCTTGTGGTATCTTCAACTCTTCGTTGTCTGCTTACGAGTGG TTTACTCAGTAATTATCTATAATATGTTATTTTTTTTCCCTCATCTTTTAGTTGTT GTTTCATTACATTGAAAAGCTTGTAATGTCTTTATATGGTATATATGGATCTTATG AGTGAGGCAAGATCCATGATGTTTTTGATCTTAGAATGTATATGATGATCTTAGAA TGTATTTGACCGCCCACAAATTATTGTTCATTGGGATTATATCTCTAGTCCAACTC CAAGCAATCGAAATGGGTCCTGCTTTTAAGAACAACAGTATATGTTTAAGAATAAT AACTTTATATATTCTCGATTTTAAGATCTTTTGACAAAACCTCCTTTTCGTTAGGA GCGTACTAATTTCCAAGTGTTTGATTAGTGGGGTCTCCGTAAATTTATTTAGAGTT TCTATCTATTTATTAATAGCTCAATTAATTAATCTATACTGTATCTAAACATCAAT TTATATATTTACTCTTGAGACCAAAACTGTCAATTTATAACATTGGATAGTTTCTT AATTCTTATTATATATTTTTCAAACACTTTTCAAGACTAATCTCCACATTAGGTAC TCTCTCTAGAGATAAAAATATTTATCAAAAACATTTTTATTTATTTATTAAGTAGT AGATAAACTACTGTGGCAAAATCGTAAATGTCTAAATGCTGATGAATTTTTTTTGC TGCTCCAATCTGGTTTAGTGCTCCATATACATCCACGGCCAAAATGAATCTATGGC GGCATTAAGATTCATTAGTAAGCAACGATTATATTAATATAATTGTTTTTAGCAAT GATTTTCCGTAATTTCCCAAATATGTTTCAGTTAATGTGTTCCAATCCCAACAACT GGTTGTTGCAAAAGACCACCAACGCAAGCAATCATCAAACATCAAAATAATCTTAC CTTAGCGAACAAACAATAACTACACAATTCTCATAAAGCTCTTATATATCACTAAC TTCACACATTTTGTTTTCCACAAAAATAAAAACGGAACTCACTCAAGAAACCTTCT TCCTTGAAGAGAGGGTT SEQ ID NO: 45 Polynucleotide sequence PATGUT1_PATIRX10 AATAACAACCACTTAAGTTACTGCAAGTTACCACAAAGAAAAATGATCTAGCAA ATGAGTAGCATCATATTGATCAAAGACACTGCAAGATAAAAGTCACCTTGCTAA TGTTCGAGATAATGATAAAGTGTAGACTTGGAGCAAGAAGCCATTTAAACTAAC AACTTCCTAATTGAGACCTTTCATGTAACTTAATGTCAAAATCACAAGCAACTA GAGGAAGAAATAAAAATGTACCAGGTAGCTTCTTGGGCTTCCTCATGGGAACAA ATTTGGCACCAATAGCCAACGCAATAGGAGGGCCAAAAATGAAACCTCTAGCTT CAACACCTGCATTTACCACAACATCAATTTAGGCAGAACCAAAAATCATCCACC AATTCATTTCAACTTTTCAGTTTAAGCTAAAGCACTCAGTATCTAAAAAGGCCA AAAGAAACTAAATCCACAAGCTGTTAATCGATTGGAGTACCAAACAGAACCATA CGAGTTGTTACCTGCAACAACAGATATGCCTTTATCTTTGTATCTATCAACAAA CAAAGCAATAGTATCCTTAAAGGCCTCAGTGTCGAGAAGAAGCGTCGTTATGTC CTGAAACATGATTCCTGCCAAGTATCCAAATTAAAACCTTAAGATCCCAACGCA GATCAAGACTAGAGACGATATTAATCGGTATAAATGGAAAAAATGGAGACCTGG TTTAGGGAAGTCGGGGATGACTCTAATGGAAGAGGCAATCTTAGCGATTCTGGG ATCTTGCACATCTTCAGTCGCCATTTCACTGTCCCGACTGGCTGCTGCTTTAGC AAAATACTCGGCGTCAGATTTGCAAACACAGAGAGACCCTAAAGACTCAATAGA GAGACACAGTGATGAAAAAATGACCAATTTATCCCGAATGGTAACGCTTTGACG GAATTGCCCCACGCAAGCAAAATATCTTTTTCAAAAGGAAACAAAAAGTTTAAA AGGGAAATAGAAGGTGGTGGGGTCTACCGGCGGAGGAGAAGAGGCGGAGTGAGG TGGTTGAACGGTGGTTTGAGAGGCGGATCGAAGGAGGAGCACGGTGGTGGTTGT TGAGAAGACGGTTGCAAGGAACAGCACGAGCAAGACAGAGACGATGAGAAACAA GTGGAGAAATTATTATTGTTTGCATTGTCTTTGGACTGAGAGATCTTAAAAGAG AATGTAAATTACTTTAAACACGGAATAATGGACAAAAGCCGTGATCAATGACTT TTCAAGTCTTAACCAAACCTATAACTCATCCATTGTTTGTTTTTTCTACATATT TCTTCACATAAAATTGGATGATTTAGAATCTTTCAGAGTGTTCACACTCCAACA GATTATTATCCACAATGTTATGGTTACATTTAGAGATATATAACAATGTTCATT TCATCGTTGCTAATGACATAAAACGATCAAAAACTGAATCATAGTACTTCTTTT ACAGTGATCTCAAATATATTAATCGCTAATCAATGAATTATGTCACCTATAATT GTCGTATTACCAACAACTATAAAACATATATATAAAAAATTGTTGTCGTTAACT AGTTGTTGATAGTGGCCACTCTAAAACGATCATGACCTACTACGGAAGTTATAA CTAGTCAACGTTGGACGTTAGCAAGGCCCAATGGACATTAACTCAGCCCATAAT AGCACGCGCCTTGTGATGTGCACCAGTTTCCGTCTTTGGTCGTTGAATTCAAGG AAAAAAAAAGTACATCACAAGCAATTTCTTACTTATCTGTGACTTGAAGCTATT TCTCCAATTTCGTTTTCCATCGACACTCTATTTCATTTTCACCATTCACGTCTT CCTTCTGAATAAAATAAACCCTAAAACCTAATACCGAAGTAAACTCGTCAACCA CTGCGCCCATGACCTCCCAACGATACTCTTCCCTTATATTCTTCCTCTTCCTTC TTCCTTTCTGCGATCCAAACCTTCAAACACATCTCCGGTAGAT SEQ ID NO: 46 Polynucleotide sequence PATIRX14 ACCTGCATCGAATTTATATAAATTTAAAACACATTATCATCATCTCTAACTTGAA CTTTTAAACAAGTTTATCTTTTTGTTTCACAAAAAAAAACAAGTTTATCTTTATG TCCCTCCTGAGACATATAAAACAAGATTATCTTTCTTCTTAGTAGGGATATAGCA AGTCCGGACGAGATCAAAAGTAGATTGACTCTTAAGATCTTACTAAGTTTGAGCT TGCTTTGGTTCCCACCTCTAAAAACCAGTTTTGCATAGTCTGAGACTCGTGTTAA ATTCGATCAAATCTCTCTTTCAACGACGGTTAACTATGGACGTATTCGCAAAACA TCACATAAAAACATCTCTAAAGTATTTGGCTATTTGCATAAATATTTCACTCTTA CAGTCGTCAAAAGTATGAATGAACTCTACATATCGGCCCAATATGAACCAATTTG TAAGACCATAATGGAAAGCCCATGTTTCTCTTGTGCTTGTTTTAGTTGCAGAATC ATTAGTTCACATATTGACCGGATTATATTAGTTTTTAAAAACGCATGTATGATGT AGTCACTGTATCATACCCAAGTTACTGTATTCATTACCCAAGTTCAAACTCGATA AAATGCATAAACTAAACATACGTTCTTTAGCCTTTTGTTTTCACTTCAATTAACT CATTTTGTGCGTTGTATATTTTTTTTCTTTCCAACAGCTACTTTTCTCACGTCTA TATTTTTTACCGTTTGTGATTTTTGAGTCTCAAATATATGGAATTGTTTTTTTTA AATGGCTACTTTCCAAAGTCTTATATTTTTTACCGTTGTAAATGTTCAGTTTCAG ATATATATGGATTTCTTTTTCTAATGGCTACTTCTCTAACGTCTATATCTTTTAC CGTTGTAAATTTTAAATTCTGAAATATATTACCGTTTGTGATTGAGTTCACTTGA CACACCTTCGTTAAAAATTACACAACAAAAAGCGTTCACAATAAGCCCAATGGGC CTAAAAGACCCTAACAATCGAACATACCCTTCTGACCAACACATTTTCTTAAGGA GACACTGTTGGTCCATTTACTCATTTAAGTAGGATTCATAACACTTGTCATGGTC GTCATTTCTTGTTCAAATGCCTTTTTAAGTAATAACGCAATGGAAGCATATATAT ACTTTAAACCCACAAATTAATAATGCATATGTATCTATTTTTCTTGCATATACTA AACATGTCTAAGTATGATATAAACTTTGACACTTTGGTGGTGCTGAGTAATCATC ATATTTATGCTTTGTGTGCAAGTGAAAACGAACCGATAACAATCTTTAAGACTTC CCTACCAAACCGGTTTAACCTTCACAACAAACAAACCTAGATCAATTATCTCTAA ACCAAAACCCTTCAAACCATGTCTTTTGTCGGACCAAACTGTACTCTTATATATG ACATGCAGATACGTCGTTTTCATGGGCCTTACTAATGGCCCATTAAAAACATTCG TAATCAATTATTTTGGTTAGTCTTTCCCAAATTCGTCTACATTCCTCCTCGATAA TCACTTTTAATTAAAACCATATGAATTTACGAAAAAAACAAAAACACAATTATCA TTATGCAAAACATTTAATTCAATAAATTGAGGGATGTTTAATGTTAACACCAAAA ATTATTACCAAAAATTGACTTCAATTAGAGACATATTAAAACGACCCTGATTTTA CTCAAAACTTAATTGAAAGATTTAATTATCCAATAATAAAACGACACGTGTACCT CCTTGTCGCTTTCCTCTGCTTTCTTCGATGGCGTTGCATCGAAGCATCAGAGAGA TTGGTATGGTGGTGGTGGTGAGAGAGCAGCAACAACAGCAAGAAGAGAAAGCGAT AATCGAACTGATTAAGATCGTGAAATCCAAGTAATCTCTGTTGCTTAATCTCAGA TCTTTTTGATAAGGAGAAGGAAGCAGAAGAAAGAGGTCAACGAAGAAG SEQ ID NO: 47 Polynucleotide sequence PATMYB46 GTTACACTAACGGTTTCTTGTTAGATTTAGCTGACGTGTCTTTATGAATATATAT AGAGTTAAATTTTAATATTTTAAGAGTAGTATTACTTCATTAAAAGCTTAGTTGT AAAATTACTAAAGATTTTCATATATTATAAACTATTTTTTCCTGGCAAACTTATA TTATAAAATTTGTTGAGCGATTGTGTGATTCTTTCATCCACAATTAGATTAAAAA AAATCGCAAAAAGTAATACAAGAAAAAATAATAATTTTACAAATTAATAATGATT GTTTCTTTGGCTAAGAGTTCAGATTTGCAGAGTGTTTTTTGGTCCTTGGGCGATA TTACGAAAAGTGAATTGTAAAGATATGTATAGATTGTGAGGAAAATGCGAGAATA ACTGAGAGCTAGGGCTATGCATGAGATGATTGAAATATCATGAACCAAATGGTTA GATGAGAGCTTGGAGTGAGAGGTGACACTTGTTTGAGATGGGGAATAGCGGATTA ATGTGCTTGCATGACCTTGGTTCTGAATTTTCGATTGATGAAATCTTGCATTTCG TTATTTTCAAACTTTGTCCACGAGTTTTACATAACTAGGTTCATTCAAGTTACAA CTTAAATTGGTTAGCTGACGTCTTTTTTCATGCATATACAAGAGGTTGCATTTGC AAGCTTCAAAAGAGATTACACCAAAAACAATTTCCCCTAAAGGTTAAGATATATC TTTGGCCITCAATTCGACATTAGGAATTATGITCAAGATTCAAGATTCAGTACTA TTCTAACTTCTTTTGTACTTTATCTATGGATGTCTTGTTTATGATTGTATAAAAA GTTTTGTTTTTTCGGATGGGTGGGCTATTAATATTATAAATCATATAATATGAGT GTTCTGTAAAAAAATAAAAATGATATGAGTGTAAATCGAGAACTTAAAAAATCAT GACACACGTTTATATATTAAAGAAAAAACGAATATAAAATATATGGATAAAAGGA GTATAACATTTTCTTCATTACAATAATTAGATTTCTTCAAGTATACGTGTTGGTG CGCGAGAGGTGGTTGTGTGAAGCCGAAGCAAAACTTCTTGCTCGCTAAGCCTCAT ATAACACAAAAAAAGGGTTCTGTGACACACGTCGATTTATTTTATACAATTGAAA TATGCTTACATACGTATACAATTAATTAAATAACACAACATTTGCTTACCTTGAA AATGAAGACATCTTTGAATAGAAATAGACATGCTCATGAATATATATATTAATGT TATATACTATCATATATCAATGTTATATATCATATATATACACACGTAAGGTTAA CGAATTAGATATGTCTGTAATGTATACCTTGTGAATGAAGAAACTAATAGAAATG AGTTATATATTCAAAAAGAACAAGAAAAGAAGAAAATAAAATTAAGAACAAGTGA AGAGCACTTCTCCTTTTTTTCTTTGATGTTTTGCATATCGGGTCTTTTTCAAAAC CGTTTTCGTCCATGACCGATCAACTAACGTTTCTTCATTTCGTCAAATTAGTTAT ATACAAAACATACATTTGTTGTTGGTGTATTTTATTTTATTTACCTTACACAATA TATGCCGACAAAAAAAATGTGTTTAATTTGAAAAAGAGCCAGGGTTCGGATGTTT TTCTTTTATGTTTTAAAACAAAGCAACACTATATTATAAATATAATATATACAAT AAAAATATAATTAAGGAATAGAGATTAAAAAGGAAGAAGTGCAAATGGTTTTTCT TCCCAGAATTGTAAGCAAACCATACAACCATCCCTTTCTCATCATCATCATTCTC CCTTCATCAAGTCTTCTCTCTTTTCTCTCTCTATTATAAAACAAACTTCACTCGT TCACATCAATGGATCCTTGAGAAAGACAAACAAATTGAAGAGAAATAATAACAAT TAACTCAACCAAAAAT SEQ ID NO: 48 Polynucleotide sequence PATMYB58 CAAAGACTAGAGACAGAGGCGTGCCAATAGCAACACGTTTGCTTTCGTCATGCA AATTGGGATATTTCAACTTTCTTCCATTTTTTCAACCTAGTTTACTAAACTTTT CTTTTTCCAGTGCGAACCTAATTGGTTCTAGTTAAAATAACATTTTCGTAAGTT GTTCACCAAACAAAGGAACATATGATTATAACTTTACTAGAGATGCATGCACAA TAATGCTATTGTCGAATAAATACTTATATCTTCTCCAAAAAAGTTTCTTTATTA TGTTAGAAGATCCATCAATATACTAATTGATTTTTGGTTATATGTTTTGATTTA AAGACAAAACTATACAGGACATGCATGTGAGAACAAAAATTGTTGTTGTTGTAG TTGCTAGTTGAGTTTTATTTATGTTGCCAAAATAACACCATGTCAACTTTAATT TTCGTCATATAATTTAACGTAAGCATGATGTGTTTCGTCATATCTTGTTTGGCA TATGGAATATAAATCATACTATTGATTTGGAATCTTTAACTTAACTTCCTATTA AGTAAGCGATTGATGCTGATATGTATGTTTCTTTAGATTGATGAACGTAATATT AATCAGTAGTGGATATACATTGTATCTTTAGAATTTAGGTTAGTATATTATGGC CAAAATGACTAAATTGAGTACCATAAACTAAAGTTAAAGTAGTGGTAAAAGCTT ACGATATTGTTTTATAACAATTTTCAAAAAGTAAAAGATATATAAATGTTAGAG GTTTTGGATAACCATATTGTTCTATAACATTTTAAACATATGTCATATATGTTT CGTTTATAATATTTATGACTTGACCAAATAATTTGTGTATGTTATTTAAATCCA AATATATATGAGAAATATATAGACGACATGATTAAAATTATTTAAAAGAGTCAT GATGAGAGGGATGGAGACTAAAAAAAAGAGGAGAAAAAGATAGAACGTCGAGAA ATGTTGTGTGTGTATAAAGTAAAGGAAAGCTAATTTGATCATTGTATTCGAAGA AAACAAAAAAGTATACACATGTTACAGGGTTATAGGACCCATTTTCTTTAAAAT AAATCCACTATGGACTGATGTACATATTTTTTCTTACTGTTCTTAAGCATGATT TTATATGTATAATATGGTTATAGATTAGAATTTTATTCAGCCTTCCACGATTCT TAACCCTAACCAGTCAATTTTTTCTTCCTTATAAATATGAGTGCCAATCGGAAG GTGATAGCATCCTTACGTCTTGTTTGGTAGATTACTAAGTCAAGTTTTATTCAT GAAATTTCCACTTATCAAACTTTCTCATTTTGTTAAAATTTAAAACCGTTTTTC AAAAGTTGGTATAGCCATAGACAGAAAAAAATTATTACAATCCTATCTGATTTG ACTCAGACACCCTAATTAGTCAAATCTCAAAATTAGCTAATATTAACTAACGAG TTGCGCATTTTGCAGCAGTACAACAAAATTAGTCAAAATAATTTAGGATAACAG CACTAATCACAGGAACAGGTATTTTTTTTTTTCCTTTCTTTTGACATCATAAAG ATGGATTCAACTTATAGATTGGTCAGAGGCAATCTTTATAGGTTTCATGATTGA ATAAAAAATATGAGACTCAGTATCTAAGTTTCAAACATGTTTCATCTGTGTTTA GTTGATTACATTTTCATAATAGTTTATTAATGACATATAGAAATGCGAACTATA CAATTATAAAAAAGATGTGAATTTTGCCAGATACTCATCCACAATATAGACAAG TTTTTAACCTCAACAAATCTGATGTGACATTTGTCAATGTCTGTGGTTTATAAC ATGTTTCTCAATGTCAGGATCACACACACCACTTCTCATGTATAAATACACATA AAAGCAATTGGATTTGGTAAGAGGGAATCTCAAAAGTGTGTGTCTGTGAGAGAG GAGAGAGAGAAT SEQ ID NO: 49 Polynucleotide sequence PATMYB63 GTTGATATATATTAATATGTGTCCCTATTATGATCACACAAAACATACACATGCA GAGCTTTATTCCAATAGCTAAAATCTGAACTTTAAAGTCAGTACACTCGAAATTG ATATTGACGTATGTATTACTAATAGCAACATGTGTTCTTTCATCATAAGTTTACA TAATTTTTTAATTTTATTCTACTTAATTAATGTCACAGTTTCCATCGTTTTGATA AGGTCCATACTCCATAGGGACGTTGAAAATTTAATTTAATTTTTTCCACTCATAG TTGTCCTTTTTTTCTTAGTAAAGTTTGGGAAAGTTTTCCCACTCATACTTGTTTG TTCACCAACCTTCTGATTACCAAGAGTCGTATAAAAATGCAAAACTAATAGATCG TCATTTATATATGTTGCTCCTATAGACTTTTATCGACAAAATTTTCCGAATTAAT CATTTTGTAACTTCAATACATATACGTCCAGATATTTACCCTAGTGAAAAATATT TCTTCTTTTTCAAACCTCTTTTCCTCTCTATTCCTCCTAAGAGCTTGTTAACGTA ACAAAATTGTTGGGTTTATTAACTTCAATTATTGTCGATACTTAGTACTTTAAAA TATTTGGAGTAATAGATGTAGTGATGGCTGTGTCGTAATTGCTTGAATAATTTTG GATGGGTACAGAGGAATTAATTAAGTAATGAAGGTTTGGTGGAATTAAGTAATTA ACGTAGCCAAGAGCCAACAACAACACCAAACCCACCAAACATTAAAAAAGTCAAA AAGACGTAAGTCTTTGACCTCTTCCACTCTCTTTGGTCTTTAGTTTGGTGAGTTC GTGCACTATGCTCACACACACTCCTTACGCCTTTTGGTGTTTTCGGATGTGATTA GAAATGACTTTTTAACAGTTTTTTTTTTTTTCTGTCTCTCATTTTAATGTTATAT TTAAGGATTATATATATTTCTGCTTTTTTGTATACAAAATATGAAAATATTCCAT GGAGTGACGTATGGAGTGACTGCGTACTTAGTAAAACAGCATTATTAGTGAGAGT TCATTTTTCTCGTGTTACACTGTATCTACATGATGATCACGGGACTATCTATTAT TCAAAAGTTGGTAATTATACACTGAGCCTGATTACAGAAGACTCGCAGACAAAAA CTAATATAATCAATTCCTCCTATGTATACCTTAAGCTAATTCTTAATTAACAAGT TGCAGATTTACAATCTTATTTTAGTCAAAACACTACCTAATATTTTGCCACTTTA TAACTATATATTCTTACTCCTCCAAAGTATTTTTATTAAGAAATACATAAAACTC TTATCATTACCGCTGTAAATTCCTAAGACCATTTCAATTAACACTCGTCGACATG TAGTAGTTTCTTACATTAGCGAAATTTATTTCAGACAATTTTATAAGATATGTCA AATCTGATAATATTTTTAACACGAGATGCTAGTTTCCATTATTACTTGATGTCAA AAAAGAAGAAAATATTATTTAAGGATTTTGGTTTCTAAAAACGAATGTGAAATAT TCATGCATCGGTGTTAGAAGGAAAGATAAGTTGCATGCATCATAAGGATGCCAAA TGAAGTAAAAATGAGAAAATGGAATCATACCAAATAATCAACCATACCACAGACA GACAACCTTTTCCCACTCAACAAATCTGATTTGACATTTATCAATTCCTCTGTTT ACATATTCATCTTTTCTCATGTCAAGATCACACACTCTTACCTCTCATATATATA AAACAGAACCAAATTATCTTTGGTAAAAGTGAATCTCATCAGGAACTGAGTGATA TAAAGTTATATATATAGAGGAGAGAGGGAGTGAGAGGGAGTGAGAGAGAGAGA SEQ ID NO: 50 Polynucleotide sequence PATMYB83 TTTGATACAGCAACAGAAAAAAAATAAAAATACAGAAGAACATTAAGAATGATC TTCTACCATCTGAGAATGGCAAATCCAGAAAGGATGAGAGAAGAGATGATCATG ATAATAGACATTCCTGGGAAACAAGAGGCTCCTGTCTGTGACTCTGAATCGTAC TGTGCGGAGGCGGTAAAGACAGAGGAGAGCGTCATTGTGGCGAAAACAGCCATC GCTGTGTATTGATTGTAGCCAGAAGCCATGTTTACTAAATTTGACCCTCTCAAA ACCAATTATGTCACCTTTGGCTTTGGCTTTACCAATGTTGTTGTTTTATAGGGA AAGAAGAAGTTCGTGGGGACGTGAAGAGCATAAGGTTAATGCTCATTTCATAAA ACCCCACTTTCTGTTTGTTGGTCAACGATTGTTATTGTAATGACTAATGACCTA TAGAACAAAACCCATCTAACATGAATCTTCTTTTAAATGGATTTGGTGAAAAGA CCAAGTTTTAAAATCATCATACGTGCGATGAAAGAATACCCAATTTGAAGCATG AGCCCAATGATAGTTTATAGGCCCAAATAATTTTGATTTATAGTCACAGACAGG ACAGGAGCCTCTTGTTTTATGAGTTGAATTGGGCCGAAGATGATACAATATAAA GCATGAGACCAATAGAGGACTGACCAGTTTCTTACCTTCGTTCGTCGAAGAATC GAACAGTCCCTTAATTTTTCCAGATTCAGATTAATAGCCTATGTATCATCTGTT TGGATGTGTTAGGCTCTTTTGAATTTCTTAAAATTAGTCTAGATTTTGATTTGT GATATCCTTGTTATACAAAATTTGAATTTTTCAGAAAATTCATACTTAATTTCA TGGTAGACTTGTCGAACACTGTGATTTGTTTGGGAAAAAAAAGGTTTAGTTTAT ATTCATTACGTACGTGATGCATGATGCTTAGTATGCATTAAGATAGAGTATATG ATCCGTGCTCCATCATTACTTGCTATTATCGATCGATACTTACTATTATTGATC CTTAAAAGCTGATTTTTGCATGCGCATTATTTTCAATATGCTATTTTGAAAATA TTTTTTGATGATGATGATTGTTTTATTTCGGTTATAAGTTATAAACGGACTCGT TTTTGTGATTGAATTATGGGCTTTTGATATCACATCAAATGTTATTTATGTGGA AATGAATTGAGAAAAAATGATGATTTTATCTTGCACCTATTCTTAAGTTTGGCT TTGATGTGTTTGGCTTTTGATGCTATATTTCTGTCAAAGAATCCTGAATTTATT TATTTATTTAGATTCGGTTGATTGTGTCGTAAAATGGAAGTTACTTCAAAATAA GCCTCCTTGCAAGAGTATATATACTATATTACTTTTAGATAGTGAAAATTGGTT ATTAGTTGTCGTTTAGAAAGAAGGAAATTTTAAGAAAAAATACTGATCGTAAAC TATAACCAATGTATGTATTAGTATACTTTGATACTTCAAACACACGTGTGTGGT GCGGGGATGAGACAGAGAAAGAGGTTGGTCTTGTTCTTGTCTTTGACTCTAAAC CAGTCTTTTTCGATACATTTTTCTTCACTCACAAGTCTATCATCATGTTTCTAA CGAAGACATTTATTTTATTTATATTTTGTAACAAAAAAATGAAGACCCACCTCT TGCTTCTTCTTCACATCCCCATTTCATCTTCTCTCTGTCTCTCTCTATTAGAGA CTCTCTCTACTCTACCCATCAATCTCAACAAACACTACTTTCTATCTCTTTCTC TCTTTGTCATATCCATTACGCATATTCGTATCATTCCAAAGCAATCCCCACAAA TCATATCATCCTCTCCATCTTTCCTTGCTTCTTACAATCTCTCCAATTTCAAAT CTGTATACTCTTCTTCAAAAAGGCTCCACCAGTCCAAA SEQ ID NO: 51 Polynucleotide sequence PATMYB85 CTTAGCATACAATCTTTAATTTTTCATGGAAGATTTTTAAAACATTTCCGATCC GATTAAACAAAGAAGCGAGCGAGCCACATTCTGACAATAATTAAGTAGACACTA TGATACGACGAAGAATATTAATTTAATATTGAAAGATAGATCAATTTGTAGCAA AACCATGAAGCCAAAATTGCAAGTCACCCACAAGTCGCAAAGATTAGAAACATA TATTGATACAGTGATCTATACGTGTACACCATGTGTCAAATGGATATTCGTCTA TTATTTTTCGTATCGGCGACAAAGTATTTTGTGCGGCAATTCATTATTGAAGCT TTTACTAAGTTTCTTCTATGTTATGTAAAAAACAAATCTTACCAAAATTAGAGA CTCGTATATAATATACTTAATAGGTTTGTTAGGGTTGCCAAAAAAAATGGTTTA TCGCAATGGACTAAAGATCTCAATTCTCAAAACTTATCGGATTTTGCCATAGTT GAACCGGACCAAGCCAATTATTTGAGATTCTGAAAAGAGTATTATTATGGGCAA ATTCTGAATATTTTATGTAAAATCGGTTTTGTAAAGACTGGATCATATTTTTAT TCGTGTTTATTTCACAGCTGATAGCGACAACAATGAAAAATTCATTTTTTTTGT GTGTGTCATCAACTATTAGAGTCGGTGATTTATATACAGTTTTGGTGACAGAAT AAGTGCCTACAACTTAAAACTACACTAGTTTTAGTTATCAAGATCCTTAGTACT TAATGTTGAAATTAATACATTTTTTAATAAATAAATACAAAGTATATATTTATT TGAAACTTGAGCAAGTATTTGAGTAAAAAAGGTATGAATCGCACGTGTGATTGC GTACATTCGCACGCATCCTATCCTTTCACATTAGTTCCAAAGTCATTTTCACCA ACCAAATGCGACATCTCCAATACTCCTTTCTATGATCCTACTAGCAACAGATTT GACAAAGTAAGACAAATTATATTTCTTAACCTTAATCATTTCTGACCAAAAAAA ACCTGAATCATTATTTATTAGAATAATCTTATTTTATCAGAATTCGTAATTCTT TAGCTGACTAACTCCTAATTAAAATGAACCATTCAATATAAAAATATAAACGAA CGTATTATGTATAAAGTCAGATACAGAAGATCTTCTTTGAAACTGTTGTAATTT CCCCATCATGACACCTGTATATACATACGTACCTTAAAAAAATTCTGATCTATA TGTACTTTTGTATGAACGAGTAATGCATAATTCTTATTTAGATTAGACATTCTT TAATGATAAAATAGTGAAGACGGGTATTATACATATATTAAGTCACTATTAGGG TGATTAATTGTATTTATATACCAAGAAATCTCTAAGTGACAACATTATGAGGGT GATTAGTAGTCCGTACTGTTTTTCATTCTAACCAATCACATAAAAGAATACTAA AAGCGACAAAAAAAACTATTATCAGCTTTTTATACCATTTTATATGTTCGTTAT TTATACCGTTTTTAATTATTTATATGTTATCAATTACTTTTTTCATATCGACAA AAGATTTTATAATTTTTTGTGTTACCAATCGAACCATGTATATATATATAACCG TTACTAGTTAAAATGCTTTGCCATAATGCCACTAGAATTTTTAATAAAAGTTAC TAAAACAATTTCGAAAATATTAAGATGTAAAGTTATTTTTTCCTGAAACCAATT GTGGGGGAAAGGTGTGAGAAGGTTATATATAGGTGGGTGAGCTTTGGTAAGCTT TTGACATAACTTGCAAGCTGTTGAGATTTTCCATCCTCGATAACTTTATTCTTC CATATCTCTTCCATTTCGCTCTCTATTTCACATCCCCATATAACATAATATACA ATCACACATATCATTTCTATATAGTATTTA SEQ ID NO: 52 Polynucleotide sequence PATMYB103 TGGTGCCCTGGTCTACAGTTCCCTAGTTAAGATTCTATTTTGACAACAAAATTGA GTATTCCAATCATCCATATTTGTTATAGGGAGAAATTGAGCATGCTATATACGGT GATATATATGATATTTATTTAATATATTGAATAACAAACACAGAACTAGTGTTAT AGGTGCAGGTATGTAAATATAATGTGATAAACATTTTTTATATAGATTGGAAAGA ATACGAGATTGTTGTTGCTCTGTTAGAACGAACAAACAGAACTAGTGTTATAGGT GCAGGTAAGGTAAATATAATGTGATAAACATTTTTTATATAGATTGGAACAAATA AACATTTTTCTGTTAGAACGAACAAAGGCCTGTCAAAAAGAACAAACCTGATGTG ACATATTACATATATGATTATAATTGATTATTGTATATATAGTATTGCATGACTA TCTTTACAAGATTTCAATACGAAAATAAATTAAAAGGAGAAAATTTATAAACGAA GCGATTTCATTCTCGGTAAGGTTTTCCGATATGTCTCCTAACTAAATCAAAGCCT TGTAATTGAAACTTGTAATGATTGTTATTCTATATATCTTTGAAGAAAGCTTCGG TATTGGACGTACTTAATATAATTGGATTTTATTTAAATTACAAAAATCACTGTAT AATTCGGCTACATGACTTAATCAATTATTTCACGTTGAAAACAATACTATATCAA CTTCAAATACACTCCTTGTGTATGGATTCCACAAGTTCTTTTCTATCTATAGAAA TATAGAATCCACAAGTTCTATCTACTTTTATTAGAATTTTTTATTGTTCGTTGTT GTTAACATAATTATAAGCAATAAATTCAAAAAAAAAAAAATCTAAAAGACACAAA ATTTCCATCTTTGATAGGGCTTCGGAATCATTAATTACTTTTTACAAACAAAAAA GAAGAAGATAGGGCTTCGGAAATTATTAGAAAGATGGAAGGATATTGTATTAAAT TTGGCTTCATATTTTCCTTTGGTTTGCGGCCATCAAGTACTAGTACTACTCAGTA CCCACAGGCCACAGGAAAAAAAGTAGTACTGCTTTATTAAGTGTGTTACGATAAA TGGAAAGCGTTTTAGTATGTGATTACAAATTGTTGTATGTGATCATTAATTAGTT ATTGGTCCGACTTCTAAGTTTAAATATTTTCAGAATTCAGTTAGTTTAATTATAC ATGTTAGACGAAATGACTCTTTTTGAGCCAATATATAATGTATCTGAATTTTTCA TTTTGAAAAATCTTTTTATAAAATAATAGGTCAACCTCGAATTATTATAATAAAA TAAATAATTTGCGTTACTATGAAAATTAATTTACTGAATACAGTATATAGAGAGA GATAGAAATAGAGGAAAACAGTGGATAATACATGATTAGTTGATACTCATGTGCA GCGAGTCTATATATATTATATACTCATGATTAGTTGATACATATGTGACGATTAG TTCTACGAATCAATCTCTAGTTTTCGTCTTAAAATCATTTGGTTTTATAGAATAT AAGAAACAAAGAAAACAGGAACTTTCGCGGGAGACAGAAGGGTACGTGAAGAGAA AAACACATAAAAGTGATAAGGGCTTAACGTAATAATACTACAACAAAACCTCTCT ACGTACAACGAGTAATAACACATGAAAATAGAAAGTCGATGAGACATCGTTTTAA GGTTAGATCGATGAAGAAATATCTCAGGCCCCACCCCTGGGACCCGACCCGACCC GACCCGACCCGACCTTTGTCTCCTCTCCTTTTAAAAACTCTCCATTGCTTCTTTG TCTTCTCTCTTCTATAACATAACTCAAGAAATTAAAGAAGATAGATAGAGAGAGA GAGAGAGAGTAAAAACCTAAAGGGTGATATACTTATATAAAAATTAATTTAAGAT TGTGATTAAGTGGTTCACTATATTTAAGTTACTTTGAGGAGCTACTAATC SEQ ID NO: 53 Polynucleotide sequence PATCADC AAAGCAAATCGATCTGCCAAACATATCACAGCTCTTGGAGAAAATGCAGGTCTC TTCAGACTCTGATATTTCGGATCTCGATAGCCTTAAATTCGATGCTCCATTGCC TAGTCATATGCAACTAAGCTTTAATTTGTTGAAATCTAGAGTCGAAACTTGTGA CAAAAATTAGATTTTTTTTCTTACCGAGCTTTCTTCTTTGTGTTCATTGAGGCC CAAGTATTTGTGTATTTGGACCTGAATATTCTCATACAAAGATAAATAATTATA ATTAAATGATTTTTCGCATATAATCATTATTGTGGTATGATTAACACAGTTGGT GTGATGACTGATTGACACAATAATCACCGTTTGGATTCGATTCCTTTAATACTT GTCACTAGAGTTGTTTGACTAAACAGCTAACTTGTCACTAGAGTTATTGTGTTT GTATTTTGATCTGTTATTAATCTGATTGGGTATAATTACAGATAGAGAGACATC TATATTGTAATTAAGACAATCTTAAAGTGTAAACTAAAAAGATCTCTCTGACCT CTGGAAAACGAAAGGTGGGTGACACATCACTCTAGCTATGAATATGATGAATAT TCAGTACCTAACCGAACAAAGACTGGTTTGGTATTTTTATTGGAAAAAAGAGAT AAATAATTGTGAATGTGAATTATCCTGTCTGAAAGGTAAGCTGATGACATGGCG TTATATGATTGGACGAGCTTCAGAACAAAAGAGTAGCGTCGAATCGAATCTTTA CCTACTACACTTTGAACTTTGAAGTACATTACCTACTTCCTCCTTGATCGAACG TCTTTTCTCAAAACTATTTTATTTCCCCAATTAAAGTAGTGGTGATAAATTCAC AAAAATACAAACACTTTTATTTTTGACGTCAAAAACAAATACTTCTTTGAACAG GCTATTACAATATTTTTAAGAAAAAAGTAAGCAAAATAGTCCACAAACCAAAAT CTGTAACATATTAAACGATTTATGTTTTTTTTTTTTTTTCTTAACTAGAGAACA ATTCGGGCTTTTACTAAGGATGATGAGTGTAGTTACCGAATAGTGTATTCATAT AATCTTTTAATGAGCTTAAGATATGATATTATTTCGACTAATCAGATAAGAGTA GTTAGATAATTTCGTAATAGAGCAACTCTTTCGCAAATAAAACCATTGTAAACA TTACCAATTAGTTTTTCTTTTTTTTTGGTCACAACCAATTAGTTTGTTTGTTCT ATTTTATGAAGTGCGTATTAAAGCTAACGTGTTTACAGTAACGCCACACAAATA AAAATAAAAATAATTATGTACTTTATGGATTTATAGAAAAAACAAGAATAGTCA CCAAAAATTGATTGTGTCATATATCTTTTGTCAACTATTTTATCTTATTTTTCT ATGGATATGTATGTCCAAAATGTTAGACAAAAAACCAAAAAATCATGTCCAAAA TTTCGTTAGGCTGCCGATATCTCTGTTTCCCTTTCAACGACTATCTATTTAATT ACCGTCGTCCACATTGTTTTTAATATCTTTATTCGAGGTTGGTTTAGTTTTTTT TACCAAACTCACTTTGCTACGTTTTTGCCTTTTTGGTATGGTTGTATTTGTACC ACCGGGAAAAAAAAGATAAGAGGTTTGGTTGGTCGAGCTTACTGATTAAAAAAT ATACACGTCCACCAAATATTAAAACAATATATCCCATTTTTCCTCCTCTCTTTT GGTATTACATTAATATTTTATTATTTCCCCATTTGCTCTGTATATATAAACATA TGTCAATAGAGTGCCTCTACAGTCATGTTTCCATAGACATAATCTCTCACCATT GTTTTTCTCTGCAAAACTAAAGAAACAAAAAAAGAAAAATCGGAGAAACCAAGA AAAAAGAA SEQ ID NO: 54 Polynucleotide sequence PATCADD GCTTCGGTGATGCATTTCTCCTTCTCATCAATCATCCTAGCAATGTTTTGAAGC TGAGAAATTCTCCACTCGTAGCTCTTCGTTCTGCCAGAGTTGAAGTTGCTTCTG AGCTCATCTACAAGCAAAGCTGCTTCTTTTCCACTAAAGTCTGATGCTTGCTCC TTTACCACAGCAGATAGTGTTGCATAACAAGTACTGATTCAAGACACCAAAACC GCAATGTGAGAGACTTTAAGACTAAAAATCATGGATAAGACTAAAAAAACATGG ATAAGTATCAACTGTTCTCACGATTATTTATTCATACCACTGTACTTAAACTTA AAACCCACTATACTAAATAGAAAGGTAATCATCAAAAAATCAGTATGTAAAAAC CACTTTTGTGAATAAAATATGTAAAATGGGTGAATAAAGAAATGTGCTTACAAT TTCAACCGATAAGGGATACAAGCATTGCTGCAATATCCACCACCACCACGACGA GATATCCGAAAAGGTGAAGTTGCAACATTTAATCTGCAACAAAAGAGGCCATTC ATTAAAATGGTACTAATTAGATCTAATCATATCATATTGAATGACCAAATCATT CACAGAAGCATCCATTGCTCCAATTAACATTCTAGACCAAATTCAACTTAAAGG TAACTCTTTTATACAGGAAACCGAGAAACCGAAAACGCAATTCACATAAAAAGG AAGGCTTGTTTGGAGAAGCAGAATCGAACAAGTCAATCTCAAACCCTGATGAGC AGGTTTTTCAAGTTACCTGGCAGGAGAAAAACCCTTGGCAAAACAAAGGGTTTG AATATGATTAATCTCTAGAAGCTTCGTCATGACTTGGGTTCAGTTAAAAATCTC AAATTGGAGACATTATTGGTGTTTATATATTTGAGAGAGAGAGCCAGAGAGGAG ACGTTGAATTGAATGAAGGGTGTGGTCGGAAGAGAAGACGTGTAGAAGAGACGA GACAAGTAAATTTAAGCATTGGCCCCATTTACAGCCACAAGTCCGCTACAACAA ATTATTTCCAAGAAACTCTGAGATAACGTCGTGATGAAACGGCTCATGCTGCTG TTGTGATTCGTGAATTAGAGGTTTATCTTTTGGGTTTTTGAATGTTACTTAATT GGACGGTCGATTTTTCAAACTGGGTGTGAAATGTGAATGGGTCATTCATAATGG GCTTTTGTTTTAATGTGAAGCCATTCACACACTCTTTGTCCTTCTTTTCTATTA TTCATAACTGTCACTCTTTGTTCTTCGAAATAGTAAAGAGCAAATCGATTCTTT GTTGATCTGGGCCGTAAAATTTCCATGGTTGTGGGAAGTATTCTCGCAGCTGAT CTGGGCCGTCAATGCTACAGTTTCATGTCAGAGAGAGGTCAAGAATCAACACGT GGCCAACCATGATTTTAAACCAAAGCAAACACACGATTAGACCCCACATTGTTT GTTCACCAACCCCCGTGGACCCTCCTTTAGCCGACGTGTCCACGTCAATAGTGG TTTTTCTTCCTTTCAAAGTACACAAATTCCATTCTTTCTCATTTTACTTTTTGG ATTACGTTGTTGTTATAAACTGGTAAAATGAATTATGAATGCAAATAAATTTCA TTTAAGTTTTGTIGGCTICTAATATTTTTTTCACCTAAAATTCTAATAAACTAC ACAGCCATGAGCCATCGTATGAAAAGAAGAAGAAAAAAAATGTCTTTTTCTAGA AGGATCTTTCAACGACTAAAAAAGATTTTAAGCTTTTGACTAATTTTGTCAATA ATATACACAAATTTACACTCAATTATAGCCATCAAATGTGTGCTATGCAGAAAC ACCAATTATTTCATCACACATACGCATACGTTACGTTTCCAACTTTCTCTATAT ATATATATAGTAATACACACACATAAACAGCAAAAGCGTGAAAGCAGCAGATCA AGATAAGAAAGAAGAAAGAATCATCAAAAA SEQ ID NO: 55 Polynucleotide sequence PATPAL1 TTTTCCCAATGATACAACTATAAATCAAAAAGAAAAAATGTACTGATAAACGAA ACTAAACGTATAAATTAATATATTTCTTGACATAAATAGGAGGCTTTTGCCTGC TAGTCTGCTACGATGGAAGGAAAAATGCATGCACACATGACACATGCAAAATGT TTCAATGAAGACGCATTGCCCAATTAACCAACACACCACTTCTTCCATTCCACC CATATTATTTATTTCTACCATTTTCTTTAATTTATTGTTTTTTCTTTGATTCAT ACACTGTTTATGACTATTACATTTTCCCTTTCGACTAATATTAACGCGTTTAAA CCAAAGAATGGATTTGATAATGAAATTTTATTTTATTAGCATATAGATAATGGA TGGCTTCATGCTTGGTTTCCATGACAAGGAATGACACAAGATAATTATTTTGAA TAAAATCATAAATATGATAATACTAGTTGTAAAAAAACTTGAGTGTTTCGTGTG TTATTTTTCGGTTTCTTGACTTTTTATATTTCTCGTTTTTGTAATTTTAGGATG GATTATTTAGCTTGCTTTTCTCTTTTATTACTTTCTAAAATTTTATTTATAAAC TCATTTTTAATATATTGACAATCAATAAATGAGTTATCTTTTAATTAATAAAAA ATTTGTAAACTCTTGTAAACAGATCATAGTCACTAAAAGCTATTATAAGTTATT TGTAGCTATATTTTTTTATTTCATGAACTTAGGATAAGATACGAAAATGGAGGT TATATTTACATAAATGTCACCACATTGCCTTTGTCATGCAAACGGCGTGTTGCG TCACTCGCCTCCTATTGGGAATCTTATAATCGCGTGAATATTATTAGAGTTTGC GATATTTCCACGTAATAGTTATCTTTCACAAATTTTATACTCAATTACAAAATC AACGAAAATGTACATTTGTATCTTTAACTATTTACGTTTTTTTTACGTATCAAC TTTCAGTTATATGTTTTGGATAATATATTTTTTTACTTTTGACTTTTCAGTTTT CACCTAATGATTGGGATATACATATGCATGCATAGTTCCCATTATTTAAATGTA AGCTAAGTGCATATGAACTGTTAGTCAAAATTACGAAGTTTATTTGTACATATA TATAGTTATAACAAAATGGTACAGTAAATTAAACAGAACATCAAGAAAGTACAA AAGACTGAACACAATAATTTACATGAAAACAAAACACTTAAAAAATCATCCGAT AAAATCGAAATGATATCCCAAATGACAAAAATAACAATATAGAAAATACAAAAA CAAAAACAAAATATGAAAGAGTGTTATGGTGGGGACGTTAATTGACTCAATTAC GTTCATACATTATACACACCTACTCCCATCACAATGAAACGCTTTACTCCAAAA AAAAAAAAAAAACCACTCTTCAAAAAATCTCGTAGTCTCACCAACCGCGAAATG CAACTATCGTCAGCCACCAGCCACGACCACTTTTACCACCGTGACGTTGACGAA AACCAAAGAAATTCACCACCGTGTTAAAATCAAATTAAAAATAACTCTCTTTTT GCGACTTAAACCAAATCCACGAATTATAATCTCCACCACTAAAATCCATCACTC ACTCTCCATCTAACGGTCATCATTAATTCTCAACCAACTCCTTCTTTCTCACTA ATTTTCATTTTTTCTATAATCTTTATATGGAAGAAAAAAAGAAACTAGCTATCT CTATACGCTTACCTACCAACAAACACTACCACCTTATTTAAACCACCCTTCATT CATCTAATTTTCCTCAGGAACAAATACAATTCCTTAACCAACAATATTACAAAT AAGCTCCTATCTTCTTTCTTTCTTTTAGAGATCTTGTAATCTCCTCTTAGTTAA TCTTCTATTGTAAAACTAAGATCAAAAGTCTAA SEQ ID NO: 56 Polynucleotide sequence PATPAL2 TTTCCCTGTTTTTTTTCCCCTCTTTCTGTTTCCCATTTGAAAGTAAAAGATCATTT AAGCACCTAACTCAATTTTATTTTATTTTAAACACCTAATGTCATGCTCCTTGGCT CCTTGTAATTAGTTGATCGTTTCAATTTAGACCAGCAAAACATTTTAGTATGTTCG TAAATATTGCGTACATGCCATTTCGTTTGTCATGCAAACGGTGTGTGTTTCTTTAC TTAGCTTCTAGTTGGTGTATATTGCGTCGCATTAATATCGGTTTACCTTCCTCCTG TCTACGTAATGATATATTCTCCACCACAAATTTAAATTCTTATTGAAATTTCCTAA TTTTTTAGGTAGCTCAAGGTCTCAAGTATACTACGTACCCTATTTTTTTGAATATC TATCTATATTATAACAAGAGTTTTTCTGAGCTAGTTAATGAGATGACAATATTCTA CATAAATAAATGACCCTCGAAAGTTTCAAGTACTTTAGGATCTGACCAAATCGGGG TAAAACATTTTGAAACTAATTACGTTCACATCTACCATCGATGATTGACAAGCTTA TTGTCACCTTTTATGTTAAAGTGACATGGTCTTGACGTTAATTTGCATGTTATTCT ACATCTATAGTCCAAAGATAGCAAACCAAAGAAAAAAATTGTCACAGAGGGTTCAA TGTTACTTAGATAGAAATGGTTCTTTACAATAATAAATTTATGTTCCATTCTTCAT GGACCGATGGTATATATATGACTATATATATGTTACAAGAAAAACAAAAACTTATA TTTTCTAAATATGTCTTCATCCATGTCACTAGCTCATTGTGTATACATTTACTTGC TTCTTTTTGTTCTATTTCATTTCCTCTAACAAATTATTCCTTATATTTTGTGATGT ACTGAATTATTATGAAAAAAAACCTTTACACTTGATAGAGAAGCATATTTGGAAAC GTATATAATTTGTTTAATTGGAGTCACCAAAATTATACAAATCTTGTAATATCATT AACATAATAGCAAACTAATTAAATATATGTTTTGAGGTCAAATGTTCGGTTTAGTG TTGAAACTGAAAAAAATTATTGGTTAATAAAATTTCAAATAAAAGGACAGGTCTTT CTCACCAAAACAAATTTCAAGTATAGATAAGAAAAATATAATAAGATAAACAATTC ATGCTGGTTTGGTTCGACTTCAACTAGTTAGTTGTATAAGAATATATTTTTTTAAT ACATTTTTTTAGCAACTTTTGTTTTTGATACATATAAACAAATATTCACAATAAAA CCAAACTACAAATAGCAACTAAAATAATTTTTTGAAAACGAAATTAGTGGGGACGA CCTTGAATTGACTGAACTACATTCCTACGTTCCACAACTACTCCCATTTCATTCCC AAACCATAATCAATCACTCGTATAAACATTTTTGTCTCCAAAAAGTCTCACCAACC GCAAAACGCTTATTAGTTATTACCTTCTCAATTCCTCAGCCACCAGCCACGACTAC CTTTTCGATGCTTGAGGTTGATATTTGACGGAACACACAAATTTAACCAAACCAAA CCAAAACCAAACGCGTTTTAAATCTAAAAACTAATTGACAAACTCTTTTTGCGACT CAAACCAAATTCACGTTTTCCATTATCCACCATTAGATCACCAATCTTCATCCAAC TGGTCATCATTAAACTCTCACCCACCCCTCATACTTCACTTTTTTCTCCAAAAAAT CAAAACTTGTGTTCTCTCTTCTCTCTTCTCTTGTCCTTACCTAACAACAACACTAA CATTGTCCTTCTTATTTAAACGTCTCTTCTCTCTTCTTCCTCCTCAGAAAACCAAA AACCACCAACAATTCAAACTCTCTCTTTCTCCTTTCACCAAACAATACAAGAGATC TGATCTCATTCACCTAAACACAACTTCTTGAAAACCA SEQ ID NO: 57 Polynucleotide sequence PATC3H ATCGTAAGTTTTTTTGTGTGTGTGTTAACAATGTACTCACTACTCACTGTTCCAT ATTTTTGATGTACGTATATCGAAAACATTCTGCCAACAAATGCAAACATAACAAA AGTCAAAAACAATAACATAACCGGGAATTAAACCAAAATGTAATTGCTTTTTATT AGTGTCAGGCCTTCTGCTTAAAAATATTCTCGGCCCAGAGCCCATTAACACCTAT CTCAATTCATATTGAAGAAAATGACTATATTACTTGACAAAAACTTTAGTCAGAA AAATATGGAATCTCTTTCGGTACTGCTAAGTGCTAACCTTAAATAGTATAGAATT CTTAGTTCATTCTCAAAAACATAGCTATATGTAGATTATAAAAGTTCGATATTAT TTCCTGCAAAAGATGTTATAATGTTACAACTTACAAGAAAATGATGTATATGTAG ATTTTATAAACTGGTACCGTAATTCATAAAAGATGGTGGTGGGTATGTATCAGTA ACGGAACTTACATATGCGTGTGTATTACTATGTCTATATGGTGTATTCCTTTGTG TGGAACAATGCACGTCAGAGTTGTTTATTTTCTTATAGAATTTAAGGAATCAATT ATTGGATTTCTCAAGGTGAAAGTGGACTTCTTTGCACGCAAGGTCTAGTTGCCGA CTTGCCGTTGCATGTAACATGATTGTTGAAATAAAGTGAATTGAGAGAAGTTTGG CCAGACATTTTAAATTTAACCCAAAAAAAGTAGGGCCTAACACAAAATATAACCT CTCTTTGTTCAAAGGAAATAACACCTACGTCTTATAATTGAACCAAACATTGAAT CATTGAACTCACCTATAATAATTATAATAACACGAATTCACAAGACACCTAAAAG AAAAAGTTCACAAAAACAAATAAAAATTTACCTCTCACCAAACACACTCACCTAC CCGTCTGGTCCCACTGACCCCAACATACAACACCGACTCTCTCCCACACCAATTT TTTTTTTTGGCGTTTTAAAACAAATAAACTATCTATTTTTTTTTCTTACCAACTG ATTAATTCGTGAATAATCTATTATCTTCTTCTTTTTTTTGTGACGGATGATTAGT GCGTGGGGAAATCAAAATTTACAAAATTTGGGATGATTCCGATTTTTGCCATTCG ATTAATTTTGGTTAAAAGATATACTATTCATTCACCAAGTTTTCAGATGAGTCTA AAAGATAATATCATTTCACTAGTCACTTAAAAAAAGGGTTAAAAGAACATCAATA ATATCACTGGTTTCCTTAGGTGACCCAAAAAAAGAAGAAAAAGTCACTAGTTTCT TTTTGGAAATTTTACTGGGCATATAGACGAAGTTGTAATGAGTGAGTTTAAATTT ATCTATGGCACGCAGCTACGTCTGGTCGGACTATACCAAGTTACCAACTCTCTCT ACTTCATGTGATTGCCAATAAAAGGTGACGTCTCTCTCTCTCTCACCAACCCCAA ACCACTTTCCCCACTCGCTCTCAAAACGCTTGCCACCCAAATCTATGGCTTACGG GGACATGTATTAACATATATCACTGAGTGAAAAGAAGGGTTTATTACCGTTGGAC CAGTGATCAAACGTGTTTTATAAAAATTTGGAATTGAAAACATGATTTGACATTT TTAATGATGGCAGCAGACGAAACCAACAACACTAAGTTTAACGTTCGTGGAGTAT ACTTTTCTATTTTCGAAGAAGACATATAACTAAGCTGATTGTTATTCTTCATAGA TTTCTTTTCACTGCGAATAAAAGTTTGTGAACATGTCACCGTTTGAACACTCAAC AATCATAAGCGTTTTACCTTTGTGGGGTGGAGAAGATGACAATGAGAAAGTCGTC GTACATATAATTTAAGAAAATACTATTCTGACTCTGGAACGTGTAAATAATTATC TAAACAGATTGCGAATGTTCTCTACTTTTTTTTTGTTTACATTAAAAATGCAAAT TTTATAACATTTTACATCGCGTAAATATTCCTGTTTTATCTATAATTAATGAAAG CTACTGAAAAAAAACATCCAGGTCAGGTACATGTATTTCACCTCAACTTAGTAAA TAACCAGTAAAATCCAAAGTAATTACCTTTTCTCTGGAAATTTTCCTCAGTAGTT TATACCAGTCAAATTAAAACCTCAAATCTGAATGTTGAAAATTTGATATCCAAGA AATTTTCTCATTGGAATAAAAGTTCAATCTGAAAATAGATATTTCTCTACCTCTG TTTTTTTTTTTCTCCACCAACTTTCCCCTACTTATCACTATCAATAATCGACATT ATCCATCTTTTTTATTGTCTTGAACTTTGCAATTTAATTGCATACTAGTTTCTTG TTTTACATAAAAGAAGTTTGGTGGTAGCAAATATATATGTCTGAAATTGATTATT TAAAAACAAAAAAAGATAAATCGGTTCACCAACCCCCTCCCTAATATAAATCAAA GTCTCCACCACATATATCTAGAAGAATTCTACAAGTGAATTCGATTTACACTTTT TTTTGTCCTTTTTTATTAATAAATCACTGACCCGAAAATAAAAATAGAAGCAAAA CTTC SEQ ID NO: 58 Polynucleotide sequence PATCCR1_PATIRX4 AAAATTGTGTCTAAGAATGTGGAACCGAGTAGTTCTCCAGAAGTCAGGTATGAA AGTATATAAGAATTCTAGTTTTAGTTGTTTGAAAGTTTGATCCGTGAGTGAATT AGTTCACAATTATGGATGTAGATCCTCTATGCAAACAATGAAGAAGAAAGACTC TGTAACAGACTCCATTAAGCAAACAAAAAGAACCAAAGGTGCACTGAAGGCTGT AAGCAATGAACCAGAAAGCACTACAGGGAAAAATCTTAAATCCTTGAAAAAGCT GAATGGTGAACCTGATAAAACAAGAGGCAGAACTGGCAAAAAGCAGAAGGTGAC TCAAGCTATGCACCGGAAAATCGAAAAAGATTGTGATGAGCAGGAAGACCTCGA AACCAAAGATGAAGAAGACAGTCTGAAATTGGGGAAAGAATCAGATGCAGAGCC TGATCGTATGGAAGATCACCAAGAATTGCCTGAAAATCACAATGTAGAAACCAA AACTGATGGAGAAGAGCAGGAGGCAGCGAAAGAGCCAACGGCAGAGTCTAAAAC TAATGGAGAGGAGCCAAATGCAGAACCCGAAACTGATGGAAAAGAGCATAAATC ATTGAAGGAGCCAAATGCAGAGCCCAAATCTGATGGAGAAGAGCAGGAGGCAGC AAAAGAGCCAAATGCTGAGCTCAAAACTGATGGAGAAAATCAGGAGGCAGCAAA AGAGCTAACTGCAGAACGCAAAACTGATGAGGAAGAGCACAAGGTAGCTGATGA GGTAGAGCAAAAGTCACAGAAAGAGACAAATGTAGAACCGGAAGCTGAGGGAGA AGAGCAAAAGTCAGTGGAAGAGCCAAATGCAGAACCCAAGACCAAGGTAGAAGA GAAAGAGTCAGCAAAAGAGCAAACTGCAGACACAAAATTGATTGAGAAGGAGGA TATGTCTAAGACAAAGGGAGAAGAGATTGATAAAGAAACATATTCAAGCATCCC TGAGACTGGTAAAGTAGGAAACGAAGCTGAAGAAGATGATCAGAGAGTGATTAA GGAACTGGAAGAAGAGTCTGACAAGGCAGAAGTCAGTACTACGGTGCTTGAGGT TGATCCATGAATGAAGGATTGTTAGGTAAATGTTAATCCAGGAAAAAAAGATTG GTTCTTGTGGTTTAGGTAACTTATGTATTAAGTGAAGCTGCTTGTTTAGAGACT AATGGTGTGTTTTATGAGTAGATTCTTCTGACCTATGTCTCGTTATGGAACTAG TTTGATCTTATGTCACCTTGCTAGCAGCAGATATTGATATTTATATATTTAAGA GACATGCGCATGAGAATGAGGGTATGGAAAAGTCCATATCAGATGACACAAACA ATGATCGTATGTGTAGTCACTTGTGCATTTCCAGTTTTGGACATAAAATTCTGA TATTGCATAGAAATGTTTTTAAATAACACTAATCCAAACCTAAATAAAATATCT CTATACATCATCTAGAAATGTATGGCTTGATCAAGAATTGTAGATAATAATACC CTGAGTTAAATGATTGTAGGTATTATTTCAGTTTTCAAAATTGTCCAAATTTAT GAGCTATATTAAAGATAATATTTTCAATAAGGTGTGTAGTTCTAAATGTTTCTT CTTCTTCCACCAACCCCTCTTTCTATATGTATGTTCTTTTTTCTAAAATAATTG TTTGTTCTTTTTTAGATATATCAAATTAAATATAAAAAATATTGACAAAACTTA TTTACCATTGTTAGGTGAACTTGGCAAGTGTGTAAATATAAAGATAACATTCCT TTTCGTTCTTTATATATACGAAACGTACCACAAATTTCTAACTAAAGCATTCAT AGTCTCTCGAAAGCCTCTTTTCAGAACCGAAGCTCTTTACTTTCGTCCACCGGG AAAT SEQ ID NO: 59 Polynucleotide sequence PATF5H AAATTTTTGTATGAAATATTTCTTTAACGAAAATAAATTAAATAAAATTTAAAA TTTATATTTGGAGTTCTATTTTTAATTTAGAGTTTTTATTGTTACCACATTTTT TGAATTATTCTAATATTAATTTGTGATATTATTACAAAAAGTAAAAATATGATA TTTTAGAATACTATTATCGATATTTGATATTATTGACCTTAGCTTTGTTTGGGT GGAGACATGTGATTATCTTATTACCTTTTTATTCCATGAAACTACAGAGTTCGC CAGGTACCATACATGCACACACCCTCGTGAAACGAGCGTGACTTAATATGATCT AGAACTTAAATAGTACTACTAATTGTGTCATTTGAACTTTCTCCTATGTCGGTT TCACTTCATGTATCGCAGAACAGGTGGAATACAGTGTCCTTGAGTTTCACCCAA ATCGGTCCAATTTTGTGATATATATTGCGATACAGACATACAGCCTACAGAGTT TTGTCTTAGCCCACTGGTTGGCAAACGAAATTGTCTTTATTTTTTTATGTTTTG TTGTCAATGTGTCTTTGTTTTTAACTAGATTGAGGTTTAATTTTAATACATTTG TTAGTTTACAGATTATGCAGTGTAATCTGATAATGTAAGTTGAACTGCGTTGGT CAAAGTCTTGTGTAACGCACTGTATCTAAATTGTGAGTAACGACAAAATAATTA AAATTAAAGGGACCTTCAAGTATTATTAGTATCTCTGTCTAAGATGCACAGGTA TTCAGTAATAGTAATAAATAATTACTTGTATAATTAATATCTAATTAGTAAACC TTGTGTCTAAACCTAAATGAGCATAAATCCAAAAGCAAAAATCTAAACCTAACT GAAAAAGTCATTACGAAAAAAAGAAAAAAAAAAGAGAAAAAACTACCTGAAAAG TCATGCACAACGTTCATCTTGGCTAAATTTATTTAGTTTATTAAATACAAAAAT GGCGAGTTTCTGGAGTTTGTTGAAAATATATTTGTTTAGCCACTTTAGAATTTC TTGTTTTAATTTGTTATTAAGATATATCGAGATAATGCGTTTATATCACCAATA TTTTTGCCAAACTAGTCCTATACAGTCATTTTTCAACAGCTATGTTCACTAATT TAAAACCCACTGAAAGTCAATCATGATTCGTCATATTTATATGCTCGAATTCAG TAAAATCCGTTTGGTATACTATTTATTTCGTATAAGTATGTAATTCCACTAGAT TTCCTTAAACTAAATTATATATTTACATAATTGTTTTCTTTAAAAGTCTACAAC AGTTATTAAGTTATAGGAAATTATTTCTTTTATTTTTTTTTTTTTTTAGGAAAT TATTTCTTTTGCAACACATTTGTCGTTTGCAAACTTTTAAAAGAAAATAAATGA TTGTTATAATTGATTACATTTCAGTTTATGACAGATTTTTTTTATCTAACCTTT AATGTTTGTTTCCTGTTTTTAGGAAAATCATACCAAAATATATTTGTGATCACA GTAAATCACGGAATAGTTATGACCAAGATITTCAAAGTAATACTTAGAATCCTA TTAAATAAACGAAATTTTAGGAAGAAATAATCAAGATTTTAGGAAACGATTTGA GCAAGGATTTAGAAGATTTGAATCTTTAATTAAATATTTTCATTCCTAAATAAT TAATGCTAGTGGCATAATATTGTAAATAAGTTCAAGTACATGATTAATTTGTTA AAATGGTTGAAAAATATATATATGTAGATTTTTTCAAAAGGTATACTAATTATT TTCATATTTTCAAGAAAATATAAGAAATGGTGTGTACATATATGGATGAAGAAA TTTAAGTAGATAATACAAAAATGTCAAAAAAAGGGACCACACAATTTGATTATA AAACCTACCTCTCTAATCACATCCCAAAATGGAGAACTTTGCCTCCTGACAACA TTTCAGAAAATAATCGAATCCAAAAAAAACACTCAAT SEQ ID NO: 60 Polynucleotide sequence PATLAC4 CAATTATATTTGGTTTCGATTGAAATTCAATCTAATGTGGTTAGATGAGTCCTA TATTACCATGTCATTGTTAATACCCATTGCCAAAAATAAAAGTGAAGCAGAAGG AGAAATTGTTTTTGTATACCCGAAGGAATTAAGATGTACGATCTTAAAATAGAC ATTTCGGCCATCTATCAAAATAAATGTCTAAAAGTTTTGTGGTCGTCTTAAATA CTACTTCGAGTTCAGACGTATACGTCTCACCAAAGTAATGCACATACTTGATGT TAAGTTTATCTCTTTTTACTATTTCAAATTTCGCGTTTGACAACACTTTAAGTC TACATTATCCATAGAGAATATAACATAAAGATCATGAACTTCTCATGAATGTAT AAGACAAATCAAGCTTATATATGAGATCTATTTAGTAATTTGATATGTATGTAA TATATGATAAATCTTTGATGCAATATTTTATTATGATTATTAGATATACACTAG TCAACTTTAACTTTAGAAGATTAATCATTCCGTCGCAAACCATACCATAAATTA GCAAGGGATCGACTTAATATCTCCGATCCGCTATATATTTAAGAAGCATTTAGA TTGTTTATAATACATGTCATGATTTTATAATTATGTATATATAAATACTAATTG ATGTATGAAGTACGTAGATAATGTTACGATCTATTAATCTATTTACATTAACTT TTAATTAGTGTTGAGTAGGGAAAATTAACATATAAACCTTTAGCAGTTGGTTGT ATTATTAAAAATAATTTGAACTTAAAATCCACCTTCGAAAAGATAAATCAAACA AGTATAAAAAATGCTATAAATCCAGAATATTTACCTAAGGTTTTTATTCTTCTA CTTAATAATGTAAGATAAAACCGGCACAATACTTGTTACGTATGCATGGTAGGT ACCGCAATTGTGTAAGCAAATCGGCACAATACTAAGGTTACATATACTAACTAA ATAAAACAATCTGATTTCAGTGACACCGTATATCTAACCTTTATTCAAATCCAA GGGAACATGACTTGACTTCTTCTGTTGGAACTAACTCGATCCCTCAACCATCTC CAGGGATAGAAGAGTTAGTAAAATCAAACTTGAAGTGAGGAAGTAAGCAGTTTA ACGACTCCATATGACTACAGTTATATACAAAGTTGGGCACAAAGTACAAGTACT AAATACTCAAAGTCAGATAATAATTTTAATAAGTACAAACTATATATATGCAGT ACAATTATTGAGTATATATAAACGAGACTGGTGATTTGGGGCATTGTCCACCAG GGTGTTATATCCCAATTGAAATTTGAAAATTTAAGTGTGTGAGTGTTACGACAA AAAAAAGTGTGTGAATTGTAGGCGCGGTGAAAAGGTAAATTAAGATTGGAACTA GAAAAATAGTTGAATATCCTTTACTAAAAGTTGTCAATTCCGGTTTTAGTAAAA AAAAATTTTAAAATAGAAATTTTATCCAAAAGACTTCAAACACACATATTCGCA TATATAACATAAGATATCATTTTTTGTAAACAGTTAAAAAGAAAAACACATGTT TTTTTITTTAATTTAGAAAAAAACATGTTATTATACAAAACAGAGTTTTGCCCA CTTTTAATATGTTATGAAAAGAAAAATGATTTTCTTGGGTTTGGTCAGAGAGAT TGGTTGTGGTAAGAATGGGAATCTTAATTACAAAGAATTGGATTTTGGGTCGAC CTACCACCTAAAACGACGTCGCCTCCATCTCTGGTTTCCAAATCTCTTTCTCCT CTCCCTTTATAAGCTTGCGTTGGCCAGTCGCTCATCTCGAAAACAGAGAGAAAA AGACTAAAAACACAGTTTAAGAAGAAGGAGAGATAGAGAGAGAAGAGAAAGATA GAGAGGGAG SEQ ID NO: 61 Polynucleotide sequence PATLAC17 TAAGTTTAAGTCCAATAATTTCATTTTACTAGTAAAGATCACAATGTCATTTACC GCATTCACTTAATAATTGCTGAATTCACATAGTGCCTGTAAATTAAGACTAATTT TAGGTTTCAAATAATTTTTCTTTTTTACATAACTTACGATCGATATTTTAAATGG TATTGGTAAGTTTAAGGTATATAGATAGTGTGTCTAAACTAGAGTTCGTTGAAAT TGGTCTGAGGTATAAATACCTAAAAGGTTATATATGTTTTTAGTTTAATGTAATT CGATAAATTTTAGTCGAAACCGTTAAGAGATATCAGAATTTCGTTTTCAAATAAT ATGGGATATAATTACCCGGGATTAACCGTACCTGATAAAATATAGCTCTCGTACG TGTCACATGCCTAATGCCTAGTTAAACTTAAAACGAATATCTATATTTACTGTTA TTGATTGTGAGTTACCAACTAAAATATTGTTAAAAGACATTGTAAAACTACAAAT GGTTCGAACTGTATACTAATGATGTAAACTCGTGTTTCATCGTTATGTCCGATAT TTTTTTCATTCAACCATTATTCAATTTCAAGATTTCTTTATTGTCTTTTTTTCTT TCTAGAAAGCCTATATATTTAATTACCCACTTTGCATATTCAGAGGATAAGTTGA TACGTACTTGTTAGCAACCTGTCTAGATCATCTTTTGATTGTAGATTTGACTTTA AATTTCTCACAATTATAAATATGAAAAATAACAAGCAAAGAATTTACAAATGTAT ATAATTATATACACGCATTGATGAATAAACATATTTAGAAAATAATGTGTTCTAA GGAAATTTTGTGGCATTTTTTAAAAAATAATTAAACAAATAAGAATAGTGTAAAG TTGTTTAAATATGTATGTATAAGTGGCATGCCTTTGAGGATACGAACTTAAAAGG GAGTTAGGTAACTTGCTTGGGAAATAAAATAGCCAACCTTAATTTGAGGTTTCCT CAATGTTCTTATCAAAAAGAATAAAAATTTCGGAAATTCCCTTCATGGATTTTGA TATCTAACCCTAATCGTGACCTTCTTTGATAGCTACAATCTCCCTCTCTTTGCTT ATTCCCCAAGCAATTTTAGCTTACGAATGTTTTGACTAACTCCACATCGGTTTAT CTCTTAAGTTCCCCACCTACAAATATACAAAAAAAGAAGTAAAATAAAAATAATT ATTAACAAACCGATGAAGTACTTATCATTTATAAACATGCTTATGAAATGTATTT TCTAAAACATAACCGCTAACCAGAGAAGTTTCCTAGAGTTCTGCTTCAGACTCTT TTGGTCGATCAAGAAGTCTCCAAGAGTTGTTTTTGTTGGGTCTAAACAAAACTTG GCCAGGGAACAAATCAAACTATATTATTAATCTTCTACATCTGGTCCTAAGTTCC TTACTATCTCATGTTAAAATTTGAAGTCTAATATACTCAAAGCTGTCAAAGAAGC AGAACATGGAAGAGGAACTGTCATATCTGAGAAACCAAAATTGGCAATCTTGCAT TTCATATTTAGAATCTACGCCATAGTATTGAGATGGAAACAAAGAGTTTTCGAAG AGGGTCAAAGAGTTTGACTTATCTTTGACACCACTCATACATTAGCTGTTCATAT AATCTAACAACTAGTCAATATCAAGTGTCTCCAAATTACGGAGAGTACTTCTCTA CCAATTATCTTTTTGTTTTTCATAAACATTTTACTAATTGTTTTTTCTATATCTC CTGCTCAAGCAAACACCTAACTCTCCTTTCCTATATATACACTAAAGGTTGAAAA CAATGAATCCACAATCTACAGCAAAACATAAGCGAGGCAGAGTCTTCAGAAAACT TACCTGCTCTAAACAACGCCTCCGTGTCCAAGCTCACTTCA -
TABLE I In-vitro HCHL enzyme activities in stems of five-week-old wild type (WT) and IRX5:HCHL plants. Values are means of three biological replicates. Enzyme activity ± SE Plant line (pkat vanillin μg−1 protein) WT nda IRX5:HCHL (1) 0.112 ± 0.026 IRX5:HCHL (2) 0.075 ± 0.022 IRX5:HCHL (3) 0.042 ± 0.006 IRX5:HCHL (4) 0.160 ± 0.038 IRX5:HCHL (5) 0.025 ± 0.002 and, not detected. -
TABLE II Height of the main inflorescence stem and total stem dry weight of senesced wild type (WT) and IRX5:HCHL plants. n, number of plants analyzed. Asterisks indicate significant differences from the wild-type (*, P < 0.05, **, P < 0.01, ***, P < 0.001). Height (cm) Dry weight (mg) Plant line Mean ± SE Mean ± SE n WT 62.4 ± 4.6 477.7 ± 51.3 16 IRX5:HCHL (1) 60.3 ± 5.0 501.6 ± 62.8 14 IRX5:HCHL (2) 56.0 ± 4.6 435.3 ± 62.5 12 IRX5:HCHL (4) 48.3 ± 4.4*** 335.7 ± 63.4*** 15 IRX5:HCHL (5) 54.1 ± 7.6** 399.1 ± 61.1* 16 -
TABLE III Quantitative analysis of soluble phenolics in stems from five-week-old wild type (WT) and IRX5:HCHL plants. Values are means of four biological replicates. Mean ± SE (μg g−1 fresh weight) Plant line HBAld 3,4-DHBAld HBA HBAGlc HBAGE WT nda nda nda 2.32 ± 0.20 1.34 ± 0.41 IRX5:HCHL (1) 1.02 ± 0.07 0.33 ± 0.02 5.53 ± 0.36 544.87 ± 157.79 1653.74 ± 504.38 IRX5:HCHL (2) 0.62 ± 0.08 0.23 ± 0.02 4.77 ± 0.41 569.23 ± 138.73 1046.97 ± 439.35 IRX5:HCHL (4) 0.83 ± 0.18 0.29 ± 0.03 4.64 ± 0.57 484.06 ± 74.23 959.79 ± 189.25 IRX5:HCHL (5) 1.04 ± 0.09 0.34 ± 0.02 5.59 ± 0.27 531.29 ± 51.13 1360.03 ± 178.03 and, not detected -
TABLE IV Quantitative analysis of acid-hydrolyzed soluble phenolics in stems from five-week-old wild type (WT) and IRX5:HCHL plants. Values are means of four biological replicates. Mean ± SE (μg g−1 fresh weight) 3,4- 3,4- Plant line HBAld DHBAld Van 5OH-Van SyrAld HBA DHBA VA 5OH-VA SyrA WT 0.6 ± 0.1 0.1 ± 0.0 nda nda nda 14.0 ± 2.8 10.2 ± 2.7 5.0 ± 0.9 nda nda IRX5:HCHL 11.8 ± 2.1 14.3 ± 2.0 11.9 ± 3.8 24.3 ± 2.0 1.7 ± 0.0 2492.4 ± 534.9 17.3 ± 2.4 226.9 ± 32.6 8.1 ± 0.7 44.7 ± 7.6 (1) IRX5:HCHL 5.7 ± 1.5 10.4 ± 2.6 3.9 ± 1.28 12.4 ± 6.1 1.6 ± 0.1 1726.1 ± 706.7 13.7 ± 3.4 175.9 ± 37.1 6.2 ± 1.5 45.9 ± 10.9 (2) IRX5:HCHL 7.2 ± 0.8 9.9 ± 0.6 6.4 ± 1.26 10.7 ± 1.7 1.7 ± 0.1 1588.3 ± 181.1 15.4 ± 1.7 183.6 ± 19.0 5.8 ± 0.3 31.3 ± 2.4 (4) IRX5:HCHL 9.9 ± 1.2 12.8 ± 0.7 8.0 ± 1.73 16.9 ± 2.5 1.9 ± 0.1 2061.3 ± 336.2 16.4 ± 1.2 202.3 ± 9.2 7.0 ± 0.5 39.5 ± 3.2 (5) and, not detected. -
TABLE V Quantitative analysis of cell wall-bound phenolics in stems from extract-free senesced mature dried wild type (WT) and IRX5:HCHL plants. Values are means of four biological replicates. Mean ± SE (μg g−1 dry weight) 3,4- 3,4- Plant line HBAld DHBAld Van 5OH-Van SyrAld HBA DHBA VA 5OH-VA SyrA WT 5.8 ± 0.6 1.1 ± 0.0 59.4 ± 6.5 nda 17.8 ± 1.0 6.2 ± 0.9 nda 24.2 ± 2.0 nda 10.6 ± 0.3 IRX5:HCHL 11.1 ± 0.4 0.6 ± 0.0 36.9 ± 2.7 0.8 ± 0.1 107.8 ± 6.4 486.4 ± 28.2 nda 42.2 ± 3.2 nda 47.5 ± 2.3 (1) IRX5:HCHL 8.9 ± 0.4 0.6 ± 0.0 25.7 ± 5.9 0.6 ± 0.1 99.9 ± 4.6 427.9 ± 49.3 nda 39.6 ± 1.9 nda 43.3 ± 0.9 (2) IRX5:HCHL 9.1 ± 0.9 0.7 ± 0.0 29.9 ± 2.7 0.8 ± 0.1 122.2 ± 14.8 421.8 ± 28.2 nda 36.8 ± 1.4 nda 54.1 ± 6.1 (4) IRX5:HCHL 9.1 ± 0.7 0.7 ± 0.0 45.6 ± 6.2 0.7 ± 0.0 122.4 ± 5.9 349.6 ± 27.6 nda 47.7 ± 3.0 nda 59.3 ± 3.1 (5) and, not detected. -
TABLE VI Chemical composition of total and hemicellulosic cell wall sugars in senesced mature dried stems from wild type (WT) and line IRX5:HCHL (2). Values are means ± SE of three biological replicates. Asterisks indicate significant differences from the wild type (P < 0.001). Mean ± SE (mg g−1 CWR) Total Sugars Hemicellulosic Sugars Sugar WT IRX5:HCHL WT IRX5:HCHL Fucose 2.23 ± 0.08 2.21 ± 0.05 1.44 ± 0.03 1.49 ± 0.05 Rhamnose 10.83 ± 0.35 11.71 ± 0.19 9.12 ± 0.23 9.76 ± 0.26 Arabinose 16.01 ± 0.56 18.58 ± 0.54* 10.15 ± 0.30 12.40 ± 0.38* Galactose 23.06 ± 0.66 22.69 ± 0.82 15.34 ± 0.33 16.49 ± 0.50 Glucose 442.76 ± 7.09 388.66 ± 7.58* 10.09 ± 0.34 11.25 ± 0.33 Xylose 201.63 ± 1.71 245.20 ± 3.31* 114.39 ± 0.97 141.16 ± 4.20* Galacturonic acid 93.74 ± 2.56 99.96 ± 1.52 37.13 ± 1.86 40.58 ± 1.12 Glucuronic acid 4.10 ± 0.16 4.60 ± 0.39 2.66 ± 0.17 3.12 ± 0.09 Total 794.36 ± 13.17 793.61 ± 14.85 191.32 ± 4.23 236.25 ± 6.93* -
TABLE VII Lignin content and main H, G and S lignin-derived monomers obtained by thioacidolysis of extract-free senesced mature dried stems from wild-type (WT) and line IRX5:HCHL (2). Values are means ± SE from duplicate analyses. Total yield Klason lignin (H + G + S) Plant line KL % of CWR μmol g−1 KL % H % G % S S/ G Culture 1 WT 20.42 ± 0.14 1356 ± 40 0.98 ± 0.00 73.2 ± 0.3 25.9 ± 0.3 0.35 ± 0.01 IRX5:HCHL 20.12 ± 0.15 1014 ± 5 1.48 ± 0.04 73.7 ± 0.5 25.2 ± 0.3 0.34 ± 0.01 Culture 2WT 20.32 ± 0.25 1238 ± 13 1.09 ± 0.00 73.8 ± 0.3 25.2 ± 0.3 0.34 ± 0.01 IRX5:HCHL 21.29 ± 0.14 1041 ± 7 1.47 ± 0.00 72.7 ± 0.1 25.9 ± 0.1 0.36 ± 0.00 -
TABLE VIII Minor monomers obtained by thioacidolysis of extract-free mature senesced dried stems from wild-type (WT) and line IRX5:HCHL (2). Values are means ± SE of duplicate analyses. Values are expressed in μmol g−1 KL and as a relative percentage of the total main H, G and S monomers released by thioacidolysis. Vanalc Syralc Van Syrald Cald VA SyrA μmol g−1 KL μmol g−1 KL μmol g−1 KL μmol g−1 KL μmol g−1 KL μmol g−1 KL μmol g−1 KL Plant line (% H + G + S) (% H + G + S) (% H + G + S) (% H + G + S) (% H + G + S) (% H + G + S) (% H + G + S) Culture 1 WT nd* nd* 4.3 ± 1 0.9 ± 0.3 7.2 ± 0.6 6.7 ± 0.2 1.4 ± 0.0 IRX5:HCHL 5.0 ± 0.1 2.6 ± 0.2 (0.31) (0.06) (0.53) (0.49) (0.10) (0.49) (0.25) 6.5 ± 1.4 18.7 ± 3.5 7.9 ± 0.3 6.8 ± 0.2 2.2 ± 0.0 (0.64) (1.84) (0.77) (0.67) (0.21) Culture 2 WT nd* nd* 4.6 ± 0.7 0.8 ± 0.3 6.9 ± 0.1 6.2 ± 0.2 1.2 ± 0.0 IRX5:HCHL 5.3 ± 0.1 2.9 ± 0.1 (0.37) (0.06) (0.55) (0.50) (0.09) (0.50) (0.28) 6.3 ± 0.7 16.7 ± 1.9 6.8 ± 0.1 7.0 ± 0.0 2.1 ± 0.0 (0.60) (1.60) (0.66) (0.65) (0.20) *nd, not detected. -
TABLE IX Comparative transcriptomics of IRX5:HCHL stems and WT. Positive and negative ratios are indicative of upregulation and downregulation of the gene in plants expressing HCHL. AGI Gene ID Annotated Function log2 ratio P value MONOOXYGENASES AT1G62570 flavin-containing monooxygenase family protein 0.00E+0 AT3G28740 cytochrome P450 family protein 0.00E+0 AT4G15760 monooxygenase, putative (MO1) 0.86 AT4G37370 CYP81D8 0.72 1.20E−7 AT3G28740 cytochrome P450 family protein 0.70 5.58E−7 AT2G12190 cytochrome P450, putative 0.65 8.60E−6 AT1G69500 CYP704B1 0.58 7.38E−4 AT3G14610 CYP72A7 0.51 2.96E−2 DEHYDROGENASES/REDUCTASES AT4G13180 short-chain dehydrogenase/reductase (SDR) family protein 0.00E+0 AT2G37770 aldo/keto reductase family protein, Transcript variant 1 0.00E+0 AT2G37770 aldo/keto reductase family protein, Transcript variant 2 0.96 0.00E+0 AT2G29350 SAG13 (Senescence-associated gene 13); short-chain dehydrogenase/reductase (SDR) family protein 0.83 AT1G14130 2-oxoglutarate and Fe(II)-dependent oxygenese superfamily protein 0.72 9.59E−8 AT1G72680 cinnamyl-alcohol dehydrogenase, putative 0.90 0.00E+0 AT1G60730 aldo/keto reductase family protein 0.65 8.30E−6 AT1G18020 FMN-linked oxidoreductases superfamily protein, Transcript variant 1 0.62 7.14E−5 AT1G18020 FMN-linked oxidoreductases superfamily protein; Transcript variant 2 0.59 4.38E−4 AT2G47130 short-chain dehydrogenase/reductase (SDR) family protein, Transcript variant 1 0.58 7.60E−4 AT2G47130 short-chain dehydrogenase/reductase (SDR) family protein, Transcript variant 2 0.58 8.36E−4 AT1G18020 FMN-linked oxidoreductases superfamily protein, Transcript variant 3 0.54 6.80E−3 AT5G14780 FDH (FORMATE DEHYDROGENASE); NAD binding/oxidoreductase, acting the CH—OH group of donors 0.53 1.24E−2 AT1G54100 ALDH7B4 (ALDEHYDE DEHYDROGENASE 7B4); 3-chloroallyl aldehyde dehydrogenase 0.51 3.00E−2 UDP-GLUCOSYLTRANSFERASES AT1G05560 UGT75B1 0.00E+0 AT2G15490 UGT73B4 0.00E+0 AT4G34138 UGT73B1 0.00E+0 AT2G30140 UGTB7A2 0.79 AT4G34131 UGT73B3 0.58 8.09E−4 AT3G11340 UGT76B1 0.58 8.97E−4 AT4G01070 UGT72B1 0.52 2.00E−2 TRANSPORTERS AT3G23560 ALF5 (ABERRANT LATERAL ROOT FORMATION 5), antiporter/transporter 0.00E+0 AT2G36380 PDR6 (PLEIOTROPIC DRUG RESISTANCE 6) ATPase, coupled to transmembrane movement of substances 0.00E+0 AT3G51860 CAX3 (cation exchanger 3); cation; cation antiporter 0.00E+0 AT5G65380 Multidrug and toxic compound extrusion (MATE) efflux family protein 0.92 0.00E+0 AT1G79410 ATOCT5 (organic cation/carnitine transporter 5) 0.89 0.00E+0 AT5G13750 ZIFL1 (ZINC INDUCED FACILITOR-LIKE 1); tetracycline:hydrogen antiporter/transporter 0.78 AT1G76520 auxin efflux carrier family protein 0.70 4.27E−7 AT1G76530 auxin efflux carrier family protein 0.69 8.91E−7 AT4G18197 AT4G18200/PUP7 (purine permease 7); purine transporter 0.64 1.62E−5 AT4G28390 AAC3 (ADP/ATP CARRIER 3); ATP:ADP antiporter/binding 0.62 6.57E−5 AT5G45380 DUR3 (DEGRADATION OF UREA 3); sodium:solute:symporter family protein 0.61 1.05E−4 AT3G18830 PLT5 (POLYOL TRANSPORTER 5) 0.57 1.56E−3 AT2G17500 auxin efflux carrier family protein 0.55 3.26E−3 DETOXIFICATION AT1G17170 ATGSTU24 (Glutathione S-transferase (class tau) 24) 0.00E+0 AT2G29420 ATGSTU7 (GLUTATHIONE S-TRANSFERASE 25) 0.00E+0 AT2G47730 ATGSTF8 (GLUTATHIONE S-TRANSFERASE 8) 0.00E+0 AT4G02520 ATGSTF2 (Glutathione S-transferase (class phi) 2) 0.78 AT3G09270 ATGSTU8 (Glutathione S-transferase (class tau) 8) 0.65 1.43E−5 AT2G29490 ATGSTU1 (GLUTATHIONE S-TRANSFERASE 19) 0.54 7.21E−3 AT4G19880 unknown protein, Glutathione S-transferase family protein 0.76 AT5G39050 ATPMaT1 (phenolic glucoside malonyltransferase 1); transferase family protein 0.77 AT5G39090 ATPMaT1-like; transferase family protein 0.52 2.13E−2 JASMONIC ACID METABOLISM AT1G76680 OPR1 (12-oxophytodienoate reductase 1) 0.00E+0 AT5G54206 12-oxophytodienoate reductase-related 0.99 0.00E+0 STRESS INDUCIBLE/DEFENSE/SENESCENCE AT5G49480 ATCP1 (CA2+-BINDING PROTEIN 1); calcium ion binding, NaCl stress inducible 0.00E+0 AT1G35260 Bet v I allergen family protein, defense response 0.88 0.00E+0 AT3G62550 universal stress protein (USP) family protein, Adenine nucleotide alpha-like protein 0.87 0.00E+0 AT1G73500 ATMKK9 (Arabidopsis thaliana MAP kinase kinase 9) 0.80 AT4G02380 SAG21 (SENESCENCE-ASSOCIATED GENE 21) 0.77 AT3G04720 PR4 (PATHOGENESIS-RELATED 4), similar to the antifungal chitin-binding protein hevein 0.64 2.04E−5 AT1G75270 DHAR2; glutathione dehydrogenase (ascorbate) 0.61 1.17E−4 AT1G70530 CRK3 (CYSTEINE-RICH RLK (RECEPTOR-LIKE PROTEIN KINASE) 3), protein kinase family protein 0.60 2.36E−4 AT3G50970 LTI3O/XERO2 (LOW TEMPERATURE-INDUCED 30); dehydrin stress-related 0.58 8.28E−4 AT5G27760 hypoxia-responsive family protein 0.54 6.87E−3 AT3G56710 SIB1 (SIGMA FACTOR BINDING PROTEIN 1); binding 0.51 2.30E−2 MISCELLANEOUS Transcription factor AT5G63790 ANAC102 (Arabidopsis NAC domain containing protein 102); transcription factor. Transcript variant 1 0.00E+0 AT1G77450 ANAC032 (Arabidopsis NAC domain containing protein 32); transcription factor 0.00E−0 AT5G63790 ANAC102 (Arabidopsis NAC domain containing protein 102); transcription factor, Transcript variant 2 0.65 1.26E−5 AT1G01720 ATAF1 (Arabidopsis NAC domain containing protein 2); transcription factor 0.54 7.23E−3 Glycine-rich protein AT2G05380 GRP3S (GLYCINE-RICH PROTEIN 3 SHORT ISOFORM) Transcript variant 1 0.00E+0 AT2G05380 GRP3S (GLYCINE-RICH PROTEIN 3 SHORT ISOFORM) Transcript variant 2 0.00E+0 AT2G05530 glycine-rich protein 0.96 0.00E+0 AT2G05540 glycine-rich protein 0.90 0.00E+0 Auxin metabolism AT3G44300 NIT2 (NITRILASE 2) 0.00E+0 AT3G44310 NIT1 (NITRILASE 1) 0.51 3.32E−2 Other AT5G30870 transposable element gene; pseudogene, hypothetical protein 0.00E+0 AT3G14990 4-methyl-5(b-hydroxyethyl)-thiazole monophosphate biosynthesis protein, putative 0.00E+0 AT1G65280 heat shock protein binding/unfolded protein binding 0.00E+0 AT4G16190 cysteine proteinase, putative 0.89 0.00E+0 AT1G02850 glycosyl hydrolase family 1 protein BGLU11 0.86 AT1G17860 trypsin and protease inhibitor family protein/Kunitz family protein 0.86 AT3G49780 ATPSK4 (PHYTOSULFOKINE 4 PRECURSOR); growth factor 0.82 AT2G41380 embryo-abundant protein-related, methyltransferase activity 0.82 AT3G24420 hydrolase, alpha/beta fold family protein 0.79 AT5G52810 ornithine cyclodeaminase/mu-crystallin family protein 0.67 2.65E−6 AT5G17380 pyruvate decarboxylase family protein 0.64 1.84E−5 AT1G23890 NHL repeat-containing protein 0.59 3.35E−4 AT4G28380 leucine-rich repeat family protein, zinc ion binding 0.59 3.52E−4 AT4G01870 tolB protein-related 0.59 4.41E−4 AT1G37130 NIA2 (NITRATE REDUCTASE 2) 0.62 6.75E−5 AT1G24610 SET domain-containing protein, unknown protein 0.58 9.14E−4 AT4G11600 ATGPX6 (GLUTATHIONE PEROXIDASE 6); glutathione peroxidase 0.52 1.83E−2 UNKNOWN AT5G61820 unknown protein 0.00E+0 AT1G76600 unknown protein 0.00E+0 AT1G76960 unknown protein 0.71 2.01E−7 AT4G17840 unknown protein 0.67 2.77E−6 AT1G21680 unknown protein 0.61 1.38E−4 AT5G40960 unknown protein, DUF3339 0.59 5.08E−4 AT4G08555 unknown protein 0.58 8.16E−4 AT2G30690 unknown protein, DUF593 0.53 8.86E−3 AT5G66052 unknown protein 0.50 4.05E−2 CARBOHYDRATE METABOLISM AT2G06850 EXGT-A1 (ENDO-XYLOGLUCAN TRANSFERASE); hydrolase, acting on glycosyl bonds −0.51 2.51E−2 AT3G52840 BGAL2 (beta-galactosidase 2), Glycoside hydrolase family 35, putative lactase −0.52 1.83E−2 AT3G01345 Glycoside hydrolase family 35, beta-galactosidase putative −0.53 1.13E−2 AT3G53190 pectate lyase family protein −0.56 1.69E−3 AT5G03350 legume lectin family protein, carbohydrate binding −0.57 1.28E−3 AT1G26810 GALT1 (galactosyltransferase 1), Glycoside transferase family 31 −0.61 1.02E−4 AT1G19600 pfkB-type carbohydrate kinase family protein −0.63 3.41E−5 AT4G28250 ATEXPB3 (ARABIDOPSIS THALIANA EXPANSIN B3) −0.79 AT3G30720 unknown protein, QUA-QUINE STARCH (QQS) −1.08 0.00E+0 MISCELLANEOUS AT4G27440 PORB (PROTOCHLOROPHYLLIDE OXIDOREDUCTASE B); protochlorophyllide reductase −0.50 4.45E−2 AT5G02890 HXXXD-type acyl-transferase family protein −0.50 3.86E−2 AT1G18950 aminoacyl-tRNA synthetase family −0.51 3.29E−2 AT5G47330 palmitoyl protein thioesterase family protein −0.53 1.07E−2 AT1G03870 FLA9 (FLA9) −0.54 4.82E−3 AT1G20530 unknown protein, DUF630 and DUF632 −0.55 4.67E−3 ATCG00470 ATP SYNTHASE EPSILON CHAIN, rotational mechanism −0.55 3.12E−3 AT5G51720 unknown protein, 2 iron, 2 sulfur cluster binding −0.56 2.02E−3 ATCG00330 RPS14, CHLOROPLAST RIBOSOMAL PROTEIN S14 −0.58 8.70E−4 ATCG00340 D1 subunit of photosystem I and II reaction centers, Transcript variant 1 −0.62 5.42E−5 AT2G38870 serine-type endopeptidase inhibitor activity, pathogenesis-related peptide of the PR-6 proteinase inhibitor family −0.64 1.54E−5 ATCG00340 D1 subunit of photosystem I and II reaction centers, Transcript variant 2 −0.71 2.75E−7
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/232,018 US20150013033A1 (en) | 2011-07-13 | 2012-07-13 | Lignification reduction in plants |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161507484P | 2011-07-13 | 2011-07-13 | |
US14/232,018 US20150013033A1 (en) | 2011-07-13 | 2012-07-13 | Lignification reduction in plants |
PCT/US2012/046764 WO2013010124A1 (en) | 2011-07-13 | 2012-07-13 | Lignification reduction in plants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/046764 A-371-Of-International WO2013010124A1 (en) | 2011-07-13 | 2012-07-13 | Lignification reduction in plants |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/396,580 Continuation US11085048B2 (en) | 2011-07-13 | 2019-04-26 | Lignification reduction in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150013033A1 true US20150013033A1 (en) | 2015-01-08 |
Family
ID=47506591
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/232,018 Abandoned US20150013033A1 (en) | 2011-07-13 | 2012-07-13 | Lignification reduction in plants |
US16/396,580 Active US11085048B2 (en) | 2011-07-13 | 2019-04-26 | Lignification reduction in plants |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/396,580 Active US11085048B2 (en) | 2011-07-13 | 2019-04-26 | Lignification reduction in plants |
Country Status (4)
Country | Link |
---|---|
US (2) | US20150013033A1 (en) |
CN (2) | CN103827299A (en) |
BR (1) | BR112014000570A2 (en) |
WO (1) | WO2013010124A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10253324B2 (en) | 2015-09-30 | 2019-04-09 | The United States Of America, As Represented By The Secretary Of Agriculture | Genetically altered alfalfa producing clovamide and/or related hydroxycinnamoyl amides |
US11825472B2 (en) | 2020-12-09 | 2023-11-21 | Samsung Electronics Co., Ltd. | ACK-NACK PUCCH dropping schemes for TDD cell |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10415052B2 (en) * | 2013-03-15 | 2019-09-17 | The Regents Of The University Of California | Tissue specific reduction of lignin |
WO2014209792A1 (en) * | 2013-06-24 | 2014-12-31 | North Carolina State University | Methods and compositions for improvement in seed yield |
JP2020141576A (en) * | 2019-03-04 | 2020-09-10 | 公立大学法人 富山県立大学 | Biosynthesis method of hydroxybenzoic acid derivative |
CN112921049B (en) * | 2021-02-06 | 2024-01-23 | 石河子大学 | Gene segment for producing vanillin, saccharomyces cerevisiae engineering bacteria and construction method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035999A2 (en) * | 1996-03-23 | 1997-10-02 | Institute Of Food Research | Production of vanillin |
US20050086712A1 (en) * | 2003-10-17 | 2005-04-21 | Knut Meyer | Method to produce para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promoter |
US20080076159A1 (en) * | 2006-07-10 | 2008-03-27 | Dyadic International, Inc. | Methods and Compositions for Degradation of Lignocellulosic Material |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101191445B1 (en) | 2005-09-30 | 2012-10-16 | 엘지디스플레이 주식회사 | Liquid crystal display and method for manufacturing the same |
-
2012
- 2012-07-13 CN CN201280044622.3A patent/CN103827299A/en active Pending
- 2012-07-13 US US14/232,018 patent/US20150013033A1/en not_active Abandoned
- 2012-07-13 BR BR112014000570A patent/BR112014000570A2/en not_active Application Discontinuation
- 2012-07-13 WO PCT/US2012/046764 patent/WO2013010124A1/en active Application Filing
- 2012-07-13 CN CN201810108707.2A patent/CN108130344A/en active Pending
-
2019
- 2019-04-26 US US16/396,580 patent/US11085048B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035999A2 (en) * | 1996-03-23 | 1997-10-02 | Institute Of Food Research | Production of vanillin |
US20050086712A1 (en) * | 2003-10-17 | 2005-04-21 | Knut Meyer | Method to produce para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promoter |
US20080076159A1 (en) * | 2006-07-10 | 2008-03-27 | Dyadic International, Inc. | Methods and Compositions for Degradation of Lignocellulosic Material |
Non-Patent Citations (6)
Title |
---|
Brown ((2006), Dissertation, University of California, Davis) * |
Guo et al (2004, Proc. Natl. Acad. Sci. USA vol. 101 pages 9205-9210) * |
Hisano In Vitro Cell.Dev.Biol.-Plant (2009) 45:306-313 * |
Kim et al. (Plant Molecular Biology (1994) vol. 24 pp.105-117 * |
Merali et al, Planta (2007) 225:1165-1178 * |
Ngo et al. in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pages 491-495) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10253324B2 (en) | 2015-09-30 | 2019-04-09 | The United States Of America, As Represented By The Secretary Of Agriculture | Genetically altered alfalfa producing clovamide and/or related hydroxycinnamoyl amides |
US10711278B2 (en) | 2015-09-30 | 2020-07-14 | The United States Of America, As Represented By The Secretary Of Agriculture | Genetically altered alfalfa producing clovamide and/or related hydroxycinnamoyl amides |
US11825472B2 (en) | 2020-12-09 | 2023-11-21 | Samsung Electronics Co., Ltd. | ACK-NACK PUCCH dropping schemes for TDD cell |
Also Published As
Publication number | Publication date |
---|---|
US20190300895A1 (en) | 2019-10-03 |
CN103827299A (en) | 2014-05-28 |
US11085048B2 (en) | 2021-08-10 |
BR112014000570A2 (en) | 2017-02-14 |
WO2013010124A1 (en) | 2013-01-17 |
CN108130344A (en) | 2018-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11085048B2 (en) | Lignification reduction in plants | |
Eudes et al. | Biosynthesis and incorporation of side‐chain‐truncated lignin monomers to reduce lignin polymerization and enhance saccharification | |
US20220380790A1 (en) | Spatially modified gene expression in plants | |
US11873498B2 (en) | Tissue specific reduction of lignin | |
Rohde et al. | Molecular phenotyping of the pal1 and pal2 mutants of Arabidopsis thaliana reveals far-reaching consequences on phenylpropanoid, amino acid, and carbohydrate metabolism | |
Lin et al. | UDP‐glycosyltransferase 72B1 catalyzes the glucose conjugation of monolignols and is essential for the normal cell wall lignification in Arabidopsis thaliana | |
Berthet et al. | Disruption of LACCASE4 and 17 results in tissue-specific alterations to lignification of Arabidopsis thaliana stems | |
Anderson et al. | Manipulation of guaiacyl and syringyl monomer biosynthesis in an Arabidopsis cinnamyl alcohol dehydrogenase mutant results in atypical lignin biosynthesis and modified cell wall structure | |
Bouvier d'Yvoire et al. | Disrupting the cinnamyl alcohol dehydrogenase 1 gene (Bd CAD 1) leads to altered lignification and improved saccharification in Brachypodium distachyon | |
Fernández‐Pérez et al. | The suppression of AtPrx52 affects fibers but not xylem lignification in Arabidopsis by altering the proportion of syringyl units | |
Vanholme et al. | Lignin engineering | |
Behr et al. | Insights into the molecular regulation of monolignol-derived product biosynthesis in the growing hemp hypocotyl | |
US11326178B2 (en) | P-coumaroyl-CoA:monolignol transferase | |
Serrani-Yarce et al. | Targeting hydroxycinnamoyl CoA: shikimate hydroxycinnamoyl transferase for lignin modification in Brachypodium distachyon | |
Wan et al. | Mutant transcriptome sequencing provides insights into pod development in peanut (Arachis hypogaea L.) | |
US11807876B2 (en) | P-coumaroyl-CoA:monolignol transferases | |
US9834776B2 (en) | Method for modifying lignin biosynthesis in plants | |
US10202614B2 (en) | Digestibility of plant biomass | |
US10745707B2 (en) | Digestibility of plant biomass | |
US20120192312A1 (en) | Production of Plants with Reduced Lignin Content | |
US20140331363A1 (en) | Plants with altered glucuronoxylan methyl transferase activity and methods of use | |
Cong | A strategy to facilitate the conversion of lignocellulose to bioethanol via lignin modification | |
Frankman | Ferulate Cross-Linking and Conjugations: The Role of Ferulate in the Grass Cell Wall and Specialized Metabolism | |
Saleme et al. | Ligniication and Improves Sacchariication in Poplar | |
Tateno | Investigation into the Cell Wall and Cellulose Biosynthesis in Model Species and in the C4 Model Plant Setaria viridis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOQUE, DOMINIQUE;EUDES, AYMERICK;SIGNING DATES FROM 20140221 TO 20140311;REEL/FRAME:032686/0673 |
|
AS | Assignment |
Owner name: ENERGY, UNITED STATES DEPARTMENT OF, DISTRICT OF C Free format text: CONFIRMATORY LICENSE;ASSIGNOR:REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE;REEL/FRAME:032799/0646 Effective date: 20140311 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |